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Summary 
This dissertation focuses mainly on the elucidation of the genetics and the proposed pathways for 
the production of 2DOS-containing and related aminocyclitol aminoglycoside antibiotics 
(ACAGAs). The following results using different strategies had been achieved: 
1) Homologous and heterologous probes were constructed for screening the cosmid banks and 
the positively hybridized cosmids were identified. Analysis of the respective cosmids (restriction 
analysis, PCR, cosmid mapping) was carried out to select one or more cosmids harboring the 
ACAGAs biosynthetic gene clusters (or part thereof) for sequencing; 
2) The insert sequences of a single or of overlapping cosmid clones were determined, analysed, 
sequenced and submitted to the EMBL gene bank and received the accession codes; 
3) The biosynthetic gene clusters for NM, RM, PM, LM, KM, TM, GM, FTM, IM, Apr and HM-
B have been fully sequenced and analyzed except the one for BU which was still incomplete; 
4) Further proposals of a general pathway design for the biosynthesis of the respective ACAGAs 
was made; 
5) A characteristic feature of the gen-, kan- and tob-clusters is that some of the centrally 
important genes, also conserved in the other ACAGAs gene clusters had been duplicated or even 
multiplied in the past, most probably in order to acquire new biosynthetic functions. 
Interestingly, analysis of the for-, gen- and kan-clusters gave a good evidence that GMs are 
products formed via a hybrid of KM/FTM pathway; 
6) Newly developed heterologous primers have been designed and tested for their efficiency via 
detection of various homologous biosynthetic genes in different ACAGAs producing strains; 
7) The three kanC, kanS1 and kanE genes were selected from the KM biosynthetic gene cluster 
for biochemical characterization of their encoded proteins. In order to achieve this goal, the three 
genes were cloned, heterologous expressed in E. coli and/or S. lividans TK23 followed by 
biochemical analysis of the expressed proteins. TLC, HPLC and spectrophotometric assays were 
the tools used for testing the respective enzyme activities; 
8) Results showed that kanC encodes a 2-deoxy-scyllo-inosose synthase, kanS1 encodes a 2-
deoxy-scyllo-inosose aminotransferase as well as, 1-keto-2,3-deoxy-3-amino-scyllo inositol 
aminotransferase [bifunctional enzyme] and kanE was high likely to encode a 2-deoxy-scyllo-
inosamine 1-dehydrogenase (in the presence of Zn++ ion and NAD). 
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Zusammenfassung 
Die Dissertation befaßt sich hauptsächlich mit der Aufklärung der Genetik und der postulierten 
Biosynthesewege der 2DOS- und verwandten Aminocyclitol-Aminoglykosid-Antibiotika 
(ACAGAs).  
Folgende Ergebnisse konnten mittels der beschriebenen Vorgehensweisen erzielt werden: 
1) Durch die Konstruktion homologer und heterologer Sonden (Primer) konnten aus den 
entsprechenden Cosmidbänken positiv hybridisierende Cosmide identifiziert werden. Die 
anschließenden Analysen (Restriktion, PCR, Cosmidkarte) wurde durchgeführt um die Cosmide für 
die Sequenzierung auszuwählen, die ACAGAs-Gencluster (oder Teile davon) enthielten; 
2) Die Insertsequenzen einzelner bzw. überlappender Cosmid-Klone wurde sequenziert, analysiert, 
und bei der EMBL Genbank eingereicht; 
3) Die Biosynthese-Gencluster für Neomycin, Ribostamycin, Paromomycin, Lividomycin, 
Kanamycin, Tobramycin, Gentamicin, Fortimicin, Istamycin, Apramycin und Hygromycin B wurden 
analysiert und vollständig sequenziert. Das Butirosin-Gencluster konnte nur teilweise charakterisiert 
werden; 
4) Weiterführende Aussagen über einen allgemeinen Biosyntheseweg für die entsprechenden 
ACAGAs konnten getroffen werden; 
5) Ein Charakteristikum der gen-, kan- und tob-Cluster ist, daß einige der zentral wichtigen Gene, 
ebenfalls konserviert in anderen ACAGAs Genclustern sind, in der Vergangenheit dupliziert oder 
sogar multipliziert wurden, und so neue biosynthetische Funktionen erworben wurden. 
Interessanterweise, ergab die Analyse der for-, gen- und kan-Cluster hohe Evidenz dafür, daß die 
Gentamicine Produkte sind, die aus einem Hybrid der Kanamycin/Fortimicin Biosynthesewege 
entstanden sind. 
6) Es wurden verschiedene heterologe Primer entwickelt um Biosynthesegene aus unterschiedlichen 
ACAGA produzierenden Stämmen zu detektieren und ihre Anwendbarkeit getestet; 
7) Aus dem Kanamycin Biosynthese-Gencluster wurden die drei Gene kanC, kanS1 und kanE 
ausgewählt, um die Genprodukte biochemisch zu charakterisieren. Um dies zu erreichen wurden die 
drei Gene kloniert und in E. coli und/oder S. lividans TK23 expremiert. Die entsprechenden 
Enzymaktivitäten wurden mit DC, HPLC und spektrophotometrischen Analysen belegt; 
8) kanC codiert für eine 2-Desoxy-scyllo-Inosose Synthase, kanS1 für eine 2-Desoxy-scyllo-Inosose 
Aminotransferase, sowie für eine 1-keto-2,3-Desoxy-3-Amino-scyllo-Inositol- Aminotransferase 
(bifunktionelles Enzym) und kanE für eine 2-Desoxy-scyllo-Inosamine-1-Dehydrogenase (in 
Anwesenheit von Zn++ Ionen und NAD). 
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1 Introduction 
 
1.1 Aminoglycoside antibiotics (AGAs) 
1.1.1 Definition 
AGAs are a heterogeneous chemical class of natural products composed of most strongly 
modified sugar units bound glycosidically (mono- to oligosaccharides) and cyclitol derivatives 
(aglycone) containing amino nitrogen (Umezawa et al., 1986; Rinehart et al., 1992; Piepersberg, 
1995 and 1997; Piepersberg and Distler, 1997). AGAs are idiolities (nonessential, low molecular 
weight compounds formed enzymatically by a limited number of species) synthesized by certain 
soil bacteria (Walker, 1995). The most important group of AGAs are produced by 
actinomycetes, bacilli and pseudomonades. However, the most currently known members are 
those produced by actinomycetes. AGAs are considered one of the most important classes of 
antibiotics both on the biological and industrial levels. Aminoglycosides including the non-
antibiotic members constitute a group of natural products which is heterogeneous with respect to 
their putative evolution and ecology as well as the biochemistry of the molecules and their 
action, presumed biosynthetic routes, primary metabolic sources, resistance of producers against 
their end products and regulation of their production (Umezawa and Hooper, 1982; Piepersberg 
et al., 2002). AGAs are both indispensable chemotherapeutics and interesting targets of basic 
research (Piepersberg, 1997). The most attractive aspects of aminoglycoside research are: i- the 
emergent genetic and biochemical data on their biosynthesis and regulation (Walker, 1971 and 
1995; Rinehart and Stroshane, 1976; Grisebach, 1978; Piepersberg, 1997; Piepersberg et al., 
2002); ii- the molecular mechanisms of resistance development in both producers and clinically 
relevant pathogens (Cundliffe, 1989; Shaw et al., 1993; Piepersberg, 1997); iii- the molecular 
aspects of interaction with cellular components in both prokaryotes and eukaryotes (Fong and 
Bergheim, 2002); iv- new fields of application and new pharmacologically relevant targets such 
as the successful glycosidase inhibitors (Piepersberg et al., 2002). In this study, the biosynthetic 
gene clusters of 2DOS-containing and related AGAs having antibacterial activity were studied. 
 
1.1.2 Classes of aminoglycoside antibiotics 
Aminocyclitol aminoglycoside antibiotics (ACAGAs) are considered the predominant 
representatives of the aminoglycoside group. They are classified according to the chemical nature  
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of the aminocyclitol moiety, the basic aglycone unit in all the ACAGAs into the following: 
 
A- Streptamine containing ACAGAs 
The streptomycins, historically marking the entrance to aminoglycoside research, are basically 
composed of a scyllo-inositol-derived aminocyclitol (streptidine or bluensidine) which formally 
are derived from streptamine, the 1,3-cis-diamino-cyclitol and sugar units glycosidically attached 
to this aglycone. Several other ACAGAs probably are biosynthetically related to the 
streptomycins as judged from the structure of their cyclitol moieties and other motifs: 
bluensomycin; ashimycin A and B; and spectinomycin are members of this group which contain 
a modified cyclitol unit called actinamine (Piepersberg, 1997). The chemical structures of 
streptomycin and spectinomycin are shown in Fig. 1.1. 
 
 
 
Fig. 1.1 Chemical structures of streptomycin (A) and spectinomycin (B). Both antibiotics represent 
examples of streptamine-containing ACAGAs. 
 
B- 2-deoxystreptamine containing ACAGAs (2DOS-ACAGAs) 
The major class of the 2-deoxystreptamine (2DOS)-containing ACAGAs represent a relatively 
homogeneous biosynthetic group, since most of them share the common pseudodisaccharidic 
intermediate paromamine (Pearce and Rinehart, 1981; Kase et al., 1982; Okuda and Ito, 1982; 
Umezawa et al., 1986; Piepersberg, 1997). The most important members of the 2DOS class are  
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Fig. 1.2 Chemical structures of some selected 4,5-glycosylated ACAGAs (NM family). The letters in 
bold represent: A = paromomycin I; B = ribostamycin; C = lividomycin B; D = neomycin B; E = 
butirosin B. 
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the NMs (including PM, LM, RM and BUs), KMs and GMs. More distantly related groups are 
the 2DOS containing non-paromamine ACAGAs, members of which are Apr and HM-B (Fig. 
1.4; Piepersberg, 1997). In order to focus more on chemistry and biosynthetic origin of the 
2DOS-ACAGAs class, further classification based on the substitution of the 2DOS unit with the 
sugar side chains was attempted as follows: i- ACAGAs containing 4,5-di-glycosylated 2DOS-
ACAGAs, this subclass includes both pseudotetrasaccharidic and pseudotrisaccharidic 
antibiotics, i.e. basically the NM family (Fig. 1.2). ii- ACAGAs containing 4,6-di-glycosylated 
2DOS-ACAGAs, this subclass includes the family of KMs, and GMs (Fig. 1.3); iii- ACAGAs 
containing 4-mono-glycosylated 2DOS-ACAGAs (e.g. Apr; Fig. 1.4); iv- ACAGAs containing 
5-mono-glycosylated 2DOS-ACAGAs (e.g. HM-B; Fig. 1.4). 
 
 
Fig. 1.3 Chemical structures of some selected 4,6-glycosylated ACAGAs. The letters in bold represent: 
A = kanamycin B; B = gentamicin C1; C = tobramycin; D = gentamicin C1a. 
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Fig. 1.4 Chemical structures of apramycin (A) and hygromycin B (B). Both apramycin and 
hygromycin B represent examples of 4- and 5-mono-glycosylated 2DOS-ACAGAs, respectively. 
 
 
C- Fortamine and 2-deoxyfortamine-containing ACAGAs 
Both FTMs (astromicins) and IMs form a group of compounds strongly related to the 2DOS-
ACAGAs, containing fortamine and 2-deoxyfortamine as a basic cylitol unit, respectively. The 
more recently detected FTM/IM group of aminoglycosides has been intensively studied 
throughout the 1980s and several new members or producers have been described: the 2’’-N-
formimidoyl derivative of FTM (identical with dactimicin) produced by M. olivasterospora 
(Hotta et al., 1989b); derivatives of IM-A and -B produced by S. tenjimariensis (Kondo et al., 
1982); derivatives of sporaricin A produced by Saccharopolyspora hirsuta (Umezawa et al., 
1987); the new variant lysinomicin produced by M. pilosospora. Interestingly, the members of 
this group produced by Micromonospora sp. (FTM) and Dactylosporangium sp. (dactimicin) are 
based on fortamine, whereas the related compounds produced by Streptomyces sp. (IMs) and 
Saccharopolyspora sp. (sporaricins) are based on 2-deoxyfortamine (Piepersberg, 1997). The 
chemical structures of both FTM-A and IM-A are outlined in Fig. 1.5. 
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Fig. 1.5 Chemical structures of fortimicin A (A) and istamycin A (B). Both fortimicin A and 
istamycin A represent examples of fortamine and 2-deoxyfortamine-containing ACAGAs, respectively. 
 
E- C7-Aminocyclitol-Aminoglycoside (C7-ACAGA) 
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Zhang et al., 2002). 
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clinically relevant (nosocomial) pathogens conferring ACAGAs resistance determinants. The 
most important examples are: amikacin, dibekacin (and its derivative arbekacin); and netilmicin 
and isepamicin which were derived from the members of the KM and GM families, respectively 
(Kawaguchi et al., 1972; Kondo et al., 1973; Nagabhushan et al., 1978; Holm et al., 1983; 
Tanaka et al., 1983; Inoue et al., 1994). The major alteration leading to potent antibiotics such as 
3,4-dehydroxylation of a hexosamine moiety and introduction of an N-1--hydroxy--
aminobutyryl residue (= AHB; or its propionyl analog, AHP), also similarity occur in the 
naturally produced FTM (cf. Fig. 1.5) and the BUs (cf. Fig. 1.2), respectively. Some selected 
semisynthetic ACAGAs are structurally outlined in Fig. 1.6. 
 
 
Fig. 1.6 Chemical structures of some selected semisynthetic ACAGAs. A = amikacin (N-1-AHB-
kanamycin A); B = isepamicin (N-1-AHP-N-3’’-acetylgentamicin B); C = arbekacin (habekacin; N-1-
AHB-derivative of dibekacin = 3’,4’-dideoxykanamycin B); D = netilmicin (N-1-ethylsisomicin). AHB = 
-hydroxy--aminobutyryl residue; AHP = -hydroxy--aminopropionyl residue. The arrows and the 
substitution groups in bold represent the type of alterations made on the naturally occurring ACAGAs. 
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in both actinomycetes and Gram-negative bacteria (Piepersberg, 1997). Moreover, the 
aminoglycoside hygromycin A which is produced in the same strain that produces HM-B, the 
monosaccharidic glycosidase inhibitors and antibiotics (such as prumycin, galactostatin, sistatin 
and streptozotocin) and several disaccharidic amino-N-containing secondary or semisynthetic 
carbohydrates lack an (amino-)cyclitol constituent (such as trehalosamines, mannosyl 
glucosaminide, etc.) are examples of this group (Numata et al., 1986; Tsuno et al., 1986; Hardick 
et al., 1992). 
Completely new structural classes of ACAGAs have been detected in the past with the isolation 
of the allosamidins and trehazolin by screening actinomycetes cultures for the formation of 
glucosidase inhibitors. Allosamidin is the first chitinase inhibitor isolated from streptomycetes 
(Sakuda et al., 1987). Trehazolin (or trehalostatin) is a very specific trehalose inhibitor produced 
by Micromonospora sp. and Amycolatopsis sp. (Ando et al., 1991; Kobayashi and Shiozaki, 
1994).  
 
1.1.3 Mode of action 
The major classes of AGAs inhibit cellular protein synthesis through their binding to the smaller 
30S ribosomal unit of the bacterial ribosome (Moazed and Noller, 1987; Fourmy et al., 1996; 
Ban et al., 1998, 1999 and 2000; Cate et al., 1999; Clemons et al., 1999; Brodersen et al., 2000). 
The recent elucidation of the three-dimentional structures of the bacterial 70S ribosomes and 
ribosomal subunits now allow identifying the exact type of molecular interaction with their target 
sites. Specifically, AGAs bind to the A-site of the 30S ribosome, including conformational 
changes in key nucleotides in the decoding center of the 16S rRNA. As a result they affect the 
fidelity of protein translation via wrong codon-anticodon pairing which in turn is expressed as 
mistranslation of mRNA or premature termination of protein synthesis leading to cell death (Ban 
et al., 2000; Carter et al., 2000; Cech, 2000; Nissen et al., 2000; Pape et al., 2000; Schlünzen et 
al., 2001; Fong and Berghuis, 2002; Brodersen et al., 2002 and 2003). 
 
1.1.4 AGAs in medical treatments 
Aminoglycosides are considered one of the most important classes of antibiotics which have a 
broad spectrum of action (mostly bactericidal) against most of the Gram-positive and Gram-
negative bacteria. AGAs are not stable in the gut and therefore, they are often administered 
intravenously or intramuscularly to treat serious systemically bacterial infections (e.g. GMs, 
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KMs, amikacin, TM etc.). Streptomycin is administered intramuscularly for the treatment of 
tubercle bacilli (TB) and leprosy caused by Mycobacterium tuberculosis and Mycobacterium 
leprae, respectively. Some aminoglycosides are also used orally to treat intestinal infections (e.g. 
NM, PM, LM), or topically to treat eye infections (e.g. NM, TM, KMs) or wounds and burns 
(NM, TM). The AGAs acting as glycosidase inhibitors, e.g. amylostatins (acarbose) are used in 
the treatment of diabetes patients. Validamycins are used as a plant-protecting antibiotic that acts 
against plant-pathogenic fungi which attack roots. They are also effective in protecting seedlings 
and clone cuttings against damping-off disease (Frommer et al., 1981; Kameda et al., 1984; 
Robson et al., 1988). 
1.1.5 Biosynthesis and regulation of ACAGAs 
The evolutionary origins of bacterial and fungal secondary metabolites in general and of 
ecological meanings and their functions as well as of their biosynthetic pathways have started to 
be discussed several times in the past two decades (Ban et al., 1998 and 1999; Chadwick and 
Whelan, 1992). Principally, we do not know what their ecological meaning are and which 
selective pressures created their biosynthetic pathways and regulatory adaptations to the 
metabolic networking of the producing cells. Moreover, the sugar-based aminoglycosidic 
microbial products are found in two forms, as cell wall-attached polymers and as excreted low 
molecular weight compounds (Piepersberg, 1992; Piepersberg and Distler, 1997). Only the latter 
are regarded as secondary metabolites in the traditional sense. However both types of variable 
uses of rare sugars and cyclitols are based on the parallel and largely alternative use of very 
similar pools of genes/enzymes (Piepersberg et al., 2002). Therefore, their distribution in 
microbial genomes and use in individual cell systems might be of more general relevance for 
both the ecological understanding of secondary sugar metabolism and the biotechnological use in 
future pathway engineering (combinatorial biochemistry). 
Mycothiol (MSH) which represents an example of a cell wall attached polymer is the major 
cytoplasmic thiol in actinomycetes, where it occurs instead of glutathione (in other bacteria and 
eukaryotes) as an antioxidant and redox buffering substance. MSH is an aminoglycoside-related 
substance involved in the reactions catalysed by NAD/coenzyme dependent enzyme and hence 
oxidized to mycothione which is later reduced by an NADPH-dependent reductase (Newton et 
al., 1995 2000; Norin et al., 1997). The occurrence of myo-inositol as an essential metabolite so 
far only found in actinomycetes, explains the stable existence of genes for a D-myo-inositol-3-P 
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synthase in actinomycete genomes. Several aspects in the design of a productive pathway for a 
strain specific and extracellulary targeted metabolite are of immediate interest for 
characterization and comparison of its natural function and evolutionary origin: i- The individual 
branch points between primary and secondary metabolism, i.e. the genes/enzymes starting the 
flow of intermediates into the branches of the biosynthetic pathway of the final product 
condensation will inform us about the use of primary precursors and possibly about general 
substrate flows inside the producing cell; ii- The adaptation of genes/enzymes involved in the 
biosynthetic steps of cytoplasmic activation, modification and condensation of oligomeric end 
products; iii- The mechanism of avoidance of accumulation of toxic intermediates and/or end 
products of the cytoplasmic and extraceullar biosynthesis will also reflect either principal or 
individual use of common strategies; iv- In general, it becomes apparent that the regulatory 
control of the secondary pathway couples the production of such metabolites not only to a 
distinct phase of the cell cycle, but also makes it responding to various environmental conditions; 
v- The mechanism and other biochemical features of the specific transport (in general export, but 
also import maybe relevant in some cases) of the product through the cytoplasmic membrane 
(Piepersberg et al., 2002). 
Furthermore, studies on the biosynthesis of AGAs have utilized three main approaches: i- 
isotopic competition techniques with 14C- and 13C- labelled putative precursors; ii- idiotrophic 
mutants; iii- enzyme characterization and assays to detect the enzymatic reactions postulated to 
be involved (Demain and Inamine, 1970; Reinhart and Stroshane, 1976; Grisebach, 1978, Lucher 
et al., 1989; Ota et al., 2000; Walker, 2002). In general, the basic design of the biosynthetic 
pathways for AGAs differ considerably. Also, the sources of precursors, before all the (amino-) 
cyclitol moieties are quite variable. In the present study, a focus will be made on the biosynthesis 
of the more closely related 2DOS-, fortamine- and 2-deoxyfortamine-containing ACAGAs.  
 
1.1.5.1 Biosynthesis of 2DOS-containing ACAGAs 
Unfortunately, the biosynthesis of none of the classical 2DOS-ACAGAs such as the KMs, NMs 
or GMs has been studied biochemically in detail as yet. All these major 2DOS families are 
produced via a common intermediate, the pseudodiasaccharide paromamine condensed from the 
preformed 2DOS and D-glucosamine units (Piepersberg and Distler, 1997). Recently, new 
molecular data have been reported on the genetics and the biosynthesis of BU in the producer B. 
circulans including a description of the partial btr-gene cluster comprising at least 17 genes 
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Fig. 1.7 General pathway design for the biosynthesis of the major classes of 2DOS-ACAGAs. The 
central role of 2DOS and paromamine intermediates are emphasized. The route leading to seldomycin, 
wether related to that of KMs or GMs, is unknown. The distribution of modifying phases are indicated 
with open arrows. AHB = -hydroxy--aminobutyryl residue; G-6-P = D-glucose-6-phosphate. P2S, P3S, 
P4S = pseudodi-, tri-, or tetrasaccharides, respectively. 
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(Kudo et al., 1999a and b; Ota et al., 2000). Gene disruption studies proved the function of the 
cluster in BU production. An extensive study of the first-step enzyme 2-deoxy-scyllo-inosose 
synthase, BtrC had already started before and as predicted, BtrC follows the same enzymatic 
mechanism as dihydroquinic acid synthase in cyclization of G-6-P via an intramolecular 
phosphate lyase which had classified as a Cb cyclitol pathway (dihydroquinate-synthase like 
2DOS synthase; Yamauchi and Kakinuma, 1993, Piepersberg and Distler, 1997; Piepersberg, 
1997). As well, the second-step enzyme, 2-deoxy-scyllo-inosose aminotransferase was later 
proven to be catalyzed by BtrS (Tamegai et al., 2002b). In fact, the protein sequence of BtrS 
demonstrated it to be a close relative of the scyllo-inosose aminotransferase, StsC in the 
streptomycin biosynthetic pathway (Ahlert et al., 1997). 
Furthermore, the gene product BtrM of B. circulans is a glycosyltransferase related to others 
postulated to participate in bacterial cell wall polysaccharide synthases. Other gene products, 
BtrI, BtrK and maybe others could be involved in the multi-step AHB formation (Yukita et al., 
2003). In addition, genes for other steps such as modification of the 2-deoxy-scyllo-inosamine, 
glucosamine subunits, resistance and transport have not yet been identified. 
For the 2DOS-containing non-paromamine ACAGAs (e.g. Apr and HM-B), the biosynthetic 
pathways have also not been characterized since the respective biosynthetic gene clusters have 
not yet been identified. However, certain genes encoding for resistance to the respective 
antibiotics such as kamB (Holmes et al., 1991) and HM-B aph (Zalacain et al., 1986) as well as 
some anticipated individual biosynthetic genes (aprA, AY129957; Walker, 2002) had been 
identified. The general pathway design for the biosynthesis of the major classes of 2DOS-
ACAGAs is illustrated in Fig. 1.7. 
 
1.1.5.2 Biosynthesis of fortamine and 2-deoxyfortamine-containing ACAGAs 
Most information on the genetics and biochemistry of the biosynthesis of this group of ACAGAs 
originates from the investigation of the FTM (astromicin) producer M. olivasterospora and the 
IM/sannamycin producers S. tenjimariensis and S. sannaensis (Hasegawa, 1992; Hotta et al., 
1994; Piepersberg and Distler, 1997). However, as pointed out earlier, the origin of the cyclitol 
moieties in this family of closely related compounds might follow either a Ca (myo-inositol 
phosphate synthase) in case of fortamine-containing ACAGAs (i.e. FTM, dactimicin) or a Cb 
(dihydroquinate synthase like 2DOS synthase; AroB proteins) in case of 2-deoxyfortamine 
containing ACAGAs (i.e. IM, sananamycin, sporaricins).  
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Fig. 1.8 The proposed biosynthetic pathway of fortimicins (astromicin). The same pathway starting 
from 2-deoxy-scyllo-inosamine appears to be established in the producers of IMs, sannamycins and 
sporaricin. The known intermediates and postulated enzymatic steps are given according to Hasawaga 
(1992); Hotta et al. (1994); Piepersberg (1997). The known or assumed enzymatic conversions involved 
in the pathway are given: DH = dehydration (dehydroxylation) or dehydratation (e.g. enolase); Epi = 
epimerization; FIT = forimidoyltransfer; FTM = fortimicin; GLY = glycyltransferase; GT = 
glycosyltransferase; MT = methyltransferase; OR = oxidoreductase; PT = phosphotransferase (kinase); 
TA = transaminase. 
Note: in FTM producers NO BtrC-like function is required while in IM producers BtrC-like function is 
required; first two steps similar to that in 2DOS synthesis (cf. Fig. 4.1); Steps no. 8 and 9 occur also in 
GMs (Fig. 1.3). 
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The DNA sequences have been reported for a few fms genes in the respective cluster for FTM 
biosynthesis (Hotta et al., 1989b; Dairi et al., 1992a, b and c; Hasegawa, 1992; Ohta et al., 1993; 
Hotta et al., 1994). Most of these genes products are involved either in resistance or in the late 
modification pathway such as, FmrO, Fms7 and Fms14 (Kuzuyama et al., 1995; Dairi et al., 
1992a). The branch points from primary metabolism can be identified to be the formation of 
scyllo-insose (in case of FTM and related antibiotics) and 2-deoxy-scyllo-inosose (in case of IM 
and related antibiotics) from G-6-P and synthesis of NDP-(N-acetyl-)D-glucosamine. The 
condensation reaction of the starting pseudodisaccharide (FTM-FU-10) from scyllo-inosose and 
D-glucosamine could be quite similar to that of the paromamine-forming pathway in the 
production of 2DOS-ACAGAs (Piepersberg et al., 2002). 
The pathway design for the FTM/IM group is thus in the other extreme as compared to the 
distribution of modification and condensation reactions in the streptomycin biosynthetic route: 
here condensation comes first and major modifications second (Piepersberg et al., 2002; Fig. 
1.8). 
 
1.1.6 Resistance mechanisms 
Another and arguably more alarming drawback of the aminoglycosides (and antibiotics in 
general) is the global development of microbial multi-resistance. In the case of ACAGAs, which 
are used predominantly against aerobic Gram-negative bacteria, the most common resistance 
mechanism is structural modification and thereby inactivation of the antibiotic compound by 
bacterial enzymes: e.g. aminoglycoside phosphotransferases (APH); adenyltransferases (AAD or 
ANT); and acetyltransferases (AAC). A widely distributed second mechanism of action is 
alteration of the target site (16S rRNA) via methylation (16S rRNA methyltransferase). A third 
type of resistance mechanism, mostly occurring via mutation is decreased uptake and/or 
accumulation of the drug in bacteria (Cundliffe, 1989; Shaw et al., 1993; Piepersberg, 1997; 
Haddad et al., 1999; Mingeot-Leclercq et al., 1999; Neonakis et al., 2003).  
Aminoglycoside resistance is achieved in 2DOS producers typically by either a combination of 
aminoglycoside modification (N-1-acetylation and O-3’-phophorylation) in the producers of 
NMs and RM, HM-B or target site modification (16S rRNA methylation) in the producers of 
GMs, KMs, Apr (Zalacain et al., 1986; Holmes et al., 1991; Hotta et al., 1994; Piepersberg and 
Distler, 1997). On the other hand, resistance to the fortamine- (i.e. FTM, dactimicin) and 2-
deoxyfortamine- (i.e. IM, sannamycin) containing ACAGAs is achieved by 16S rRNA 
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methylation of the target site in the producers, where sometimes acetylation of the antibiotic 
occurs as a second resistance mechanism (Ohta et al., 1993; Hotta et al., 1996). 
 
1.1.7 Toxicity 
Despite the apparent advantages, extensive clinical use of ACAGAs is limited due to the 
associated toxicities, most notably nephrotoxicity and ototoxicity and to a lesser extent 
neuromuscular blockade (Walker and Duggin, 1988; Zembower et al., 1998). The exact 
mechanism of toxicity is unknown although aminoglycosides are known to accumulate in renal 
cortical tubes and then be able to damage the proximal tubules. Nephrotoxicity is dose-
dependant and generally reversible in the majority of patients when the drug is discontinued or 
using effective monitoring procedures (Prins et al., 1998). Ototoxicity is the second main 
adverse effect of aminoglycoside and in contrast to nephrotoxicity is irreversible since it leads to 
vestibular and/or cochlear damage. 
Because ACAGAs are very effective antibiotics especially in the treatment of severe bacterial 
infections, it seems important to maintain and even develop efforts to improve their therapeutic 
indices. Clinical research aimed at obtaining intrinsically less toxic compounds has met modest 
success and a few of other approaches proposed to reduce the toxicities of the available agents 
have reached clinical practical applications (Piepersberg, 1997; Mingeot-Leclercq and Tulkens, 
1999). 
 
1.2 ACAGAs producers 
Aminoglycosides are mainly produced by actinomycetes including Streptomyces, 
Streptoverticillum, Nocardia, Micromonospora and Streptoalloteichus. Some Bacilli and 
Pseudomonades species also produce aminoglycosides. These organisms often produce 
simultaneously several structurally related antibiotics which are mutually convertible by 
chemical, enzymatic, or microbiologic procedures and give valuable information on the 
biosynthesis of these aminoglycosides. In general, the Gram positive bacteria include two major 
branches: the low G+C organisms forming the order Firmicutes, containing genera such as 
Bacillus, Clostridium, Staphylococcus and Streptococcus; and the high G+C organisms forming 
the order Actinomycetes. (Kieser et al., 2000). Tab. 1.1 summarizes the most useful and widely 
used ACAGAs produced by a variety of strains. However, in the present study, a focus was made 
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for some selected useful ACAGAs produced by some actinomycetes (including Streptomyces, 
Micromonospora and Streptoalloteichus sp.) and by B. circulans. 
 
1.2.1 Actinomycetales 
Streptomyces, Micromonospora and Nocardia are genera that belong to the order 
Actinomycetales. These contain Gram-positive bacteria that form branching filaments, all of 
them form a true mycelium and some are normally bacillary or irregular in shape. With a few 
exceptions notably the Streptomyces members of this order live saprophytically in soil however, 
most of them produce a variety of biologically active substances, e.g. various antibiotics, 
pigments, enzymes, amino acids, vitamins, toxins, growth promoting substances and others 
(Krassilnikov, 1950; Waksman, 1959). Members of the genus Streptomyces are filamentous 
gram positive bacteria (Waksman and Lechevalier, 1962) with a high potential in biotechnology 
(Piepersberg, 2003). This genus is defined by both chemotaxonomic and phenotypic characters 
(Miyadoh, 1990). The major taxonomical emphasis lies now on the 16S rRNA homologies, in 
addition to cell wall analysis, fatty acids and lipid patterns (Wellington et al., 1992; Mehling et 
al., 1995b). One of the quickest methods for preliminary identification to genus level was the 
precursor of LL isomer of diaminopimelic acid (LL-DAP) as the amino acid in the cell wall 
peptidoglycan. Streptomyces are ubiquitous in nature. Their ability to colonize the soil is greatly 
facilitated by growth as a vegetative hyphal mass which can differentiate into spores which not 
only assist in spread and persistence (Mayfield et al., 1972; Ensign, 1978), but also impart 
resistance to low nutrient and water availability (Karagouni et al., 1993). Members of the genus 
Streptomyces are well known as producers of many secondary metabolites having some kind of 
activity (Zaehner and Fielder, 1995). Actinomycetes make two-thirds of the known antibiotics 
that are produced by microorganisms and among them nearly 80% are made by members of the 
genus Streptomyces (Omura, 1992; Piepersberg, 1993; Kieser et al., 2000). A typical property of 
the genomic DNA of streptomycetes is the high G+C content of 72 – 75 mol% (Enquist and 
Bradley, 1971; Piepersberg, 1993) which results in a highly biased codon usage (Wright and 
Bibb, 1992). The G+C content is of intermediate concentration (about 70%) in the first codon 
position, lowest in the second (about 50%) and highest (about 80-90%) in the third codon 
position. The family Micromonsporaceae comprises nine genera, namely Micromonospora, 
Actinoplanes, Catellatospora, Couchioplanes, Catenuloplanes, Dactylosporangium, Pilmelia 
(Koch et al., 1996b), Spirilliplanes (Tamura et al., 1997) and Verrucosispora (Rheims et al., 
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1998). Phylogenetically, this family forms one of the major sublines within the suborder 
Micromonosporineae in the order Actinomycetales (Stackebrandt et al., 1997). Genus 
Micromonospora (Ørskov, 1923) is the type genus of the family Micromonosporaceae and 
contains many interesting strains such as antibiotic producers i.e. M. echinospora (formerly M. 
purpurea), M. olivasterospora (Luedemann and Brodsky, 1964) and degraders of natural rubber 
(Jendrossek et al., 1997). 
 
Tab. 1.1 Widely used ACAGAs and their applications 
________________________________________________________________ 
ACAGAs    Producer(s)    Application 
_____________________________________________________________________________ 
 
apramycin     St. hindustanus & S. tenebrarius veterinary antibacterial  
butirosin     B. circulans    antibacterial 
fortimicin     M. olivasterospora   antibacterial 
gentamicin     M. echinospora    antibacterial 
hygromycin B     S. hygroscopicus    antihelminthic 
istamycin     S. tenjimariensis   antibacterial  
kanamycin     S. kanamyceticus   antibacterial  
lividomycin     S. lividus    antibacterial 
neomycin     S. fradiae    antibacterial  
paromomycin     S. rimosus    antiamoebal 
ribostamycin     S. ribosidificus    antibacterial 
sisomicin    M. inyoensis    antibacterial 
spectinomycin    S. spectabilis     antibacterial 
streptomycin    S. griseus    antitubercle (anti TB) 
tobramycin     St. hindustanus & S. tenebrarius antibacterial 
_____________________________________________________________________________ 
 
 
According to the approval lists of bacterial names (Skerman et al., 1980), 12 species and seven 
subspecies are listed in the genus Micromonospora. A 16S rRNA sequence based study on the 
taxonomy of Micromonosporaceae has been performed by Koch et al., (1996a). The 16S rRNA-
homologies, based phylogeny of the genus Micromonospora, however did not always agree with 
other taxonomic characteristics. It was assumed that the 16S rRNA homologies are not 
sufficiently divergent in the genus Micromonospora to distinguish the different species. 
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Yamamoto and Harayama, (1995) proposed that protein encoding genes such as gyrB could be 
suitable for phylogenetic classification and identification of the closely related bacteria. 
They succeeded in discriminating among closely related strains of the genus Pseudomonas 
(Yamamoto and Harayama, 1995). In subsequent works (Yamamoto and Harayama, 1996, 1998; 
Harayama and Yamamoto, 1996; Yamamoto et al., 1999), they showed the gyrB-based grouping 
of the genus Acinetobacter to be consistent with the results of the DNA-DNA hybridization, 
indicating the gyrB sequence would be useful for resolving bacterial strains at the genomic 
species level. Moreover, the same method was applied to distinguish different species of 
Micromonospora and it was succeeded to distinguish 15 validly described species and four 
subspecies. Also this method showed that they form a tight cluster as previously demonstrated by 
16S rRNA homologies. However, the intrageneric relationships deduced from the gyrB-based 
phylogeny were different from those based on their 16S rRNA homologies (Kasai et al., 1998).  
 
1.2.2 Bacillus 
Members of the genus Bacillus are aerobic or facultatively anaerobic endspore-forming Gram-
positive rods. The ubiquity of Bacillus species in nature, the unusual resistance of their 
endospores to chemical and physical agents, the developmental cycle of endospore formation, 
the production of antibiotics, the toxicity of their spores and protein crystals for many insects, 
and the pathogen B. anthracis, have attracted ongoing interest in the genus since Koch's time 
(Sneath et al., 1986; Topley and Wilson, 1998). The cell wall peptidoglycan of most species 
belongs to a type with directly cross-linked meso-diaminopimelic acid (Schleifer and Kandler, 
1972). 
Most Bacillus species are versatile chemoheterotrophs capable of respiration using a variety of 
simple organic compounds (sugars, amino acids, organic acids). In some cases, they also ferment 
carbohydrates in a mixed reaction that typically produces glycerol and butanediol. A few species, 
such as B. megaterium, require no organic growth factors, others may require amino acids, B-
vitamins, or both. The majority are mesophiles, with optimum temperatures between 30 and 
45°C, but the genus also contains a number of thermophilic species with optimum growth 
temperatures as high as 65°C. In the laboratory, under optimum growth conditions, Bacillus 
species exhibit generation times of about 25 minutes (Norris et al., 1981; Berkeley et al., 1984; 
Priest, 1993). Early attempts for setting-up a classification system for Bacillus species were 
based on two characteristics: aerobic growth and endospore formation. This resulted in tethering 
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together many bacteria possessing different kinds of physiology and occupying a variety of 
habitats. Hence, the heterogeneity in physiology, ecology, and genetics, makes it difficult to 
categorize the genus Bacillus or to make generalizations about it. There is great diversity in 
physiology among members of the genus, whose collective features include: degradation of most 
or all substrates derived from plant and animal sources including cellulose, starch, pectin, 
proteins, agar, hydrocarbons, and others; antibiotic production; nitrification; denitrification; 
nitrogen fixation; facultative lithotrophy; autotrophy; acidophily; alkaliphily; psychrophily, 
thermophily and parasitism. Spore formation universally found in the genus is thought to be a 
strategy for survival in the soil environment wherein the bacteria predominate. Aerial 
distribution of the dormant spores probably explains the occurrence of Bacillus species in most 
habitats examined (Hurst and Gould, 1984; Dring et al., 1985).  
Currently, there are 40 recognized species in the genus Bacillus listed in Bergey's Manual of 
Systematic Bacteriology, Vol. 2 (1986). The G+C content of known species of Bacillus ranges 
from 32 to 69% (DeLey, 1978; Golovacheva et al., 1975). This observation, as well as DNA 
hybridization tests, reveals the heterogeneity of the genus. Not only is there variation from 
species to species, but there are sometimes profound differences in G+C content within strains of 
a species. For example, the G+C content of the B. megaterium group ranges from 36 to 45 mol% 
and of B. circulans ranges from 31.6 to 61.0 mol% (Nakamura and Swezey, 1983; Famy et al., 
1985). Another approach to Bacillus taxonomy has been analysis of 16S rRNA molecules by 
oligonucleotide sequencing. This technique, of course, also reveals phylogenetic relationships. 
Surprisingly, Bacillus species showed a kinship with certain nonsporeforming species, including 
Planococcus, Lactobacillus and Staphylococcus (Woese et al., 1975; Joung and Côté, 2002.). In 
one study, 16S rRNA cataloging showed that B. subtilis and other ellipsoidal-sporeforming 
species, B. cereus, B. megaterium, and B. pumilus, formed a coherent cluster, but the round-
sporeforming species, B. sphaericus, B. globisporus, and B. aminovorans, did not cluster. In 
another 16S rRNA sequencing study, three major Bacillus taxonomic cluster groups were 
defined by determining complete or partial sequences of 16S RNA (exceeding 1100 Nt) on 35 
recognized reference strains. These cluster groups were quite different from those previously 
noted. Finally, species of Bacillus are attractive microorganisms for industrial application due to 
several characteristics: i- they synthesize products of commercial interest (e.g. antibiotics, amino 
acids, etc); ii- they have a large range of metabolic properties (proteolytic, lipolytic, 
saccharolytic, etc.); iii- most of them are non-pathogenic. 
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1.3 Aim of the work 
ACAGAs are considered one of the most important groups of antibiotics especially in the 
medical field. However, our knowledge on the genetics and biochemistry for the biosynthesis of 
such metabolites is still incomplete, especially for the major classes of 2DOS- and 2DOS-related 
ACAGAs. So, the main goal attempted in this work falls into two main items: 
 
I- Cloning, identification and sequencing the biosynthetic gene clusters from some selected 
producers of ACAGAs. To fulfil the regarded goal, the following strategies were carried out: 
1- Construction of appropriate probes for screening the cosmid banks delivered on a service 
basis. 
2- Identification, mapping and analysis of the positively custom-screened cosmids for selection 
    of those harboring the ACAGAs biosynthetic gene clusters for sequencing. 
3- Analysis and evolutionary study of the respective gene clusters. 
4- Development of heterologous primers for isolation and characterization of strains producing 
hybrid ACAGAs. 
 
II- Biochemical characterization of some selected 2DOS biosynthetic genes. In order to 
achieve the respective aim, the three genes kanC, kanS1 and kanE which are putatively involved 
in the biosynthesis of the 2DOS moiety were selected from the kan-gene cluster to fulfil the 
following points: 
1- Cloning and heterologous expression of the selected genes. 
2- Biochemical characterization of the respective expressed proteins. 
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2 Materials and Methods 
 
2.1 Chemicals and enzymes 
 
Antibiotics 
 
Ampicillin      Roth, Karlsruhe 
Apramycin      Sigma, Steinheim 
Chloramphenicol     Serva, Heidelberg 
Kanamycin      Sigma, Steinheim 
Nystatin      Merck, Darmstadt 
Spectinomycin     Sigma, Steinheim 
Thiostrepton      Squibb and Sons, Princeton, USA 
 
Chemicals 
  All the chemicals used were of high quality standards and were supplied from the 
following companies: 
 
        Fluka Chemie, CH-Buchs 
        Merck, Darmstadt 
        Roth, Karlsruhe 
        Sigma, Steinheim 
        Roche Diagnostics, Mannheim 
 
Enzymes 
 
DNA polymerase I Klenow fragment  Roche Diagnostics, Mannheim 
 L-Lactate dehydrogenase    Roche Diagnostics, Mannheim 
 Proteinase K      Sigma, Steinheim 
 Lysozyme      Serva, Heidelberg 
 Restriction endonucleases    Invitrogen, Karlsruhe 
        Roche, Mannheim 
        BioLabs, New England 
 RNase       Fluka Chemie, CH-Buchs 
 Taq DNA polymerase    Invitrogen, Karlsruhe 
T4-DNA ligase     Roche Diagnostics, Mannheim 
 T4-polynucleotide kinase    BioLabs, New England 
 
Kits 
 
 Thermo-Sequencing kit    Amersham Bioscience, Freiburg 
 BioRad Protein Assay Kit    BioRad, München 
 BM Chromagenic Western Blotting Kit  Roche Diagnostics, Mannheim 
 QIA prep Spin Miniprep kit    Qiagen, Hilden 
 QIA quick Gel extraction kit    Qiagen, Hilden 
 QIA quick PCR Purification kit   Qiagen, Hilden 
 
MATERIALS AND METHODS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
22 
Various materials 
 
  HybondTM-C Extra membranes  Amersham Bioscience, Freiburg 
HybondTM-N+ membranes   Amersham Bioscience, Freiburg 
  Membrane filters BA 85 (0.45 µm)  Schleicher & Schuell, Dassel 
  TLC plates (ALUGRAM® SIL G/UV254) Merck, Darmstadt 
  3MM Whatman paper   Biometra, Göttingen 
  X-ray Hyperfilm- MP   Amersham Bioscience, Freiburg 
 
2.2 Media 
 
2.2.1 Media for culturing E. coli and Bacillus strains 
 
LB-Medium (Miller, 1972) 
 
Tryptone     10.0 g 
Yeast extract     5.0 g 
NaCl      5.0 g 
ad. distilled water    1000.0 ml 
pH adjusted to 7.2 before autoclaving 
 
LB-Agar (Miller, 1972) 
 
LB-Medium 
Agar      15.0 g/l 
 
LB-Medium with Sorbitol and Betaine (Chen et al., 1972) 
 
LB-Medium 
Sorbitol     1.0 M 
Betaine     2.5 mM 
 
2x TY-Medium (Miller, 1972) 
 
Tryptone     16.0 g/l 
Yeast extract     10.0 g/l 
NaCl      5.0 g/l 
 
SOB- Medium (Hanahan, 1983) 
 
Tryptone     20.0 g/l 
Yeast extract     5.0 g/l 
NaCl      0.58 g/l 
KCl      0.19 g/l 
After autoclaving add: 
MgCl2 (1M)     10.0 ml 
MgSO4 (1M)     10.0 ml 
 
 
 
 
MATERIALS AND METHODS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
23 
SOC- Medium (Hanahan, 1983) 
 
   Glucose     3.6 g/l 
   in SOB-Medium 
 
Slant-Medium (50:50) (Miller, 1972) 
 
Tryptone     10.0 g 
Yeast extract     5.0 g 
Glycerin 96%     500.0 ml 
Ad. distilled water    1000.0 ml 
 
2.2.2 Media for culturing Streptomyces  and Micromonospora strains 
 
Trypticase soy broth (TSB) (Kieser et al., 2000) 
 
Trypticase soy broth (Oxoid)   30.0 g/l 
(soyabean casein digest broth) 
 
 
TSB-PEG 8000 (Babcock and Kendrick, 1988) 
 
Trypticase soy broth    30.0 g/l 
PEG 8000     50.0 g/l 
After autoclaving add: 
Glycine (20%)     50.0 ml 
MgCl2 (1 M)     10.0 ml 
 
  
SPMR (Babcock and Kendrick, 1988) 
 
Sucrose     103.0 g/l 
MgCl2      10.0 g/l 
Glucose     5.0 g/l 
Yeast extract (Difco)    5.0 g/l 
Bacto-agar (Difco)    22.0 g/l 
TES, pH 7.2     4.58 g/l 
After autoclaving add: 
CaCl2 (5 M)     2.0 ml 
Trace element solution    2.0 ml 
 
  Trace element solution (Kieser et al., 2000) 
 
  ZnCl2      0.04 g/l 
  FeCl3 x 6 H2O     0.2 g/l 
  CuCl2 x 2 H2O     0.01 g/l 
  MnCl2 x 4 H2O     0.001 g/l 
  Na2B4O7 x H2O     0.01 g/l 
  (NH4)6Mo7O24 x 4 H2O    0.01 g/l 
  Sterilized by filteration 
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SMA (Distler et al., 1985) 
 
Soy meal     20.0 g/l 
Mannit      20.0 g/l 
Agar      20.0 g/l 
 
  M65 (DSMZ, Braunschweig) 
 
  Glucose     4.0 g 
  Yeast extract     4.0 g 
  Malt extract     10.0 g 
  Agar      12.0 g 
  Distilled water ad.    1000.0 ml 
  pH adjusted to 7.2   
 
  YEME (Kieser et al., 2000) 
 
Yeast extract     3.0 g/l 
Peptone     5.0 g/l 
Malt extract     3.0 g/l 
Glucose     10.0 g/l 
Sucrose     340.0 g/l 
After autoclaving add: 
MgCl2 (1 M)     10.0 ml 
 
2.2.3 Aminoglycoside production medium (Nam and Ryu, 1985) 
 
Soy meal     30.0 g/l 
Ammonium chloride    4.0 g/l 
Calcium carbonate    5.0 g/l 
Glycerol     40.0 ml 
pH adjusted to 7.5 
 
2.3 Buffers and Solutions 
 
 
2.3.1 For the preparation of plasmid DNA from E. coli 
 
 Alkaline lysis solution (Birnboim and Doly, 1979) 
 
Solution I     
 
Glucose     50.0 mM 
Tris-HCl, pH 8.0    50.0 mM 
EDTA, pH 8.0     10.0 mM 
 
Solution II 
 
SDS      1.0 % 
NaOH       200 mM 
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Solution III (HSS; high salt solution) 
 
Potassium acetate    3.0 M 
Formic acid     1.8 M 
 
2.3.2 For the preparation of competent E. coli cells (Hanahan, 1983) 
 
TMF-1 buffer  
 
CaCl2 x 2H2O     100.0 mM 
RbCl2      50.0 mM 
MnCl2 x 4H2O     40.0 mM 
 
2.3.3 For the preparation of genomic DNA 
 
 i- Pospiech & Neumann method (Pospiech and Neumann, 1995) 
 
 SET buffer 
 
NaCl      75.0 mM 
  EDTA pH 8     25.0 mM 
  Tris-HCl pH 7.5    20.0 mM 
 
TE buffer (Sambrook and Russell, 2001) 
 
  Tris      10.0 mM 
  EDTA       1.0 mM 
  pH 8.0 
 
ii- Modified CTAB method (Mehling et al., 1995a) 
 
 CTAB solution 
  
 Cetyltrimethylammonium bromide (CTAB) 10.0 g 
 NaCl    0.7 g 
 Distilled water   100.0 ml 
 
2.3.4 For the preparation of protoplasts from Streptomyces (Chater et al., 1982) 
 
P-buffer  
 
Sucrose     103.0 g 
K2SO4      0.25 g 
MgCl2 x 6 H2O     2.02 g 
Trace element solution    2.0 ml 
Distilled water to      800.0 ml 
Dispense in 80 ml aliquots and autoclave. Before use, add to each flask in order: 
KH2PO4 (0.5%)    1.0 ml 
CaCl2 x 2 H20 (3.68%)    10.0 ml 
TES buffer (5.73%, adjusted to pH 7.2)  10.0 ml 
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2.3.5 For the transformation of Streptomyces (Babcock and Kendrick, 1988) 
 
T-buffer  
 
Sucrose  (10.3%)   25.0 ml 
K2SO4 (2.5%)     1.0 ml 
H2O      75.0 ml 
Trace element solution    0.2 ml 
CaCl2 x 2 H20 (0.25 M)   0.2 ml 
 
2.3.6 For agarose gel electrophoresis of DNA fragments  
 
 DNA loading buffer (Invitrogen, Karlsruhe) 
 
EDTA pH 8     100.0 mM 
Glycerol     43.0 % 
Bromophenol blue    0.5 % 
Xylene cyanol 0.5%    0.5 % 
 
TAE (50 x) (Sambrook and Russel, 2001) 
 
Tris      242.0 g/l 
EDTA      0.4 g/l 
Glacial acetic acid    57.1 ml 
 
2.3.7 For harvesting and sonification of cells (Ahlert et al., 1997) 
 
Cell washing buffer  
 
Tris-HCl pH 7.5    25.0 mM 
 
 
 
Cracking buffer 
 
  Tris-HCl pH 7.5    25.0 mM 
  Dithiothreitol (DTT)    1.0 mM 
  Phenylmethylsulfonyl fluoride (PMSF)  0.2 mM 
 
2.3.8 For Western blotting and detection of proteins (Qiagen, Hilden, Germany) 
 
Blotting buffer 
 
Tris      48.0 mM 
Glycine     39.0 mM 
Methanol     20.0 % 
 
TBS buffer 
 
Tris-HCl pH 6.8    10.0 mM 
NaCl      150.0 mM 
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TBS-T buffer 
 
  Tris-HCl pH 6.8    20.0 mM 
NaCl      500.0 mM 
Tween 20     0.05 % 
Triton X-100     0.2 % 
 
 Blocking buffer 
 
3.0% (w/v) BSA in TBS buffer 
 
2.3.9 For SDS polyacrylamide gel electrophoresis (Laemmli, 1970) 
 
 Collecting gel (Focus gel) 
 
Acrylamide 30% (29:1)   1.25 ml 
Tris buffer 0.5 M pH 6.8   1.9 ml 
SDS 10%     75.0 µl 
APS 10%     75.0 µl 
TEMED     10.0 µl 
Distilled water     3.5 ml 
 
Separation gel 
 
Acrylamide 30% (29:1)   6.1 ml 
Tris buffer 1.5 M pH 8.8   3.75 ml 
SDS 10%     150.0 µl 
APS 10%     150.0 µl 
TEMED     10.0 µl 
Distilled water     5.0 ml 
 
Running buffer (10 x) 
 
Tris-HCl pH 8.3    30.0 g/l 
Glycine     143.0 g/l 
SDS      10.0 g/l 
 
Sample buffer 
 
Tris      50.0 mM 
Glycerol     12.0% w/v 
SDS      4.0% w/v 
2-mercaptoethanol    2.0% v/v 
Serva Blue G     0.01% w/v 
Adjusted to pH 6.8 with 1 M HCl 
 
Gel staining solution 
 
  Coomassie Brilliant Blue R250   1.5 g/l 
  Methanol     450.0 ml/l 
  Acetic acid     100.0 ml/l 
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Gel destaining solution 
 
  Methanol     250.0 ml/l 
  Acetic acid     100.0 ml/l 
  Distilled water     650.0 ml/l 
 
2.3.10 For visualization of spots on TLC  
 
 Cer reagent (Drepper et al., 1996) 
 
Phosphomolybdic acid x H2O   25.0 g/l 
Cer (IV)-sulfate x 4 H2O   10.0 g/l 
H2SO4 (conc.)     60.0 ml/l 
H2O      940.0 ml/l 
 
 
 
Ehrlich reagent (Cooper, 1978) 
 
p-Dimethylaminobenzaldehyde   1.0 g 
Ethanol 95%     95.0 ml 
Concentrated HCl    20.0 ml 
 
Ninhydrin solution  
 
Ninhydrin     1.0 g 
Ethanol 95%     1000.0 ml 
 
2.3.11 X-Gal solution 
 
X-gal       0.2 g% in DMF  
 
2.3.12 IPTG stock solution 
 
IPTG      0.1 M in sterilized water  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
29 
 
2.4 Bacterial strains, vectors and recombinant plasmids 
 
2.4.1 Bacterial strains 
 
Tab. 2.1 List of strains used in this study 
________________________________________________________________ 
Strain     Relevant markers/Product  Source/Reference 
_____________________________________________________________________________ 
1- Escherichia coli  
 
E. coli DH5    F-, 80 lacZ M15, endA1, recA1, Hanahan, 1983 
     hsdR17 (r-, m+), gyrA96, thi, relA1 
     supE44, deoR 
 
E. coli ET12567   F-, dam13, dcm6, hsdM, hsdR,   MacNeil et al., 1992  
     recF143, galT22, ara14, lacY1, hisG4 
 
E. coli JM109(DE3)   F-, recA1, supE44, endA1, hsdR17, Novagen, Darmstadt 
     gyrA96, thi(lac-proAB),  
lacUV5-T7 gene 1 
      
E. coli BL21 (DE3)   F-, ompT, -prophage-T7-polymerase Studier et al., 1990 
     gal, dcm 
 
E. coli BL21 (DE3) Rosetta  F-, ompT, -prophage-T7-polymerase Novagen, Darmstadt 
     gal, dcm, pRARE, cat 
 
2- Bacillus   
 
B. circulans    butirosin producer   ATCC 21558 
B. subtilis    AGAs sensitive strain   DSM 618 
 
3- Micromonospora 
 
M. echinospora    gentamicin producer   DSM 34036 
M. olivasterospora   fortimicin B producer   DSM 43868 
 
3- Streptomyces 
 
S. lividans TK23   spc-1, actinorhodin   John Innes Institute, 
          Norwich, UK 
S. kanamyceticus   kanamycin producer   DSM 40500  
S.  fradiae    neomycin producer   DSM 40063 
S. rimosus subsp. paromomycinus paromomycin producer   NRRL 2455  
S. hygroscopicus subsp. hygroscopicus hygromycin B producer   DSM 40578 
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________________________________________________________________ 
Strain     Relevant markers/Product  Source/Reference 
_____________________________________________________________________________ 
S. tenebrarius    apramycin/tobramycin producer  DSM 40477  
S. ribosidificus    ribostamycin producer   NRRL B-11466 
S. tenjimariensis   istamycin producer    ATCC 31603  
S. lividus    lividomycin producer   ATCC 21178 
St. hindustanus    apramycin/tobramycin producer DSM 44523 
 
 
 
 
2.4.2 Vectors 
 
Tab. 2.2 Vectors used in this study 
_____________________________________________________________________________________ 
Vector    Description/Scope of use   Reference/Source 
_____________________________________________________________________________________ 
pUC18    bla, lacZ- / cloning in E.coli   Vieira and Messing, 1982 
pUCPU21   bla, lacZ- / cloning in E.coli   U. Wehmeier, Wuppertal 
pUCBM21   bla, lacZ- / cloning in E. coli   Roche-Mannheim 
pUWL201   bla, lacZ-, tsr / expression in Streptomyces Doumith et al., 2001 
pUWL218   bla, lacZ-, tsr / cloning in Streptomyecs Wehmeier, 1995 
pUWL201PW   bla, lacZ-, tsr / expression in Streptomyecs Doumith et al., 2001 
pET11a   bla, lacIT7 / expression in E. coli  Novagen, 1992 
pET16b   bla, lacIT7-10 lacO s10 His-tag /  Novagen, Madison, USA 
    expression in E. coli 
pOJ436    aac(3)IV, apramycin resistant, ori ColE1  Bierman et al., 1992 
    oriT RK2, attP C31, int C31/ cosmid library 
_______________________________________________________________________ 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
31 
2.4.3 Recombinant plasmids 
 
 
Tab. 2.3 Newly constructed plasmids created in this study 
_____________________________________________________________________________________ 
Plasmid Target gene  Description     Receptor  
 (Source)        strains 
_____________________________________________________________________________________ 
 
pKAW5
 
neoB   1.356 kb NcoI/BamHI PCR fragment   E. coli DH5 
(S. fradiae)  (primer KA1-2 & KA3) in pUCBM21  
 
pNPW1 aacC7   0.88 kb PCR fragment (primer -1 (NcoI) E. coli DH5 
  (S. rimosus subsp.) & primer-2 (pact-1)) in pUC18 (SmaI) 
  paromomycinus) 
 
pKAC2  parC   0.35 kb PCR fragment (primer HC-F &  E. coli DH5 
  (S. rimosus subsp. HC-R) in pUCPU21 (EcoRV) 
  paromomycinus) 
pKAA1 parA   0.55 kb PCR fragment (primer HparA-F &  E. coli DH5 
  (S. rimosus subsp.) HparA-R) in pUC18 (SmaI) 
  paromomycinus) 
 
pKMR1 kmr   0.567 kb NdeI/BglII PCR fragment (primer  E. coli DH5 
  (S. kanamyceticus) kmr-1 and kmr-2) in pUCPU21 (NdeI/BamHI) 
 
pLIVS2 livS   0.5 kb PCR fragment (primer HS1-F  E. coli DH5 
  (S. lividus)  HS1-R) in pUCPU21 (EcoRV) 
 
pKANS1 kanS1   1.3 kb NdeI/BamHI PCR fragment (primer  E. coli DH5 
  (S. kanamyceticus) kanS1-F and kanS-2) in pUCPU21 (NdeI/BamHI) 
 
pKS16b1 kanS1   1.3 kb NdeI/BamHI fragment  from pKANS1 E. coli JM109 (DE3) 
  (S. kanamyceticus) in pET16b (NdeI/BamHI)   E. coli DH5 
 
pS1W41 kanS1   1.3 kb NdeI/BamHI fragment  from pKANS1 E. coli DH5 
(S. kanamyceticus) in pUWL201PW (NdeI/BamHI)  E. coli ET12567 
           S. lividans TK23 
 
pKANC kanC   1.1 kb NdeI/BamHI PCR fragment (primer  E. coli DH5 
  (S. kanamyceticus) kanC-F and kanC-R) in pUCPU21 (NdeI/BamHI) 
 
pKC16b1 kanC   1.1 kb NdeI/BamHI fragment  from pKANC E. coli DH5 
  (S. kanamyceticus) in pET16b (NdeI/BamHI)   E. coli BL21 (DE3)
           E. coli JM109 (DE3) 
 
pKANE kanE   1.0 kb NdeI/BamHI PCR fragment (primer  E. coli DH5 
  (S. kanamyceticus) kanE-F and kanE-R) in pUCPU21 (NdeI/BamHI) 
 
pKE16b1 kanE   1.0 kb NdeI/BamHI from pKANE  E. coli DH5 
  (S. kanamyceticus) in pET16b (NdeI/BamHI)   E. coli Rosetta 
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_____________________________________________________________________________________ 
Plasmid Target gene  Description     Receiver  
 (Source)        strains 
_____________________________________________________________________________________ 
 
pKE11a-4 kanE   1.0 kb NdeI/BamHI from pKANE  E. coli DH5 
  (S. kanamyceticus) in pET11a (NdeI/BamHI)   E. coli Rosetta 
 
pKEW1-2 kanE   1.0 kb NdeI/BamHI fragment  from pKANE E. coli DH5 
(S. kanamyceticus) in pUWL201PW (NdeI/BamHI)  E. coli ET12567 
         S. lividans TK23 
 
pKANS2 kanS2   1.3 kb NdeI/BamHI PCR fragment (primer  E. coli DH5 
  (S. kanamyceticus) kanS2-F and kanS2-R) in pUCPU21  
(NdeI/BamHI) 
 
pK2S16b1 kanS2   1.3 kb NdeI/BamHI fragment from pKANS2 E. coli DH5 
  (S. kanamyceticus) in pET16b (NdeI/BamHI)   E. coli JM109 (DE3) 
 
pS2W12 kanS2   1.3 kb NdeI/BamHI fragment from pKANS2 E. coli DH5 
  (S. kanamyceticus) in pUWL201PW (NdeI/BamHI)  E. coli ET12567 
           S. lividans TK23 
 
pGRM1 grm   0.83 kb NdeI/BamHI PCR fragment (primer  E. coli DH5 
  (M. echinospora) grm-1 & grm-2) in pUCPU21 (NdeI/BamHI) 
 
pFMO3 genI    0.9 kb PCR fragment (primer Fm3O-F &  E. coli DH5 
  (M. echinospora) Fm3O-R) in pUC18 (SmaI) 
 
pHYG3 HM-B pht 0.83 kb PCR fragment (primer hyg-1 &   E. coli DH5 
(S. hygroscopicus hyg-2) in pUCPU21 (EcoRV) 
  subsp. hygroscopicus) 
 
pHYGC92 hygC   0.3 kb PCR fragment (primer HC-1  E. coli DH5 
(S. hygroscopicus HC-2) in pUCPU21 (EcoRV) 
subsp. hygroscopicus) 
 
pHYGC-2 hygC   1.2 kb PCR fragment (primer HygC-F & E. coli DH5 
(S. hygroscopicus HygC-R) in pUCPU21 (NdeI/BamHI) 
subsp. hygroscopicus) 
 
pBC9  btrC   1.1 kb PCR fragment (primer BC-1  E. coli DH5 
  (B. circulans)  BC-2) in pUCPU21 (SmaI) 
 
pBS1  btrS   0.7 kb PCR fragment (primer btrS-1  E. coli DH5 
  (B. circulans)  & btrS-3) in pUCPU21 (EcoRV) 
 
pBB1  btrB   1.3 kb NcoI/BamHI PCR fragment   E. coli DH5 
  (B. circulans)  (primer btrB-1 & btrB-2) in pUCBM21  
 
pFMS1419 fms14   1.5 kb PCR fragment (primer Fms14-1-  E. coli DH5 
  (M. olivasterospora) & Fms14-2) in pUCPU21 (EcoRV)  
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____________________________________________________________________________________ 
Plasmid Target gene  Description     Receptor  
 (Source)        strains 
_____________________________________________________________________________________ 
 
pFMRO9 fmrO   0.9 kb PCR fragment (primer FmrO-1-  E. coli DH5 
  (M. olivasterospora) & FmrO-2) in pUCPU21 (EcoRV)  
 
pRC1  ribC   0.3 kb PCR fragment (primer HC-1  E. coli DH5 
  (S. ribosidificus) HC-2) in pUCPU21 (EcoRV) 
 
pRPH1  rph   0.8 kb PCR fragment (primer SribAPH-1 E. coli DH5 
  (S. ribosidificus) SribAPH-2) in pUCPU21 (EcoRV) 
 
pAPRA5 aprA   1.12 kb PCR fragment (primerPHaprA-3 E. coli DH5 
  (S. tenebrarius)  PhaprA-4) in pUCPU21 (HincII) 
 
pKAMB1 kamB   0.5 kb NdeI/BamHI PCR fragment (primer E. coli DH5 
  (S. tenebrarius)  PhkamB-1 & PhkamB-2) in pUCPU21  
 
pTOBS2 tobS2   0.5 kb PCR fragment (primer HS1-F  E. coli DH5 
  (S. tenebrarius)  HS1-R) in pUCPU21 (EcoRV) 
 
pKAMA3 kamA   0.5 kb NdeI/BamHI PCR fragment (primer E. coli DH5 
  (S. tenjimariensis) PhkamB-1 & PhkamB-2) in pUCPU21  
 
pLIVB6 livB   0.55 kb PCR fragment (primer HB-1  E. coli DH5 
  (S. lividus)  HB-2) in pUCPU21 (EcoRV) 
_____________________________________________________________________________________ 
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2.5 Oligonucleotides  
 
Tab. 2.4 Homologous primers and PCR conditions 
_____________________________________________________________________________________ 
Primer Target  Primer sequences 1   Annealing temperature 
designation  gene       (T), Annealing time (t) 
_____________________________________________________________________________________ 
 
Kmr-1 (NdeI)  kmr 5’ AGAGGATGGCATATGTCGCAGTCC 3’  50°C, 1 min 
Kmr-2 (BglII)   5’ GCCCGTCGTCAGATCTTCGTGA 3’  
 
KanS-F (NdeI)  kanS1 5’ GAGGTATGTCATATGCCCCTGCAA 3’  45°C, 1 min 
KanS-R (BamHI)  5’ TGTGACGGATCCGGCTCAAG 3’ 
 
KanS2-F (NdeI) kanS2 5’ CCGACAAGGAGTCCATATGAGCAAG 3’ 45°C, 1 min 
KanS2-R (BamHI)  5’ TGCGGGATCCGTCAGGTCA 3’ 
 
KanC-F (NdeI)  kanC 5’ ATTGGGGACAGCATATGCAGGTCACC 3’ 52°C, 1 min 
KanC-R (BamHI)  5’ CGCGCACGGGATCCCTCACCC 3’ 
 
KanE-F (NdeI)  kanE 5’ GGAGCAGACCATATGAAGGCACTCGT 3’ 50°C, 1 min 
KanE-R (BamHI)  5’ CGGACGGATCCTAGTCGCGCA 3’ 
 
KA1-2 (NcoI)  neoB 5’ CGACTTTCCCATGGGGTGAA 3’   50°C, 1 min 
KA-3 (BamHI)   5’ CGGGATCCGTCGTCCAGCA 3’ 
 
neoQ-F (NdeI)  neoQ 5’ AAAGGCACCATATGAAGCGCCTTC 3’  55°C, 1 min 
neoQ-R (BamHI)  5’ CGCGGATCCGCTCAGACGT 3’ 
 
Primer-1 (NcoI) aacC7 5’ CCGTCCATGGACGAAC 3’   48°C, 45 sec 
Pact-I    5’ CAGGTGATCATCCGCC 3’ 
 
Phkamb-1 (NdeI) kamB 5’ ACAAGAGCCATATGGAGAAGATCTCGG 3’ 53°C, 1 min 
Phkamb-2 (BamHI)  5’ CCGGGATCCGGCGTCAC 3’ 
 
PhaprA-3  aprA 5’ ATGCTGCTGCTGACCTGCCG 3’   53°C, 1 min 
PhaprA-4   5’ TCAGCCCCGCGACCGGT 3’ 
 
PhkamC-1 (NdeI) kamC 5’ CAAGGACCATATGCAGAAGATCGC 3’  53°C, 1 min 
PhkamC-2 (BamHI)  5’ CCTCCGGGATCCTCCAGCATC 3’ 
 
Hyg-1 (NdeI)  pht 5’ GAATAGAGGTCCCATATGACACAAGAATCCC 3’ 52°C, 45 sec 
Hyg-2 (BamHI)  5’ GGGCGGATCCGGGCGGC 3’ 
 
HygC-F (NdeI)  hygC 5’ TTTGGGAACATATGGCGATGGACTTACA 3’ 52°C, 45 sec 
HygC-R (BamHI)  5’ GACGGGATCCCGGTCATGACGGA 3’ 
 
grm-1 (NdeI)  grm 5’ TTCGGAGGACCATATGACGACATCTG 3’ 50°C, 45 sec  
grm-2 (BamHI)   5’ GCCATCGGATCCTTCCGGAA 3’ 
 
Fm3O-F  genI 5’ GTGGCAGAGGCGGACGGAAC 3’  50°C, 45 sec 
Fm3O-R   5’ TATCCGCCGTTCCGGTCGC 3’ 
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_____________________________________________________________________________________ 
Primer Target  Primer sequences 1   Annealing temperature 
designation  gene       (T), Annealing time (t) 
_____________________________________________________________________________________ 
 
Fms14-1 (NdeI) fms14 5’ GATGGTAATTCATATGGTTGATGCTGCCCC 3’ 50°C, 1 min 
Fms14-2 (BamHI)  5’ TCACGCCGGGATCCGTCCT 3’ 
 
FmrO-1 (NdeI)  fmrO 5’ AGGTGGCCCGACATATGCTCGCCGCGG 3’ 60°C, 1 min 
FmrO-2 (BamHI)  5’ ACGGCCTGCCGGATCCGCCTACCCCG 3’ 
 
BC-1   btrC 5’ CATGACGACTAAACAAATTTGTT 3’  50°C, 1 min 
BC-2    5’ TACAGCCCTTCCCGGAT 3’ 
 
BtrB-1 (NcoI)   btrB 5’ GAACGATGCCATGGAACAGGAA 3’  44°C, 1 min 
BtrB-2 (BglII)   5’ TTGTTTAGTCGAGATCTTTAACCTCCA 3’ 
 
BtrS-1 (NdeI)  btrS 5’ TTCATATGACCATTCCATTTGACCA 3’  44°C, 1 min 
BtrS-3 (BamHI)   5’ AGCAATAGTTGGATCCTTGAAT 3’ 
 
BtrM-F   btrM 5’ GCGGCATGCAGGTTCAAAT 3’   58°C, 1 min 
BtrM-R    5’ AATTCGTGAAACAAAGAGATCGGA 3’ 
 
BtrJ-F   btrJ 5’ AAGCCCTATGAAGTTCACTCA 3’  50°C, 1 min 
BtrJ-R     5’ TTCATGAGTTAATGAACAGCC 3’ 
 
BtrP-F   btrP 5’ GAGATAGCATGCGATTGATTT 3’  51°C, 1 min 
BtrP-R    5’ TCATATCGAGCGTGCAGTC 3’ 
 
ribN-F (NdeI)  ribN 5’ GAGAAGGCATATGCCTACATC 3’  40°C, 45 sec 
ribN-R (BamHI)  5’ GTTGTTGGGATCCTGGTTG 3’ 
 
SribAPH-1 (NcoI) rph 5’ ATGCCGACCATGGAAAGCAC 3’  57°C, 1 min 
SribAPH-2 (BamHI)  5’ GTCTCCGTGGATCCAGAAGAACTCG 3’ 
 
nbrB-1 (NdeI)  nbrB 5’ GAGGACCCCCATATGCCGCACCCG 3’  56°C, 45 sec 
nbrB-2 (BamHI)  5’ TGCCCCGGGATCCTCAGGCGTT 3’ 
 
StenjkamA-1 (NdeI) kamA 5’ CAAGGACCATATGCGCAAGGTCGC 3’  55°C, 1 min 
StenjkamA-2 (BamHI)  5’ AAGAGCCTGGATCCGCGGCTCAG 3’ 
 
aac4-F   aacC4 5’ GTGCAATACGAATGGCGAAAAGC 3’  50°C, 1 min 
aac4-R    5’ TGAGCTCAGCCAATCGACTGG -3’ 
 
aadA-F   aadA 5’ AACATCATGAGGGAAGCGGTGAT 3’  55°C, 1 min 
aadA-R    5’ AGACATTCTTTGCCGACTACC 3’ 
_____________________________________________________________________________________ 
1 
= the recognition sequence for restriction endonucleases are underlined. 
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Tab. 2.5 Newly developed heterologous primers  
_____________________________________________________________________________________ 
Target genes    Designation and sequence   Expected size of 
(examples)    of the heterologous  primer   PCR product (kb) 
 
2-deoxy-scyllo-inosose  HC- F: 5’ CTSTCGATSAAGCAGGCSGTCAACTT 3’ 0.35 
synthase (kanC) HC- R: 5’ TGSCCSATSGTGTSGCCGTA 3’ 
 
2-deoxy-scyllo-inosose HS1- F: 5’ TGYGGSGTCGGYGCSGGIGAC 3’  0.5 
aminotransferase (kanS1) HS1- R: 5’ AKGCASCGGTTGCTGCCCATCA 3’ 
 
Aminotransferase (kanS2) HS2- F: 5’ GGCGGCATCCCCTTCCCSAACACC 3’  0.8 
 HS2- R: 5’ GCCCTCGGCRAGGATCGCCIISAC 3’ 
 
Aminotransferase (tobS2) HtobS2- F: 5’ TCGGCGGCATCCCCTTCCCGAAC 3’  0.7 
 HtobS2- R: 5’ CGGCGTGAAGCCGCCGATCTCG 3’ 
 
6’-hexosamine- HB- F: 5’ CGGCTACCACGGCTACGAC 3’  0.55 
-aminotransferase (kanB) HB- R: 5’ CGCCGGTACGAACTGGAAG 3’ 
 
Protein of unknown function HparA- F: 5’ CCCTGGATCGTSCGCAGTTCG 3’  0.85 
(parA- like) HparA- R: 5’ GAACATCACSGCSGCGTGCTC 3’ 
 
6’-C-methyltransferase (forK) HKL1- F: 5’ GGMCGKCACGTGCCGATCGG 3’  0.75 
 HKL.1- R: 5’ ACGTAGTGCTCGATCTCGTCGACCAC 3’ 
_____________________________________________________________________________________ 
The following letters in the primer sequences indicate: I = deoxyinosine; K = (T or G); M = (A or C); R = (G or A); 
S = (C or G); Y = (C or T). 
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2.6 Probes and cosmid banks 
 
Tab. 2.6 Probes used for screening of the different cosmid banks  
 
_____________________________________________________________________________________ 
Strain    Cosmid bank (CB) Template gene and size of the probe (kb) 
_____________________________________________________________________________________ 
 
S. kanamyceticus  2460   kmr (16S ribosomal RNA methylase), 0.5  
DSM 40500 
 
S. fradiae   2458   neoB (aminotransferase), 1.2 
DSM 40063 
 
S. rimosus subsp.  2459   aacC7 (aminocyclitol N-acetyltransferase), 0.88 
paromomycinus     parC (2-deoxy-scyllo-inosose synthase), 0.35 
NRRL 2455      parA (protein of unknown function), 0.8 
 
S. tenebrarius   3730   kamB (16S ribosomal RNA methylase), 0.5 
DSM 40477      aprA (apramycin biosynthesis gene), 1.1 
       tobS2 (putative 3’’-aminotransferase), 0.5 
 
S. hygroscopicus  2720   pht (hygromycin B 7’-phosphotransferase), 1.1 
subsp. hygroscopicus      hygC (2-deoxy-scyllo-inosose synthase), 0.35 
DSM 40578 
 
M. echinospora   2700   grm (16S ribosomal RNA methylase), 0.8 
DSM 43036      fmrO3’-like (protein of unkown function), 0.9 
 
M. olivasterospora  3664   fms14 (formimidoyl fortimicin A synthase), 1.5 
DSM 43868      fmrO (16S ribosomal RNA methylase), 0.9 
 
B. circulans   2695   btrC (2-deoxy-scyllo-insose synthase), 1.1 
ATCC 21558   2695.2   btrS (2-deoxy-scyllo-inosose aminotransferase), 0.7 
 
S. ribosidificus   3753   ribC (2-deoxy-scyllo-insose synthase), 0.35 
NRRL B-11466     rph (aminoglycoside-3’-phosphotransferase), 0.8  
 
S. lividus   3759   livB (aminotransferase), 0.55  
ATCC 21178      livS (2-deoxy-scyllo-inosose aminotransferase), 0.5 
 
S. tenjimariensis   3758   kamA (16S ribosomal RNA methylase), 0.5 
ATCC 31603      istC (2-deoxy-scyllo-inosose synthase), 1.0 
 
St. hindustanus   2730   kamB (16S ribosomal RNA methylase), 0.5 
DSM 44523      aprA (apramycin biosynthesis gene), 1.1 
       tobS2 (putative 3’’-aminotransferase), 0.5 
_____________________________________________________________________________________ 
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Tab. 2.7 Cosmids positively screened and used for sequence determinations 
_____________________________________________________________________________________ 
Strain    Cosmid Probe/total number of  Selected cosmids  
    banks (CB) positively screened cosmids for sequencing 
_____________________________________________________________________________________ 
 
S. kanamyceticus  2460  kmr / 4    SkaJ19 & SkaJ15 
DSM 40500 
  
S. fradiae   2458  neoB / 10   SfrF04 & SfrA10 
DSM 40063 
 
S. rimosus subsp.  2459  aacC7 / 6   SriA13 
paromomycinus    parC / 6   SriG07 & SriD03 
NRRL 2455     parA / 9   SriL03 
 
S. tenebrarius   3730  aprA / 7   SteO08 
DSM 40477     kamB / 15   SteO08 
tobS2 / 11   SteM07 & SteK17 
 
S. hygroscopicus  2720  hyg-pht / 18   ShyG17 
subsp. hygroscopicus  
DSM 40578 
 
M. echinospora   2700  grm /13   MecP21, MecE04  
DSM 43036         & MecG05 
      genI / 9    MecO02 
 
M. olivasterospora  3664  fms14 / 5   MolI14  
DSM 43868     fmrO / 6   MolJ05 
 
B. circulans   2695  btrC / 19   BciH11 
ATCC 21558     btrM / 5   - 
      btrS / 2    - 
    2695-2  btrS / 10   - 
 
S. ribosidificus   3753  ribC / 5    SribP10 
NRRL B-11466    rph / 8    SribL03 
 
S. lividus   3759  livS / 7    SliD01 
ATCC 21178     livB / 11   SliD01 
 
S. tenjimariensis   3758  kamA / 20   StenF24 
ATCC 31603     istC / 5    StenO22 
 
St. hindustanus   2730  kamB & aprA / 15  ShinN01 
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2.7 Antibiotics  
 
The antibiotics used in this work were normally supplemented to the corresponding growth 
media at the concentration mentioned in Tab. 2.8. 
 
Tab. 2.8 Antibiotics 
_____________________________________________________________________________ 
Antibiotic Final concentration in media Solvent for dissolving 
 (µg/ml) the antibiotic 
_____________________________________________________________________________ 
Ampicillin 100 sterilized water 
Apramycin 50 sterilized water 
Chloramphenicol 25 ethanol 
Gentamicin 5 sterilized water 
Hygromycin B 5 sterilized water 
Kanamycin 50 sterilized water 
Lividomycin 5 sterilized water 
Nystatin 50 0.1 N NaOH * 
Ribostamycin 5 sterilized water 
Spectinomycin 100 sterilized water 
Tetracycline 5 ethanol 
Thiostrepton 25 DMSO 
Tobramycin 50 sterilized water 
_____________________________________________________________________________________________ 
* = dissolved in a small volume of sterile 0.1 N NaOH and made up to volume with sterilized water 
 
 
2.8 Growth and maintenance of bacterial strains 
 
2.8.1 Growth and maintenance of E. coli and B. strains 
 
E. coli and B. sp. strains were generally cultivated at 37°C on LB plates, in LB medium or in 2x 
TY liquid media. Strains harboring plasmids or cosmids were grown on plates or in liquid media 
supplemented with the appropriate antibiotics. For stock cultures, cells were concentrated and 
suspended in slant medium 50:50 and stored at - 20°C (Sect. 2.2.1). 
 
2.8.2 Growth and maintenance of Streptomyces sp. and Micromonospora sp. strains 
 
Most Streptomyces sp. strains were grown on solid media such as SMA and SPMR plates or in 
liquid media such as YEME and TSB whereas Micromonospora sp. strains were grown on M65 
plates or in TSB liquid media. Both Streptomyces sp. and Micromonospora sp. strains were 
incubated at 28 - 30°C for 2 - 7 days. Testing of aminoglycoside antibiotic production by the 
producing strains was performed through inoculation of each strain in the aminoglycoside 
antibiotic production medium and incubation for 3 - 7 days at the appropriate temperature (28 - 
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30°C for Streptomyces sp. and Micromonospora sp. and 37°C for B. circulans). 300 - 400 µl of 
the supernatants was taken and put into wells made in LB plated previously seeded with 107 
spores of B. subtilis followed by incubation of plates at 37°C for 12 hrs. The resulted inhibition 
zones were recorded and annotated. Strains harboring plasmids were cultivated in media 
supplemented with the appropriate antibiotics (Tab. 2.8). Spore suspensions were generated 
according to Kieser et al. (2000) by separating spores from a well sporulated plate by flooding it 
with 6 ml of 20% (v/v) glycerol and scraping the spores off the substrate mycelia with a 
sterilized inoculating loop. The spore suspension was filtered through sterile non-absorbent 
cotton wool to remove mycelial fragments. The spore suspension was then stored at - 80°C. 
 
2.9 In vitro manipulation of DNA 
 
2.9.1 Preparation of plasmid DNA from E. coli 
 
Preparation of plasmid DNA from E. coli was performed according to two methods: I- Plasmid 
DNA for DNA sequencing was prepared using the QIA prep Spin Miniprep kit according to the 
manufacturer’s specification. II- The alkaline-SDS method was used for rapid screening of 
transformants (Birnboim and Doly, 1979). 
 
2.9.2 Preparation of cosmid DNA from E. coli 
 
Preparation of cosmid DNA from E. coli was carried out using the method of Birnboim and Doly 
(1979) with some modifications. After addition of solution III and centrifugation for 15 min, the 
supernatant was extracted with an equal volume of chloroform/isoamylalcohol (24:1). The 
aqueous phase was further extracted using an equal volume with phenol/chloroform (1:1) and 
transferred to a new tube where the DNA was precipitated by the addition of 400 µl isopropanol 
with subsequent centrifugation for 30 min at 13,000 rpm. The supernatant was discarded and the 
DNA was washed in 70% cold ethanol, centrifuged at 13,000 for 15 min and dried. DNA was 
then dissolved in 100 µl TE buffer containing RNase 100 µg/ml. 
 
2.9.3 Extraction of genomic DNA from actinomycetes and bacilli 
 
Chromosomal DNA was prepared according to two methods: I- Genomic DNAs of S. 
kanamyceticus, S. fradiae, S. rimosus and M. echinospora were extracted according to the 
method of Pospiech and Neumann (1995) with minor modifications. Strains were inoculated in 
10 ml TSB or YEME liquid media in a 10 x 22 cm glass tubes with a short metal spring. The 
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culture was grown at 28°C on a shaker (180 rpm) for 3 - 4 days to the late logarithmic phase. The 
mycelia was then harvested by centrifugation at 4,000 rpm for 7 min and washed twice with 
10.3% sucrose. Approximately 0.5 g of cells was then resuspended in 10 ml SET buffer with 1 
mg/ml lysozyme and incubated for 1 - 2 hrs at 37°C. Furthermore, 1/10 volume SDS 10% and 
proteinase K to the final concentration of 0.5 mg/ml were added and incubated at 55°C for 1 - 2 
hrs with frequent gentle inversion. 1/3 volume 5 M NaCl was added and an equal volume 
phenol/chloroform was added and incubated at room temperature for 20 min with gentle 
inversion. The mixture was then centrifuged at 4,000 rpm for 10 min and the aqueous phase was 
further extracted with an equal volume of chloroform/isoamyl alcohol (24:1), incubated at room 
temperature for 20 min with gentle inversion, centrifuged at 4,000 rpm for 10 min. The DNA 
was precipitated by the addition of an equal volume of isopropanol, centrifuged at 4,000 rpm for 
5 min. DNA was then washed using 70% ice cold ethanol, dried and finally dissolved in 200 - 
400 µl TE buffer with RNase 100 µg/ml. 
II- Genomic DNAs of S. hygroscopicus, M. olivasterospora, B. circulans, S. tenebrarius, S. 
ribosidificus, S. tenjimariensis, S. lividus and St. hindustanus were prepared according to the 
modified cetyltrimethyl ammonium bromide (CTAB) procedure (Mehling et al., 1995a). 
 
2.9.4 Restriction endonuclease digestion of DNA 
 
DNA restriction was performed using approximately 2 - 4 units endonuclease enzyme per 1 µg 
DNA in the reaction mixture. The reaction volume was made up to 20 or 30 µl with sterile water 
together with the recommended enzyme buffer. The mixture was incubated 1 - 2 hrs at the 
appropriate temperature according to the recommendations of the manufacturer. 
 
2.9.5 Blunt end generation using the Klenow fragment of DNA polymerase I 
 
PCR products obtained with the Taq DNA polymerase were subjected to treatment by Klenow 
polymerase in order to generate blunt ends prior to ligation. Treatment by Klenow polymerase 
was performed according to manufacturer’s recommendations. The reaction was made in a total 
volume of 100 µl at 37°C for 30 min using 1 - 2 U of Klenow fragment. For the 5’ 
phosphorylation of both ends of the PCR product, the mixture was treated with 1 U T4-
polynucleotide kinase and 5 µl 10 mM ATP and further incubated for 30 min at 37°C. The 
mixture was then heat inactivated at 75°C for 20 min followed by addition of equal volume of 5 
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M ammonium acetate. DNA was precipitated with 2.5 fold volume ice-cold absolute ethanol, 
washed in 70% ethanol and dissolved in an appropriate amount of TE buffer. 
 
2.9.6 Recovery of DNA fragments from agarose gels 
 
DNA fragments were subjected to agarose gel electrophoresis. The DNA fragments less than 10 
kb were excised and subsequently purified using QIA quick Gel Extraction Kit (Qiagen, Hilden) 
according to the manufacture’s specifications. On the other hand, DNA fragments bigger than 10 
kb were excised from low melting point agarose, melted at 60°C, extracted with 
phenol/chloroform. The aqueous phase was transferred to a new tube, mixed with equal volume 
of 5 M ammonium acetate. DNA was precipitated with 2.5 fold volume ice-cold absolute 
ethanol, washed in 70% ethanol and dissolved in an appropriate amount of TE buffer. 
 
2.9.7 Removal of phosphate groups from DNA 
 
Linearized DNA was treated with 1 - 2 U calf intestine alkaline phosphatase (CIAP) and 
incubated at 37°C for 20 - 30 min in order to remove 5’-phosphate groups. CIAP was inactivated 
by heat inactivation at 70°C for 15 min. 
 
2.9.8 Ligation of DNA fragments 
 
Ligation reactions were performed in 20 or 30 µl total volume (4:1 molar ratio insert to vector) 
with ligation buffer and T4-DNA ligase at 16°C. Furthermore, blunt-end ligation was carried out 
using 2 U T4-DNA ligase for about 12 hrs, whereas ligation of fragments with cohesive ends 
were incubated using 1 U T4-DNA ligase for at least 2 - 4 hrs. 
 
2.9.9 Quantitation of DNA 
 
DNA concentrations were quantified photometrically at a wavelength of 260 nm as described by 
Sambrook and Russell (2001). An OD260 of 1.0 is equivalent to approximate 50 µg/ml DNA. The 
OD of the DNA solution was also measured at 280 nm to check for contamination with phenol or 
proteins. The ratio of OD260/OD280 of pure DNA solutions should range from 1.8 - 2.0. 
 
2.9.10 Construction of cosmid banks 
 
This step was basically done by Combinature Biopharm company (Berlin, Germany) using the 
protocols described in the literature (Beye et al., 1998; Burgtorf et al., 1998). In short: 
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homogenized bacterial cultures were embedded in 0.5% low melting point agarose and incubated 
with lysozyme (2 mg/ml 14 hrs RT) and proteinase K (1 mg/ml 24 hrs 50°C), successively. 
Embedded DNA was partially digested with Sau3A1, the DNA extracted using gelase and 
dephosphorylated. Ligation-reactions were set up with 750 ng digested vector pOJ436 (Bierman 
et al., 1992), desalted, packged and transfected into E. coli DH5. Colonies were robotically 
gridded into microtiterplates and transferred onto nylon membranes (Amersham Biosciences, 
Freiburg). After the colonies were grown, the membranes were processed according to Nizetic et 
al. (1991) and non-radioactively hybridized using standard procedures (Roche Diagnostics).  
 
2.9.11 Preparation and screening of the cosmid banks 
 
This step was also carried out by Combinature Biopharm (Berlin, Germany) using the protocol 
described by Trefzer et al. (2002) under use of roboting devices for the handling of large sets of 
cosmid libraries at the laboratories of Combinature Biopharm. Cosmids were considered 
positively tested when giving signals with two different homologous probes or when showing-up 
in two independent rounds of screening with the same probe. The positively screened cosmids 
were confirmed by PCR, mapped by restriction and ordered for overlapping genomic areas in 
order to select the appropriate cosmids for sequencing (Tab. 2.7). Sequence determination for the 
creation of publishing quality data sets was carried out using customer service via first shotgun-
cloning and sequencing of whole cosmids and subsequent primer-walking strategies in order to 
create single contigs for a given genomic region from overlapping cosmids at GATC Biotech 
company (Konstanz, Germany), Seqlab (Göttingen, Germany) or at AGOWA company (Berlin, 
Germany). 
 
2.9.12 DNA sequencing  
 
DNA sequencing was performed according to the method described by Sanger et al. (1977) 
using the Thermosequence Cycle-Sequencing kit (Amersham Bioscience, Freiburg) and primers 
labelled with Cy5 according to manufacturer’s specifications on an automatic sequencer (A.L.F. 
express; Amersham Bioscience, Freiburg). 
 
2.10 Preparation of competent E. coli cells 
 
E. coli competent cells were prepared according to the modified Hanahan (1983) method. The 
cells were incubated for 12 - 14 hrs at 300 rpm at 37°C in 3 ml LB medium. 200 µl from this 
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culture were inoculated in 20 ml SOB medium and incubated at 37°C for 2 - 3 hrs at 300 rpm 
until the OD600 reached 0.5 - 0.6. All the following steps were carried out on ice or at 4°C. The 
cells were spun for 5 min at 3,500 rpm, resuspended in 5 ml ice-cold TMF-1 buffer and kept on 
ice for 30 min. The cells were harvested again by centrifugation at 3,500 rpm for 10 min and 
resuspended in TMF-1 buffer containing 20% glycerol. Cells were left on ice until use or 200 µl 
aliquots were made and stored at - 80°C until use. 
 
2.11 Transformation of E. coli strains 
 
E. coli cells were transformed according to Sambrook and Russell (2001). In general 10 µl of a 
ligation mixture containing 0.01 - 1.0 µg DNA were added to 200 µl competent cells and kept on 
ice for 30 min. Following a heat shock (90 sec, 42°C), cells were regenerated in 800 µl SOC or 
LB medium for 1 hr at 37°C, 300 rpm then the cell suspension was plated out on LB agar plates 
containing the appropriate antibiotic and/or X-Gal as a selective medium. 
 
2.12 Preparation of protoplasts from Streptomyces strains 
 
Protoplasts were prepared according to the method of Hopwood and Wright (1978). Mycelium 
were grown in 30 ml of YEME or TSB supplemented with PEG 8000 and 0.5% glycine in 250 
ml buffled flasks for 16 hrs at 30°C at 150 rpm. Media was inoculated with 300 µl of a culture 
previously grown to the stationary phase (30°C for 36 - 48 hrs). The mycelium was sedimented 
by centrifugation at 3,000 rpm, washed twice with 10.3% sucrose and suspended in 10 - 15 ml P- 
buffer containing 1 mg/ml lysozyme. The cell suspension was incubated at 30°C for 30 - 90 min 
or until the cells were protoplasted. The protoplast suspension was filtered through sterile cotton 
wool. The protoplasts were sedimented by spinning at 3,000 rpm for 4 min at 4°C and 
resuspended in 2 ml P-buffer. Protoplasts were stored at -80°C in aliquots of 100 µl or used 
directly for transformation. 
 
2.13 Transformation of streptomycete protoplasts with plasmid DNA 
 
Protoplasts were transformed according to Babcock and Kendrick (1988). Frozen protoplasts 
were quickly thawed and centrifuged at 3,000 rpm for 7 min then resuspended in 50 - 100 µl 
freshly made P-buffer. In general 100 - 200 ng of plasmid DNA and 500 µl of 25% PEG1000 in 
T-buffer were added to the protoplasts and gently mixed by pipeting up and down three times. 
After 1,000 µl P-buffer had been added, the cells were plated on predried SPMR plates. Plates 
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were incubated at 30°C overnight and then overlaid with the appropriate antibiotic. Plates were 
checked for transformants after 3 - 7 days. 
 
2.14 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was carried out essentially as described by Sambrook and Russell 
(2001). DNA was separated on 0.7 - 1.5% agarose gels (according to the size of the DNA 
molecules) containing 0.1 µg/ml ethidium bromide. DNA solution had to be mixed with 1/5 of 
its volume with DNA loading buffer before loading into the wells. Electrophoresis was 
performed using TAE buffer (1x) at 5 - 10 V/cm. DNA was then visualized by illumination with 
long wavelength UV-light (302 nm). DNA fragment size was determined by comparison to 
conventionally used or commercially available DNA size markers.  
 
2.15 Polymerase chain reaction (PCR) 
 
Amplification of different probes by PCR was performed using 200 - 400 ng of the genomic 
DNA of each strain as a template and the selected primers for each probe (Tabs. 2.4 & 2.5). 
Amplifications were performed in a Personal Cycler (Biometra, Göttingen, Germany). Each 
assay (50 µl) contained 200 ng chromosomal DNA, 100 pmole of each appropriate primer, 0.2 
mM dNTPs (Invitrogen, Karlsruhe, Germany), 3 mM MgCl2, 10% DMSO to improve the 
denaturation of the template DNA and 2 U Taq DNA polymerase (Invitrogen, Karlsruhe, 
Germany). Sterilized mineral oil were layered over the reaction mixture to prevent evaporation. 
The following general conditions for the assay were used: 98°C for 5 min, then 30 cycles [95°C 
for 1 min, annealing temperatures and time according to Tab. 2.4, 72°C for 1 min (normally 1 
min for 1 kb)], and 72°C for 5 min (ramping rate 1°C/sec). The PCR products were cloned either 
by blunt end after their treatment with Klenow and kinase or restricted with the appropriate 
restriction endonucleases and then cloned into the appropriate vector hydrolyzed with the same 
restriction enzymes. 
 
2.16 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE was used for the electrophoresis of proteins in vertical slab gels using the method of 
Laemmli (1970). Electrophoresis was based on the separation of proteins according to their 
molecular weight where the proteins were collected first in the focus gel and then the separation 
was performed in the following separation gel. The final concentration of acrylamide in the focus 
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gel was 5.5% where polymerization was started with 0.1% APS and 0.01% TEMED. On the 
other hand, the concentration of acrylamide in the separation gel was 12% and the 
polymerization was started with 0.1% APS and 0.005% TEMED. Before electrophoresis, an 
equivalent volume of sample buffer was added to the protein solution and the mixture was heated 
for 3 - 5 min at 100°C for denaturing the proteins. Electrophoresis started at 80 V for 1 hr after 
which the voltage was adjusted to a constant 120 V for the rest of the run. Gels were stained in 
10 - 15 ml gel staining solution for 2 - 3 hrs or overnight with gentle shaking at 55°C. The 
staining solution was discarded and the gels were then destained using gel destaining solution for 
1 - 2 hrs at 55°C. The protein standard (Biolabs), -galactosidase from E. coli (Mr = 116.3 kDa), 
phosphorylase-b from rabbit muscle (Mr = 97.18 kDa), bovine serum albumin (Mr = 66.4 kDa), 
glutamic dehydrogenase from bovine liver (Mr = 55.5 kDa), MBP2 from E. coli (Mr = 42.7 
kDa), lactate dehydrogenase from porcine muscle (Mr = 36.6 kDa), triosephosphate isomerase 
from rabbit muscle (Mr = 26.6 kDa) and trypsin inhibitor from soybean (Mr = 20.1 kDa) was 
applied to the gels in order to determine the molecular weight (Mr) of the proteins. 
 
2.17 Heterologous gene expression 
 
2.17.1 Protein production in E. coli using the T7 RNA polymerase system  
 
Expression of KanC (2-deoxy-scyllo-inosose synthase), KanS1 (L-glutamine: 2-deoxy-scyllo-
inosose aminotransferase), KanE (3-amino-2,3-dideoxy-scyllo-inositol 1-dehydrogenase) in E. 
coli were carried out as described by Studier et al. (1990). Expression was performed under the 
control of the T7 promoter using either of the E. coli Rosetta BL21 (DE3), E. coli JM109 (DE3) 
or E. coli BL21 (DE3) strains. Single colonies harboring the plasmid pKC16b1 (KanC), 
pKS16b1 (KanS1) or pKE16b1 (KanE) and the host strain harboring pET16 (empty vector) as a 
control were grown overnight in 3 ml LB medium containing 100 µg/ml ampicillin [plus 25 
µg/ml chloramphenicol in case of E. coli Rosetta BL21 (DE3)] at 37°C on a shaker incubator 300 
rpm. 200 µl of these precultures were used to inoculate 20 ml fresh LB medium or LB medium 
supplemented with 1 M sorbitol and 2.5 mM betaine in 250 ml normal flasks and let them grow 
to an OD600 of 0.5 - 0.6. T7-RNA polymerase production was induced by the addition of 0.5 mM 
IPTG. Samples (1 ml) were taken prior to induction and at the following time intervals after the 
addition of IPTG: 1, 2, 4, 6 hrs and overnight. The cells were centrifuged at 13,000 rpm for 2 - 3 
min, washed two times with ice cold 25 mM Tris-HCl, pH 7.5 and kept at - 20°C until use or 
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resuspended in 50 - 100 µl of cracking buffer for sonification and appropriate amounts were 
subjected to SDS-PAGE gels as described in Sect. 2.16. 
 
2.17.2 Gene expression in S. lividans TK23 under the control of ermE-up promoter 
 
The recombinant plasmids pS1W41 (expressing KanS1) and pKEW1-2 (expressing KanE), 
derivatives of pUWL201PW, were transformed in S. lividans TK 23. A single transformant was 
inoculated into 10 ml TSB medium supplemented with 25 µg/ml thiostrepton. After growth for 
72 - 96 hrs at 28°C as preculture, a 0.5 ml sample was inoculated into 50 ml TSB containing 25 
µg/ml thiostrepton and incubated for another 2 - 3 days. Cells were harvested by centrifugation 
and washed twice with ice- cold 25 mM Tris-HCl buffer pH 7.5. Cells were sonified and proteins 
were analyzed by SDS-PAGE (Sect. 2.16). 
 
2.18 Cell-free extracts of E. coli and Streptomyces 
 
The E. coli or S. lividans TK23 cells harboring the expression plasmids were harvested by 
centrifugation at 13,000 rpm for 2 - 3 min and washed twice with ice-cold 25 mM Tris-HCl 
buffer pH 7.5. The pellet was resuspended in cracking buffer (Sect. 2.3) in a ratio of 6.0 ml 
buffer/g for E. coli cells and 2 ml/g for S. lividans TK23 cells. The cells were disrupted by 
sonification (3 times, each time for 45 sec following a 30 sec interval at 60 watt). Finally, the cell 
debris was sedimented by centrifugation (13,500 rpm, 30 min and 4°C) and the cell free extract 
was then transferred to a fresh cold microfuge tube prior to protein determination. 
 
2.19 Determination of protein concentration 
 
Protein determination in cell-free extract was carried out according to Bradford (1976) using the 
Protein Assay Kit (Bio-Rad) and BSA as a standard at a wavelength () of 595 nm. 
 
2.20 Western blotting and immuno-detection of proteins 
 
His-tagged proteins produced in E. coli were separated by SDS-PAGE using a prestained protein 
marker. The proteins were transferred from the PAGE to a HybondTM-C Extra membrane 
(Amersham) using a Semi-Dry Transfer cell (Bio-Rad) at 20 V for 10 min. Western blotting was 
applied and the method of immuno-detection of proteins was adapted here as recommended by 
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the provider of BM Chromagenic Western Blotting Kit (Roche-Mannheim) using an Anti-His-
tag antibody. 
 
2.21 Thin-layer chromatography (TLC) 
 
Samples of the enzyme reactions were applied on silica thin-layer sheets (Merck) using the 
mobile phase (methanol/chloroform/ammonia/water = 6/4/2/1). Detection of the spots was 
carried out with different solutions: (i) Cer reagent for detection (blue spots after heating) of 
sugars or other polysaccharides (Drepper et al., 1996b); (ii) ninhydrin solution for the detection 
of aminated compounds (i.e. 2-deoxy-scyllo-inosamine); (iii) Ehrlich reagent for the detection of 
-keto-glutaramate, where it produces a red spot on the TLC (Cooper, 1978). 
 
2.22 High performance liquid chromatography (HPLC) 
 
Samples of enzyme reactions were applied to HPLC (DIONEX Corporation, Chromeleon and 
PeakNet ® 6 Release 640, 2001) using the column Phenomenex Hypersil 3U NH2 APS (150 x 
4.60 mm, 3 micron) and the mobile phase acetonitrile/water with the ratio of 80: 20 v/v. 50 µl of 
each enzyme reaction was injected into the HPLC using an automated pipetting system. The 
running time for each sample was 60 min with a flow rate of 1 ml/min. HPLC runs were carried 
out at room temperature and the substrates were detected by a UV-detector at  210 nm. 
Activities of KanC and KanS1 were determined using HPLC with the previously mentioned 
conditions and the dilutions made for each assay was described in Sects. 2.23 & 2.24. 
 
2.23 Determination of the activity of KanC 
 
The activity of the 2-deoxy-scyllo-inosose synthase (KanC) was determined according to the 
protocol developed for the AcbC enzyme assay described by Stratmann et al. (1999) with minor 
modifications. The enzyme assay (100 µl) was performed at 30°C for 6 - 12 hrs using 20 µl G-6-
P (60 mM), 2 µl NAD (125 mM), 2 µl NaF (200 mM), 2 µl CoCl2 (4 mM), 20 µl phosphate 
buffer (100 mM, pH 7.5) and 30 µl of the soluble fraction of the cell free extract of KanC (1.5 - 
2.5 mg protein/ml). After incubation the reaction was stopped by heating at 95 - 100°C and 
centrifuged at 13,000 rpm for 2 - 3 min. 4 - 6 µl of the reaction supernatant was analysed by TLC 
and detected with Cer reagent (Sect. 2.21). 70 µl of the assays were diluted with 50 µl water and 
applied to the HPLC (Sect. 2.22). Standard 2-deoxy-scyllo-inosose was kindly provided via 
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chemical synthesis from the organic chemistry department, BU Wuppertal (Prof. Dr. H.J. 
Altenbach and Dr. M. Podeschwa). 
 
2.24 Determination of the activity of KanS1  
The activity of the putative bifunctional (L-glutamine: 2-deoxy-scyllo-inosose and L-glutamine: 
1-keto-2,3-dideoxy-3-amino-scyllo-inositol) aminotransferase KanS1 was analyzed using a 
coupled enzyme assay with the KanC protein: 
 
 KanC assay reaction (2.23) 70 µl 
 100 mM L-glutamine  15 µl 
 150 mM Tris-HC buffer pH 7.5 with 6 mM PLP 15 µl 
 KanS1 extract (2.0 mg protein/ml) 30 µl 
 
The reaction was incubated at 37°C for 4 - 6 hrs then the reaction was stopped by heating at 95-
100°C and centrifuged at 13,000 rpm for 2 - 3 min. Samples of 4 - 6 µl of the reaction 
supernatant were analysed by TLC (Sect. 2.21), where ninhydrin solution and Ehrlich reagent 
were used to detect formation of both 2-deoxy-scyllo-inosamine and -keto-glutaramate, 
respectively. Samples of 120 µl of the assays were applied to the HPLC (Sect. 2.22).  
Furthermore, a spectrophotometric assay was performed to detect the activity of KanS1 using L-
alanine as aminodonor. The newly formed pyruvate can be reduced to L-lactate in the presence 
of NADH and L-lactate dehydrogenase (550 U/mg; Roche-Mannheim). The activity of KanS1 
was measured via the decrease in absorption of NADH by time at 340 nm using the Perkin-
ELMER UV/VIS lambda spectrometer. The spectrophotometric assay was performed as follows: 
 
 20 mM 2-deoxy-scyllo-inosose 50 µl 
 100 mM L-alanine 50 µl 
 150 mM Tris-HC buffer pH 7.5 with 6 mM PLP 100 µl 
 125 mM NADH di-sodium salt 10 µl 
 L-lactate dehydrogenase (25 mg/2.5 ml, 550 U/mg) 10 µl 
 KanS1 extract (2.0 mg protein/ml) 50 µl 
 Water ad. 1000 µl 
 
Similar reactions but in absence of L-alanine as aminodonor or 2-deoxy-scyllo-inosose as amino 
acceptor or using the same protein concentration of cell-free extract of the host strain harboring 
pET16 plasmid (empty vector) were also performed as control reactions.  
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Reactions were incubated at RT and the specific enzyme activity (1 U = formation of 1 µmol 
NAD/min/mg protein) was calculated as follows: 
 
  
 
C  = specific enzyme activity (mol/min/mg protein)  d  = width of the cuvette (cm) 
E  = rate of change in absorbance at 340 nm (A/t in min) V1  = total volume of the reaction (ml) 
	  = molar extinction co-efficient of NADH  V2 = volume of the probe (ml) 
  (6.22 x 106 mol/cm x 1)  cp  = protein concentration of the  
n  = molar ratio (mole NADH oxidized per mole pyruvate reduced)  probe (mg/ml) 
 
 
2.25 Determination of the activity of KanE 
The enzymatic activity of the putative NAD(H): Cyclitol 1-dehydrogenase (KanE) was 
determined using the coupled assay with KanC and KanS1 protein (Sect. 2.24). The reactions 
were incubated at 30°C for 12 - 20 hrs in absence and in presence of 3 - 4 mM ZnCl2. Samples of 
4 - 6 µl were monitored by TLC using ninhydrin solution for detection. In addition, 30 µl fresh 
extract of KanS1 (2.0 mg/ml protein) was added and the mixture was further incubated at 37°C 
for 4 - 6 hrs then samples of 4 - 6 µl were applied to TLC (Sect. 2.21). Furthermore, an attempt 
was made to measure the KanE activity spectrophotometrically via measurement the increase of 
absorbance at 340 due to formation of NADH. 
 
A- For TLC analysis the tests were performed as follows: 
 KanC/KanS1 assay reaction (2.24) 100 µl 
 NAD (125 mM)  1.0 µl 
 ZnCl2 (100 mM) 5.0 µl 
 KanE extract (1.5 - 2.5 mg protein/ml) 15 µl 
 KanS1 extract (2.0 mg protein/ml) 30 µl 
 
B- The spectrophotometric assays were performed as follows: 
 KanC/KanS1 assay reaction (2.24) 100 µl 
 NAD (125 mM)  8.0 µl 
 ZnCl2 (100 mM) 10.0 µl 
 KanE extract (1.5 - 2.5 mg protein/ml) 30 µl 
 Sterilized water ad. 1000.0 µl 
C = 
E x V1 
 x d x V2 x cp x n 
mol/min/mg protein 
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2.26 Computer programs 
The algorithms and program packages used for the computer-assisted analysis of DNA and 
protein sequences were: Staden package (Staden 1996; http://staden.sourceforge.net/), FramePlot 
(Ishikawa and Hotta, 1999; http://www.nih.go.jp/~jun/cgi-bin/frameplot.pl), Clustal V (Higgins 
et al., 1991), Clustal W (Thompson et al., 1994; http://www2.ebi.ac.uk/clustalw/), FASTA 3 
(Pearson and Lipman, 1988; http://www2.ebi.ac.uk/fasta3/), BLAST (Altschul et al., 1990; 
http://www.ncbi.nlm.nih.gov/BLAST/), Nucleic acids research (SMART; Letunic et al., 2004; 
http://nar.oupjournals.org/cgi/content/full/32/suppl_1/D142), Sequence Manipulation Suite 
(http://www.cbio.psu.edu/sms/index.html), Mac-plasmap (CGC Scientific. Inc.), DNA-
STRIDERTM 1.2 (Marck, 1988). Restriction enzyme analysis was performed using: Restriction 
Enzyme Site Mapper version 3 (http://www.restrictionmapper.org/) or Webcutter 2.0 
(http://www.firstmarket.com/cutter/cut2.html). PCR amplification temperatures were computed 
using PRIMER-FIND 3.0  (Fröbel Labor-Geräte, Lindau), pDRAW32 
(http://www.acaclone.com) or Primer X (http://bioinformatics.org/primerx/). 
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3 Results 
 
A Gene clusters for the production of 2-deoxystreptamine (2DOS) 
and related ACAGAs 
 
3.1 Isolation and sequence analysis of the biosynthetic gene clusters 
 
For the elucidation of the genetics and the different pathways for the production of 2DOS and 
related aminocyclitol-aminoglycoside antibiotics (ACAGAs), an attempt was made to identify, 
clone, sequence and analyse the respective gene clusters and their immediate genomic 
environment. For this purpose, genomic DNAs were prepared from a series of strains producing 
ACAGAs (see Sect. 2.9.3). Genomic cosmid libraries were constructed at Combinature 
Biopharm in the Streptomyces-E. coli shuttle-cosmid vector pOJ436 (Bierman et al., 1992) and 
screened by various homologous and heterologous probes (cf. Sect. 2.9.11). This strategy was 
based on the existing knowledge that in Actinobacteria as a rule all the genes involved in 
production of an antibiotic or other secondary metabolite (i.e. genes for biosynthesis, resistance, 
transport, and often regulation) are located in one single gene cluster. Also, resistance and very 
few biosynthetic genes for many ACAGAs had already been described from our and other 
laboratories in the past, such that the partial sequence information could be taken from the data 
base for a majority of cases to be studied. All probes used were isolated by PCR using 
homologous or heterologous primers, cloned and sequenced for verification (cf. Tabs. 2.4 & 2.5). 
The positively screened cosmids were identified, analysed and some of them were selected for 
sequencing as described in Sect. 2.9.12 (cf. Tabs. 2.6 & 2.7). The insert sequences of a single or 
of overlapping cosmid clones were sequenced, analysed, and submitted to the EMBL gene bank 
and received the accession codes as given in Tab. 3.1. 
From the ACAGAs chemical point of view as well as from the analysed gene clusters of the 
ACAGAs regarded, the ACAGAs can be categorized into five subgroups as follows: (i) 
ACAGAs containing 4,5-glycosylated 2DOS which includes both pseudotetrasaccharidic 
antibiotics such as NMs, PMs, LM and pseudotrisaccharidic antibiotics such as RM and BUs; (ii) 
ACAGAs containing 4,6-glycosylated 2DOS which includes KMs, GMs and TM; (iii) ACAGAs 
containing 4-glycosylated 2DOS with one representative, Apr; (iv) ACAGAs containing 5-
glycosylated 2DOS with one representative, HM-B; (v) Other ACAGAs related to the2DOS 
containing antibiotics, i.e. FTMs (or astromicin) and IM. 
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Tab. 3.1 Sequence data of fully sequenced ACAGA gene clusters which have been 
submitted to the EMBL data base and their accession codes 
_____________________________________________________________________________ 
Strain Number AGA- Size of submitted Accession  
 cluster sequences (kb) codes 
_____________________________________________________________________________ 
S. kanamyceticus DSM 40500  kan  41.576   AJ628422 
 
S. fradiae DSM 40063  neo  50.466   AJ629247 
 
S. rimosus subsp. NRRL 2455  par  48.169   AJ628955 
paromomycinus 
 
S. tenebrarius DSM 40477  tob  43.220   AJ810851 
    apr  41.623   AJ629123 
 
S. hygroscopicus subsp. DSM 40578  hyg  34.921   AJ628642 
hygroscopicus  
 
M. echinospora DSM 43036  gen  80.880   AJ628149 
 
M. olivasterospora DSM 43868  for  47.238   AJ628421 
 
B. circulans ATCC 21558  btr  19.248   AJ781030 
 
S. ribosidificus NRRL B-11466  rib  43.190   AJ744850 
 
S. lividus ATCC 21178  liv  40.579   AJ748832 
 
S. tenjimariensis  ATCC 31603  ist  69.904   AJ845083 
 
St. hindustanus  DSM 44523  apr  39.979   AJ875019 
__________________________________________________________________________________ 
apr = apramycin; btr = butirosin; for = fortimicin; gen = gentamicin; hyg = hygromycin B; ist = istamycin; ; kan 
= kanamycin; liv = lividomycin; neo = neomycin; par = paromomycin; rib = ribostamycin; S. = Streptomyces; 
St. = Streptoalloteichus; tob = tobramycin. 
 
 
Furthermore, all the above mentioned ACAGAs possess 2DOS or a similar diamino cyclitol as 
the basic aglycone subunit. In the FTMs, this unit is basically derived from the myo-insitol 
pathway (see Sect. 1.1.5.2). On the other hand, in the IM, the aminocyclitol unit is derived from 
2-deoxy-scyllo inosamine. All these mentioned antibiotics are produced by actinomycetes except 
BUs which are produced by B. circulans. Upon screening of both cosmid banks of both S. 
tenebrarius DSM 40477 and St. hindustanus DSM 44523, it was found that both strains contain 
two separate gene clusters for the two ACAGAs, Apr and TM, these two strains produce in 
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parallel. It was also observed that both gene clusters were not located in vicinity to each other on 
the genome since no overlapping cosmids were found by hybridizing with both probes specific 
for apr- and tob-clusters. Furthermore, all the submitted DNA sequences exhibit typical 
actinomycete G+C content (70%) and codon usage except the one from B. circulans (Bibb et al., 
1984). The characterization and nomenclature of the ORFs for the respective gene clusters are 
indicated in the appendix section (see Tabs. A.1-A.14). 
 
3.2 Gene clusters for the individual classes of 2DOS and related ACAGAs  
 
3.2.1 4,5-glycosylated 2DOS-ACAGAs (NM group) 
The NMs, PMs, LMs, RM and BUs are members of this group (cf. Fig. 1.2). The insert 
sequences containing their encoding neo-, par-, liv-, rib- and btr- gene clusters on single or 
overlapping cosmids were determined and annotated. All the respective gene clusters seem to be 
complete except for the btr-cluster (Fig. 3.2). For isolation of the neo-cluster, the cosmid bank 
from the NM producer S. fradiae DSM 40063 was screened by use of the neoB probe, where a 
total of 10 cosmids were positively hybridized. The two overlapping cosmids SfrA10 and SfrF04 
were selected for sequencing and used to determine a total of 50466 bp representing a contiguous 
DNA segment on which the neo-cluster was located (Fig. 3.1). A total of 30445 bp from both 
cosmids comprising 22 ORFs was annotated for the neo-cluster, i.e. the gene cluster was flanked 
by ORFs SfrA10.7c (aphA; encoding aminoglycoside 3'-phosphotransferase) and SfrF04.17 
(neoY; encoding putative AGA biosynthetic protein; Fig. 3.2).  
For isolation of the par-cluster, the cosmid bank from the PM producer S. rimosus subsp. 
paromomycinus NRRL 2455 was first screened by use of the aacC7 probe (Lopez-Cabrera et al., 
1989) where a total of 6 cosmids were positively hybridized (cf. Tab. 2.7). The cosmid SriA13 
was selected for sequencing (cf. Tab. 2.7). Upon partial sequencing and analysis of the regarded 
cosmid, it was found that the par-cluster was not located in the area of the aacC7 resistance gene. 
Nevertheless, a partial insert sequence (4812 bp) around the aacC7 gene was determined from 
this cosmid and submitted to the EMBL data base under accession code AJ749845. Upon 
analysis of this DNA segment, a putative second resistance gene namely aac(6’)-IIc encoding an 
aminoglycoside 6’-N-acetyltransferase type IIc enzyme was found downstream of the aacC7 
gene (Fig. 3.3; cf. Tab. A.4). 
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Fig. 3.1 Restriction maps and arrangement of the selected cosmids containing gene clusters of the 
NM group. The names in bold on the left side of the figure indicate the names of those cosmids from 
which the sequences were derived. The regions covering the individual gene clusters for each strain are 
indicated by the bar with the blue color. The numbers in bold on the right side represent the total length of 
the DNA segment determined in a single contig and submitted to the EMBL data base. Other numbers in 
the figure represent the lengths of the subsegments obtained from inserts of the individual cosmids in bp. 
E, B, Bg = restriction sites for EcoRI, BamHI, BglII, respectively. 
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Fig. 3.2 Organization of ORFs for the gene clusters of the 4,5-glycosylated 2DOS-ACAGAs (NM 
group). The color codes for differentiating the genes encoding proteins putatively involved in: 
 
paromamine biosynthesis  sugar phosphate phosphatase 
attachment and modification of sugar units  transport 
 
ACAGAs biosynthesis  regulation 
UDP-D-glucosamine synthase or amidase  resistance 
 extracellular aminoglycoside-phosphate phosphatase 
 represent genes outside the ACAGA gene clusters 
 
Therefore, for isolation of the par-cluster, two new probes (parC and parA) were prepared, using 
especially designed heterologous primers, for screening the same cosmid bank of S. rimosus 
subsp. paromomycinus (cf. Tab. 2.7). A total of 6 and 8 cosmids were positively hybridized with 
the parC and parA probes, respectively. Both SriG07 and SriD03 cosmids were hybridizing with 
parC as well as the cosmid SriL03 hybridizing with the parA probe were selected for sequencing 
of a total of 48169 bp of contiguous DNA (cf. Fig. 3.1). A total of 27061 bp within the submitted 
sequence was attributed to the par-cluster comprising 21 ORFs, flanked by ORFs SriD03.20 
(parE) and SriL03.15c (parH; cf. Fig. 3.2).  
For isolation of the rib-cluster, a total of 5 and 8 cosmids from the cosmid bank of the RM 
producer S. ribosidificus NRRL B-11466 were positively hybridized with ribC (isolated via 
      aph ribG H    I  E   S     C    M      T       U       Q   N P X F  D      L     B          A         aacC8                
                        parE    S    C    M      T       U       Q   N  P X F  D     L     B          A              Z  I pph Y  G H                        
                          livE     S   C    M      T      U        Q   N  P  F  D      L     B        Z  I   H  G            A            XO  V    W     Y  
                                                     btr(M )    L          A            B   C  D   E  F G H I   J    K   O  P     Q 
      aph neoG  H  I  E   S    C    M      T       U        Q    N  P X F  D      L     B            A        aacC8     R   (Y) 
0 10 20 30 40 50 kb 
RESULTS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
57 
heterologous primers; cf. Tab. 2.6) and rph (Hoshiko et al., 1988) probes, respectively. Both 
SribP10 and SribL03 cosmids were determined, analysed and selected for DNA sequencing. A 
total of 43190 bp of a contiguous DNA segment was completely sequenced of which the rib-
cluster covered a total of 26036 bp. The rib-cluster was composed of at least 23 ORFs and 
flanked by two resistance genes (aacC8 and rph; cf. Fig. 3.2).  
For isolation of the liv-cluster, both livB and livS probes were prepared again using the respective 
pairs of heterologous primers (cf. Tab. 2.5). The screening of the cosmid bank of the LM 
producer S. lividus ATCC 21178 delivered a total of 7 and 11 positively hybridizing cosmids, 
respectively (cf. Tab. 2.7). A total of 40579 bp of a contiguous DNA segment was sequenced 
from the cosmid SliD01; of these a subsegment of 31269 bp, comprising 23 ORFs, was annotated 
representing the liv-cluster (cf. Fig. 3.2). 
For isolation of the btr-cluster, the cosmid bank of the BUs producer B. circulans ATCC 21558 
was constructed and screened by the btrC probe (Ota et al., 2000) where 19 cosmids were 
positively hybridized (cf. Tab. 2.7). Analysis of the regarded cosmids resulted in selection of 
only one cosmid (BcirH11) for sequencing. A total of 19248 bp of a contiguous DNA segment 
was sequenced, where 19197 bp were dedicated to represent the major part of the already known 
btr-cluster with minor extension (cf. Fig. 3.2). For identification of the assumingly still lacking 
part of the btr-cluster upstream the btrS gene, the cosmid bank was rescreened by using the btrM 
and btrS probes (Ota et al., 2000) as well as a new cosmid bank was constructed and screened by 
the btrS probe. A total of 17 cosmids were hybridized positively (cf. Tab. 2.7). Unfortunately, 
none of the respective cosmids was turned out to contain DNA contiguous to the btrS gene. 
Possibly this genomic region near the btrS gene does not deliver stable cosmid clones. 
Obviously, the Japanese group (Ota et al., 2002) which had published a larger portion of the btr-
cluster already before from another strain of B. circulans, had very similar difficulties in 
extending the btrS end. Therefore, the real scope and extend of the btr-cluster is left in unknown 
state at present. 
Regarding the resistance genes in the respective clusters, both the neo- and rib-clusters were 
found to have one resistance gene at each side of the cluster; each gene encoding AGA-3’-
phosphotransferase (AphA) and aminocyclitol 3-N-acetyltransferase VIII (AAC). In addition, 
only one of these two resistance genes (aphA) was found at one side of the par-cluster and none 
so far was found in the respective DNA segments covering the liv- and btr-clusters. Two genes 
(neoT, U and the related genes) putatively encode ABC transporters that would be involved in the 
export of the respective ACAGAs products were conserved among the streptomycete clusters. In 
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addition, three conserved genes (neoG, H, I and the related genes) with similarity to cinorf12, 13, 
14 in another streptomycete antibiotic cluster (Widdick et al., 2003) were also found to be highly 
conserved in all the streptomycete clusters of this group. These three genes encode proteins 
(NeoI/H/G and related proteins) which by some evidences could play a role in the regulation of 
the respective ACAGAs biosynthesis (see Sect. 4.3). 
 
 
Fig. 3.3 Genetic map around the gene for the aminocyclitol acetytransferase VII (aacC7) from S. 
rimosus subsp. paromomycinus NRRL 2455: The ORFs from left to right encode an integral membrane 
protein (TP; incomplete), aminocyclitol 3-N-acetyltransferase type VII (aacC7), a putative 
aminoglycoside 6'-N-acetyltransferase type II (aac6’-IIc), putative epoxide hydrolase (EH), a putative 
TetR-family transcriptional regulator (R), a putative cold shock protein (SP) and a hypothetical protein 
(HP; incomplete). N, K, E = restriction sites for NcoI, KpnI and EcoRI, respectively. 
 
 
3.2.2 4,6-glycosylated 2DOS-ACAGAs (KM group) 
KMs, GMs and TM are members of this group (cf. Fig. 1.3). Screening of the cosmid banks of 
the KM producer S. kanamyceticus DSM 40500, GM producer M. echinospora DSM 43036 and 
TM producer S. tenebrarius DSM 40477 with probes derived from kmr (Demydchuk et al., 
1998), grm (Kelemen et al., 1991) and tobS2 (via heterologous primers) resulted in identification 
of 4, 13 and 11 positively hybridizing cosmids, respectively (cf. Tab. 2.7). Analysis of the 
obtained cosmids resulted in selection of the cosmids: SkaJ19 and SkaJ15 from S. 
kanamyceticus; MecP21, MecE04 and MecG05 from M. echinospora; SteM07 and SteK17 from 
S. tenebrarius for sequencing. Contiguous DNA segments of a total size of 41576, 51597, 43220 
bp from the inserts on these cosmids were firstly determined, respectively. The presumed kan-, 
gen- and tob-clusters were located on these segments (Fig. 3.4). From this analysis it was unclear 
whether the gen-cluster could extend downstream beyond the last ORF (genN). For this reason, 
another probe (genI) was prepared and used for screening of the same cosmid bank where 
another 9 cosmids being positively hybridized (cf. Tab. 2.7). An overlapping cosmid (MecO02) 
was selected for sequencing and finally the contiguous DNA segment was extended to become 
                     orfTP    aacC7  aac(6‘)-II     EH          R     SP  HP  
0                   1            2              3    4      5 kb 
E K K 
 N     N N 
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80880 bp where the gen-cluster was fully present (cf. Fig. 3.4). As shown in Fig. 3.5, the 
arrangement of the three gene clusters was conserved at least in part, especially between those for 
the mostly related ACAGAs, KM and TM. A characteristic feature of the three gene clusters is 
that some of the centrally important genes, also conserved in the other ACAGAs gene clusters 
had been duplicated or even multiplied in the past, most probably in order to acquire new 
biosynthetic functions (see Sect. 4.2.4). 
 
 
 
 
Fig. 3.4 Restriction maps and arrangement of the selected cosmids containing gene clusters of the 
KM group. The names in bold on the left side of the figure indicate the names of the cosmids from which 
the sequences were derived. The regions covering the individual gene clusters for each strain are indicated 
by the bar with the red color. The numbers in bold on the right side represent the total length of the DNA 
segment determined in a single contig and submitted to the EMBL data base. Other numbers in the figure 
represent the length of the subsegments obtained from inserts of the individual cosmids in bp. K, B, N, E 
= restriction sites for KpnI, BamHI, NcoI, EcoRI, respectively. 
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Examples are the pairs of kanS1 and kanS2 (and the related genS1, genS2, tobS1 and tobS2) and 
kanM1 and kanM2 (and the related genM1, genM2, tobM1 and tobM2). Another example is 
found in the gen-cluster alone, where four copies of the aminotransferase type III genes (genB1, 
B2, B3 and B4) were found although only a single related gene is present in both kan- and tob-
clusters. A more general analysis of the respective gene clusters revealed the presence of five 
genes (kanC, S1, E, D1, M1 and the related genes) that are also conserved in the neo-like gene 
clusters. These five genes encode proteins that would be responsible for the biosynthesis of 
paromamine (see Sect. 4.2.2 and Fig. 4.1). The analysis of the kan- and gen-clusters suggested 
that they could be complete for the biosynthesis of the respective antibiotics (see Sect. 4.2.4 and 
Fig. 4.3). In addition, the gen-cluster was found to have a complete rRNA operon (is partially 
comprised in the published sequence) which seems to flank the gen-cluster at one side. 
 
 
 
Fig. 3.5 Organization of ORFs for the gene clusters of the 4,6-glycosylated 2DOS-ACAGAs (KM 
group). The color codes for differentiating the genes encoding proteins putatively involved in: 
 
paromamine biosynthesis 
 
attachment of the first sugar unit at position 4 of the cyclitol ring and its modification 
 
attachment of the second sugar unit at position 6 of the cyclitol ring and its modification  
 
UDP-D-glucosamine synthase or amidase  C-methyltransferase 
resistance   transport 
ACAGAs biosynthesis  regulation 
represent genes outside the ACAGA gene clusters N-methyltransferase 
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This rrn operon, called rrnE because of its closest relationship to the rrnE operon of S. coelicolor 
A3(2) and is completely enclosed in our sequence and located between ORFs MecP21.23c and 
MecE04.1 (Bentley et al., 2002; cf. Tab. A.9). On the other hand, analysis of the tob-cluster 
obviously lacked the gene(s) encoding proteins that could be involved in 3’-dehydroxylation. 
Furthermore, two unique genes (kanJ and kanK) were found only in the kan- and not in the tob-
cluster which therefore, encoding KanJ and KanK which might be involved in the 2’-deamination 
process and formation of KM-A from KM-B. A common feature of this group seems to be the 
use of modification of the target site (rRNA) as a resistance mechanism instead of ACAGAs 
modifications. Two resistance genes were found in both kan (kanA and kmr) and gen-clusters 
(gmrA and gmrB); however, no equivalent resistance genes could be detected in the contiguous 
DNA segment covering the tob-cluster (cf. Fig. 3.5). The possible components of a 
sensor/response regulatory system (kanG, H and I) were only present in the kan-cluster (also 
conserved in the actinomycete gene clusters of the NM group; cf. Fig. 3.2 above) while other 
possible regulatory genes were found in all three clusters (kanU, kanR, genU and tobR). Several 
genes that could encode proteins involved in the transport of these ACAGAs were found in the 
regarded gene clusters (kanZ, kanT, kanX, tobT, tobU, genT, genY, genH and genJ) however, 
only one transporter gene (kanT and the related genes) was found to be highly conserved among 
the three clusters.  
 
3.2.3 4-glycosylated 2DOS-ACAGAs (Apr group) 
Apr is an example of this group which is produced by both S. tenebrarius DSM 40477 and St. 
hindustanus DSM 44523 (cf. Fig. 1.4). From each strain, a cosmid bank was constructed and 
screened by kamB (Holmes et al., 1991) and aprA (AY129957) probes (cf. Tab. 2.7). A total of 
22 and 15 positively hybridizing cosmids were isolated from the cosmid banks of S. tenebrarius 
and St. hindustanus, respectively. Their analysis resulted in selection of the cosmids SteO08 from 
S. tenebrarius and ShinN01 from St. hindustanus for sequencing. From the two cosmids SteO08 
and ShinN01, a total of 41623 and 39979 bp of contiguous DNA segments covering the apr-
cluster were sequenced and annotated (cf. Tab. 3.1). Subsegments of about 38770 and 34462 bp 
from SteO08 and ShinN01 cosmids both comprising 26 ORFs were attributed to the apr-clusters, 
respectively. Three incomplete transposase genes (tatA, B, C) were found only inside the apr-
cluster present on cosmid SteO08. The arrangement and the relatedness of the 26 ORFs in the 
two apr-clusters were highly conserved and the sequence identity was higher than 90% (Fig. 
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3.7). Genes that encode proteins which are likely to be involved in the biosynthesis of the 2DOS 
moiety (aprC, S, E) were also conserved in both clusters.  
 
 
Fig. 3.6 Restriction maps and arrangement of the selected cosmids containing the apr-gene clusters. 
The names in bold on the left side of the figure represent the cosmid names from which the sequences 
were derived. The regions covering the apr-gene cluster are indicated by the bar with the green color. The 
numbers in bold on the right side represent the total length of the DNA segment submitted to the EMBL 
data base. Bg, E, N = restriction sites for BglII, EcoRI, NcoI, respectively. 
 
 
 
Fig. 3.7 Organization of ORFs for the two apr-gene clusters derived from SteO08 and ShinN01 
cosmids. Both the DNA segments covering the two apr-gene clusters on the cosmids SteO08 and 
ShinN01 were derived from S. tenebrarius DSM 40477 and St. hindustanus DSM 44523, respectively. 
The color codes for differentiating the genes encoding proteins putatively involved in: 
 
 2DOS biosynthesis       transport 
attachment of sugar units to the 2DOS moiety and their modifications 
 UDP-D-glucosamine synthase or amidase 
 extracellular aminoglycoside- phosphate phosphatase   resistance 
 transposases        kinase reaction 
 ACAGAs biosynthesis    N-methyltransferase 
 represent genes outside the apr-clusters  regulation 
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The apr-cluster on the cosmid ShinN01 was incomplete for a small stretch, since it lacked part of 
the last gene, aprN. It was however, assumed that in both cases the complete set of the apr-genes 
was identified and therefore, no further attempt to elongate the sequence from St. hindustanus 
DSM 44523 genome was made. 
 
3.2.4 5-glycosylated 2DOS-ACAGAs (HM-B group) 
HM-B is a member of this group as it possesses the 2DOS unit substituted at position 5 with a 
disaccharidic moiety (cf. Fig. 1.4). The cosmid bank of S. hygroscopicus subsp. hygroscopicus 
DSM 40578 was screened with the probe of HM-B phosphotransferase gene (pht; Zalacain et al., 
1986). A total of 18 cosmids positively hybridized with this probe. Analysis of these cosmids 
resulted in selection of the cosmid ShyG17 for sequencing (cf. Tab. 2.7). A total contiguous 
DNA segment of 34921 bp, mostly likely harboring the complete hyg-cluster was sequenced (cf. 
Tab. 3.1). The respective DNA segment contained 33 ORFs of which 22 - 23 ORFs belonged to 
the hyg-cluster, from the ORFs ShyG17.9c (hygV) to ShyG17.31c (hygZ). The orientation, 
restriction map, location of the hyg-cluster and organization of ORFs are shown in Figs. 3.8 and 
3.9. It is also expected that the hyg-cluster would contain all the genes required for the 
biosynthesis of HM-B (see Sect. 4.2.6). The hyg-cluster represents a unique mixture of genes 
having very few similarities with several other ACAGAs genes clusters or other sources of genes 
involved in rare sugar or oligosaccharide biosynthesis. 
A possible sensor/response regulatory system (hygI, H and G) was also conserved in the hyg-
cluster (Fig. 3.9 and see Sect. 4.3). As expected, the HM-B resistance gene, encoding APH (7’’) 
which had been previously submitted to the data base (Zalacain et al., 1986) was present inside 
the gene cluster (hygA). The submitted sequences of this gene turned out to be identical to our 
data. Moreover, the hyg-cluster was observed to be flanked on each side by a transposase gene 
(Fig. 3.9). Regarding the structural similarity between HM-B and spectinomycin that both have a 
heterocyclic ring with two oxygen atoms in condensing the first sugar unit to the cyclitol moiety, 
the hyg-cluster contains a couple of genes (hygY and hygF) with a good similarity to related ones 
in the spc-cluster (spcY and spcF; cf. Figs. 1.1 and 1.4). The hygF gene was anticipated to encode 
an UDP-galactosyltransferase where the gene product of hygY plays a role in heterocyclization 
between the first and the second sugar moiety in HM-B. In addition, the hyg-cluster contains a 
gene encoding a putative N-methyltransferase (HygM) with high level of similarity to the 
corresponding one in the spc-cluster (SpcM). Another putative glycosyltransferase gene (hygD) 
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could encode the enzyme involved in the transfer of the second sugar, a heptose to the first sugar 
(galactose). Both gene products of hygV and hygW would be expected to play a role in the export 
system for HM-B. Similar to the apr-cluster, a putative kinase gene (hygN) as well as a putative 
phosphatase gene (hygU) were also found in the hyg-cluster (cf. Sect. 3.2.3).  
 
Fig. 3.8 Restriction map of the insert of cosmid ShyG17 and location of the hyg-cluster. The region 
for the hyg-cluster is indicated by the yellow bar. The number in bold on the right side gives the total 
length of the DNA segment submitted to the EMBL data base. E, Bg, B = restriction sites for EcoRI, 
BglII, BamHI, respectively. 
 
 
Fig. 3.9 Organization of ORFs for the hyg-cluster. The DNA segment was cloned into cosmid ShyG17. 
The color codes for differentiating the genes encoding proteins putatively involved in: 
 
 2DOS biosynthesis       transport 
 attachment to the 2DOS moiety and modification of sugar units  
 regulation        resistance 
 transposases        sugar phosphatase 
 ACAGA biosynthesis       kinase reaction 
 represent genes outside the hyg-cluster     N-methyltransferase 
 
3.2.4 ACAGAs related to 2DOS-ACAGAs (FTM and IM group) 
 
Both FTM-A and IM-A are pseudodisaccharidic ACAGAs produced by M. olivasterospora DSM 
43868 and S. tenjimariensis ATCC 31603, respectively. They are grouped together because of 
their related chemical structures (cf. Fig. 1.5). However, their routes of biosynthesis are different 
in part. The cyclitol moiety of FTM-A is biosynthesized by a different route in comparison to the 
ShyG17 
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other 2DOS-ACAGAs where myo-inositol is the basic starting material. On the other hand, IM-A 
contains 2-deoxyfortamine (a 2-deoxy-3,6-diaminocylitol derivative) as a basic cyclitol unit 
which originates from 2-deoxy-scyllo-inosose as in the other 2DOS-ACAGAs. 
 
 
 
 
Fig. 3.10 Restriction maps and arrangement of the selected cosmids for the for- and ist-clusters. The 
names given in bold on the left side of the figure represent the cosmid names from which the sequences 
were derived. The regions covering the individual gene clusters for each strain are indicated by the brown 
bar. The numbers in bold on the right hand side represent the total length of the DNA segment determined 
in a single contig and submitted to the EMBL data base. Other numbers in the figure represents the length 
of the subsegments obtained from inserts of the individual cosmids in bp. Bg, B, E = restriction sites for 
BglII, BamHI, EcoRI, respectively. 
 
However, the basic routes for 3,6-diaminocyclitol biosynthesis should be quite similar. Screening 
of the cosmid banks of M. olivasterospora with fms14 (Dairi et al., 1992c) and fmrO (Ohta and 
Hasegawa, 1993b) probes and of S. tenjimariensis with kamA (Ohta and Hasegawa, 1993a) and 
istC probes resulted in isolation of a total of 11 and 25 positively hybridizing cosmids, 
respectively (cf. Tab. 2.7). After mapping of the positive cosmids: the cosmids MolI14, MolJ05 
(from M. olivasterospora); and StenF24, StenO22 (from S. tenjimariensis) were selected for 
sequencing. A total of 42807 and 69904 bp of contiguous DNA segments from M. 
olivasterospora and S. tenjimariensis covering the for- and ist-clusters were determined, 
respectively (cf. Tab. 3.1). The DNA segment from M. olivasterospora comprised 42 ORFs 
from which 33 ORFs were attributed to the for-cluster. The DNA segment from S. tenjimariensis 
covered 37 ORFs from which 28 ORFs were postulated as comprising the ist-cluster. Restriction 
maps and arrangement of genes on the selected cosmids are shown in Figs. 3.10 and 3.11. As 
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presented in Fig. 3.11, both for- and ist-clusters were fully sequenced and all the postulated genes 
products required for the biosynthesis of the respective antibiotics were putatively present (see 
Sect. 4.2.7; Fig. 4.6). Especially, the proteins encoded by the three genes forA, forC and forS are 
expected to be required for the formation of scyllo-inosamine from myo-inositol as well as the 
two proteins IstC and IstS required for the formation of 2-deoxy-scyllo-inosamine from G-6-P 
were found. 
 
 
 
Fig. 3.11 Organization of the ORFs in the for- and ist-clusters. The symbols for and ist indicate 
fortimicin and istamycin gene clusters obtained from M. olivasterospora DSM 43868 and S. 
tenjimariensis ATCC 31603, respectively. The color codes for differentiating the genes encoding proteins 
putatively involved in: 
 
 aminocyclitol biosynthesis      regulation  
 attachment and modification of the amino sugar units 
 UDP-D-glucosamine synthase or amidase 
 ACAGAs biosynthesis       transport 
 N-methyltransferase       resistance 
 C-methyltransferase       transposase 
 O-methyltransferase       3’-phosphotransferase 
represent genes outside the ACAGA gene clusters   sugar phosphatase 
 
Some genes were present only in one cluster, encode proteins that could be responsible for 
exhibiting individual functions: a putative 6’-C-methyltransferase (ForK; related to GenK in the 
gen-cluster) and a putative 6’-N-methyltransferase (IstU). Moreover, genes which would encode 
similar biosynthetic functions for both antibiotics were conserved in both clusters: 3’-
phosphotransferases (ForP and IstP) which could be involved in the 3’,4’-dehydroxylation 
process of the sugar moiety; putative 6-N-methyltransferases (ForG, IstG); putative 1-O-
methyltransferases (ForN, IstN); putative 6’-dehydrogenases (ForE, IstE); putative UDP-D-
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glucosaminyltransferases (ForM, IstM); putative 6’-dehydrogenases and 6’-aminotransferases 
(ForQ, ForB and IstQ, IstB). Both for- and ist-gene clusters contain putative resistance genes 
encoding 16S rRNA methyltransferases or some truncated proteins of this family (fmrR, fmrO, 
fmrP, fmrB for FTM and imrA for IM). Both fmrO and imrA (kamA) were previously submitted 
to the data bases and our sequence data turned out to be identical with those previously submitted 
(Ohta and Hasegawa, 1993a & b). Three transporter genes (forH, I, J and IstH, I, J) which 
encode proteins that could be involved in the export system for both antibiotics were also found 
to be conserved in both clusters. One possible regulatory gene (issC) could also be traced in the 
ist-cluster and no equivalent was found so far in the DNA segment covering the for-cluster. 
 
3.3 Newly developed heterologous primers 
Lack of suitable probes for screening of cosmid banks of some of the ACAGA-producing strains 
made the identification and design of specific heterologous primers necessary. Therefore, several 
attempts to design more universal primers for conserved genes in all the ACAGA gene clusters 
or in subgroups thereof were made. 
       HC-F  
         
NeoC        VVVALGGGVTGNIAGLMASLLFRGIRLVHVPTTVVAMLDSVLSLKQAVNTTFGKNLAGTF 157 
RibC        VVVALGGGVTGNITGLMASLLFRGIRLVHVPTTVVAMLDSVLSLKQAVNATFGKNLVGTF 157 
LivC        VVVALGGGITGNIAGLLAALLFRGITLVHVPTTVVAMLDSVLSLKQAVNASFGKNLVGTF 157 
ParC        VVVALGGGITGNIAGLLASLLFRGITLVHVPTTVVAMLDSVLSLKQAVNASFGKNLVGTF 157 
AprC        VVVALGGGITGNIAGLMAALMFRGIRLVHVPTTIVAMLDSVLSLKQAVNSSVGKNLVGTF 157 
KanC        IVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAGVGKNLVGTF 157 
TobC        VVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTF 157 
GenC        VVVAVGGGVIGNIAGLMAALLFRGIRLVHIPTSLIAMSDSVLSLKQAVNACVGKNLMGTF 155 
HygC        VVVAVGGGIPGNIAGVLAGLLFRGLRLVHVPTTVIAACDSVLSVKQAVNTGHAKNTVGLY 179 
BtrC        AIVAVGGGLTGNVAGVAAGMMFRGIALIHVPTTFLAASDSVLSIKQAVNLTSGKNLVGFY 156 
 
 
NeoC        IIAESLAAKADVTSGDKHERRSGLVLEYGHTAGHAIEHASRGA------VAHGAGVAVGM 271 
RibC        IIAESLTAKADVTRDDKHERRTGLVLEYGHTAGHAIEHASRGE------VAHGAGVAVGM 271 
LivC        IIAESVAAKADVTGADKHERGDGLVLEYGHTAGHAIEHAARGA------VAHGAGVAVGM 271 
ParC        IIEESVAAKAQVTGADKHERRDGLVLEYGHTTGHAIEHAARGE------VAHGAGVAIGM 271 
AprC        IIDESIAAKAQVTENDVHERGQGLVLEYGHTVGHALEHAARGE------VSHGAAVGLGM 271 
KanC        IIYESLAAKAQVTAYDKYERGEGLILEYGHTVGHAVEHSSQGA------VPHGAAVALGM 271 
TobC        MIDESVAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGA------VSHGAGVGVGM 271 
GenC        IISESILAKASVTVDDMHECRAGLVLEYGHTVGHAIEYTAAGG------LSHGQAIGLGM 269 
HygC        IFELSLAVKGRLXLEDPYEKHAGVLLEYGHTVGHALELAGAGRGPGGDMIKHGEAVALGM 299 
BtrC        FINFCISAKMSVLSEDIYEKKKGLIFEYGHTIGHAIELAEQGG------ITHGEAIAVGM 270 
 
      HC-R 
Fig. 3.12 Partial alignment of 2-deoxy-scyllo-inosose synthase proteins (“NeoC”-family) for the 
design of heterologous primers. Boxes mark the areas which were used to design the heterologous 
primers. The nucleotide sequences of HC-F & HC-R primers are listed in Tab. 2.5. The numbers indicate 
the position within the corresponding proteins. 
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        HS1-F 
 
NeoS        SGPYRGTDSHERRFARAFADYHGVPYCVPAASGTAGLMLALEACGVGAGDEVIVPGLSWV 103 
RibS        SGPYRGTESYERRFARAFAAYNGVPHCVPAASGTASLMLALEACGIGAGDEVIVPGLSWV 103 
ParS        SGPYRGAASQERRFAQAFAAYNGVEHCVPAASGTASLMLAMEACGIGAGDEVIVPGLSWV 103 
LivS        SGPYRGAASQERRFARAFAEYNGVAHCVPAASGTASLMLALEACGVGAGDEVIVPGLSWV 103 
KanS1       SGPYRGVESAERRFARRFADYHRIAHCVPASSGTASLMLALEACGVGAGDEVILPGVTWV 106 
TobS1       SGPYRGIESAERRFARDFAAYNGVAHCVPAASGTASLMLALESCGVGVGDEVIAPGLSWV 103 
GenS1       SGPYQGKQSFERRFAAAFAEFHEIGHCVPTSSGTASLMVALEACGVGAGDEVIIPGLTWV 102 
StsC        SCAYQGRDSYERQFASAFADYCGSAMCVPISTGTASLAIALEACGVGAGDEVIVPGLSWV 103 
HygS        SGAFTGRPSYEQEFADAFARFIGVPYAVPVCNGSAALTVALEALGVRAGDEVLVPGLTWV 120 
KanS2       FGGIPFPNTHHTAFADLFTGKLGAPYGLMVSNGTISLSIALRALGVRAGDEVITTGYTWM 100 
TobS2       LGGIPFPNRTHRAFAEQFCGRLGARHGVLVANGTVSLSVALRALGVHAGDEVITTGYTWM 100 
GenS2       LGGIPFPNTMHQQFAERFTAKLGAKYGLLATNGTVTLSMALRALGIHAGDEVITTAFTWV 100 
 
 HtobS2-F & HS2-F  
 
 
      HS1-R 
 
NeoS        EHLRADGRCLSDGPPAPGAMELVETGELMGSNRCLSEFQAAILTEQLTLLDEQNRTRRAN 283 
RibS        EHLRADGRCLSAVPPAPGAMELVETGELMGNNRCLSEFQAAILAEQLTILDEQNETRRAN 283 
ParS        EHLRADGRCLAGQPVGDGQMELVETGELMGSNRCVSEFQAALLVEQLGVLDEQNERRRRN 283 
LivS        EHLRADGRVLAGQRPGPGEMELVETGELMGNNRCLSEFQAALLTEQLKDLDAQHAIRRRN 283 
KanS1       EHLRADGRCYRDQAPPSGHMELVETGELMGSNRCISEFQAAVLTEQLGELDRFNALRRHN 286 
TobS1       EHLRADGRCYPDTAPAPGRMELVETGELMGSNRCLSEFQAAVLVEQLRELDEQNALRRRN 283 
GenS1       EHLRADGRTYTPDEPAVGEMELAQTAELMGSNRCLSEFQAALLLGQLELLDEQNERRRAN 282 
StsC        EHLRADGRVVRREPVGVGEMELEETGRMMGSNACLSEFHAAVLLDQLELLDGQNARRTRA 283 
HygS        YRKRADGRGPRPDAP-VGELQLAEHPGVQGYNYCMSEFGAALALDGLGRLAEENARRRRS 299 
KanS2       MSLANCGR----KEPGYDGFA----GRTLGWNARASELQAAFMIGQVEQHDALHAKRAAS 272 
TobS2       MSLVNCGR----KEEGYDSFE----GRMLGWNNRATELQAAFLIGQVEQHDELHAQRKSN 272 
GenS2       MSLAHVGR----KEAPYDRFP----GRVFGWNHRATEMQAAVLLGQLDRYDALDKQRTAM 272 
 
 
 
NeoS        AARLDGLLGEL-GLRPQATS-EGTTSRTYYTYAARLPEGALEDVPLTDVTGALTAELG-F 340 
RibS        AAHLDGLLGEL-GLRPQTTS-DGTTSRTYYTYAVRLPDGVLEDVPVTDVSCALTAELG-F 340 
ParS        AALLDKLLADE-GYRPQTTS-EGTSTRTYYTYAARLPEGELTHVDAAAVGEALTAELG-F 340 
LivS        AALLDGLLRES-GYVPQETS-EGTSTRTHYTYAVRLPEGRLTHVGLATVARALSAELG-C 340 
KanS1       AELLDALLTDV-GYRPQRST-PGTTARTYYTYVAELPDAELPGADITKVTEALTAELG-F 343 
TobS1       AELLNTLLAEQ-GLRPQATS-PGTTSRTYYVYAAELPDDAFVGLPITTVTEALTAELG-F 340 
GenS1       AALLDEGLGAL-GIQPQVSS-PGTTERTYYEWAGRIEDDGIGQIGVERIAPAVAAELSGA 340 
StsC        ADHLTDRLSEL-GMTAQATA-PGTTARAYYRYLVRLPDEVLAVAPVERFAHALTAELG-F 340 
HygS        MRRLEELLAGFDGAAPLSRP-EAVTEDAAYQVCVRLDPDVFGPAAKHTVAAALSRELG-V 357 
KanS2       AAKLTAGLAEIGGFTPVGNDDPRITRRQYYEVIYRFDPAAWEGLHRDEVLSAILAEGIEL 332 
TobS2       VELLTKGLTEIGGFTPVGDDDPRVTRRQYYEVLYRFDPEQWAGVHRDRVLEALLAEGVEF 332 
GenS2       AEMLTQGLVEIGGFKPLAED-PRVTRRQRYELLFRFDTEAWDGLHRDKVLEAILAEGVEF 331 
 
   HtobS2-R      HS2-R 
 
 
 
Fig. 3.13 Partial alignment of 2-deoxy-scyllo-inosose aminotransferase and other aminotransferase 
proteins (“NeoS”-family) for the design of heterologous primers. Boxes mark the areas which were 
used to design the heterologous primers. The nucleotide sequences of the primers selected are listed in 
Tab. 2.5. The numbers indicate the position within the corresponding proteins. 
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        HB-F  
 
NeoB        ATGRPLLLSAGYHGYDPMWYPSEAPLEPNADGVVDFFFDLGLLRELLRA-PERVAAVVVS 176 
RibB        ATGRPLLVSAGYHGYDPMWYPSDAPLVPNADGVVDFFFDLGLLAELLAA-PERVAAVVVS 176 
ParB        AVGAPLVLSSGYHGYDPMWYPAKAPFEPNADGIVDFFFDLDVLAGLLRDGRERVAAVVVS 177 
LivB        SVGRPLVLSSGYHGYDPMWYPPHEPLEPNADGIVDFFYDLDLLAGLLRD-RDRIAAVVIS 176 
GenB4       ARDRSIVLSSGYHGYDPMWH-CDEPFTPNQHGIVEFLFDLDVLAEWLSR-PEQVAAVVIS 178 
GenB1       VTGKRLIASCGYHGYDLMWE-FTPPGQPNSEDVLHCYHLPELIDQVLDKHAHELAAVIIA 171 
 
 
NeoB        ARKALDDASLPVEIAGDGTFFQFVPATEELEEALYGAANAEGLLFYAGDNQGVSAAFDEA 355 
RibB        ARKALQDAALPVEIAGDGTFFQFVPASEELEYAFYAAANTEGLLFYAGDNQGVSAAFDDA 355 
ParB        ARSALAAASLPLEVAGNGTFFQFVPATREVKKAFYKATEEEGLLFYRNDNQAVSAAFGPD 356 
LivB        ARKSLAGAGLPVELAGDGSFFQFVAATRELEKALWWATEDEGLLFYRGDNQAVSAAFGPD 355 
GenB4       TRAAFANAGVPIDLAGNGNLFQFVCADDEVADAFHAAAAAEGLLFFEGDNQTPSAAFTDE 356 
GenB1       AAKMISTRDLPIEMAGTGAAFQFVCA-EEVEEVLLPHALAEGLILEPSDQQYPSACFRGE 350 
 
      HB-R 
Fig. 3.14 Partial alignment of the putative 6’-aminotransferase proteins (“NeoB”-family) for the 
design of heterologous primers. Boxes mark the areas which were used to design the heterologous 
primers. The nucleotide sequences of HB-F & HB-R primers are listed in Tab. 2.5. The numbers indicate 
the position within the corresponding proteins. 
 
 
         HparA-F  
 
NeoA        PGEAAEPAETTAPAPRAEPAHEELVAGYAEFLRRRRPDLAARVREVCGEAPWIVRSSGAE 144 
RibA        ------ATDTDGLSP------KGLAVGYAAFLRERRPGLAARLREVCGDAPWIVRSSGAE 108 
ParA        TLPQNAAGGTGETLP--QDTAEELVTGYARFLRRQWPGLADEIARTCGPAPWIVRSSGAE 133 
LivA        -------RNGTRLSPDGERDHTALVSAYGAYLREQRPGLAAEVRVECGPAPWIVRSSGAE 149 
BtrA        -------------------TEEELPGRLARYLEQREPSRFDQIKKVCGDLPWIIRSSGEE 85 
 
 
NeoA        PAEHAAVMFRQEGVAVLRGRPEDVPETASYALADPWRRECHFGTG--RPPAVETETRRTA 464 
RibA        AAEHAAVMFRQEGLAVLRGRPEDIPETASYALADPWTQECYFGAG--RPPAVETEQRRMS 433 
ParA        PAEHAAVMFRQYGVAVLRCRAEDVPESASYVLADPWAERCYFGTG--HPPRARTVPRRVA 454 
LivA        PAEHAGVMFRQAGVAVLRARLDELPGWASYALADPWSRVCFFGDG--EPPLLRTVPRRVA 498 
BtrA        RTEHAGIMFNQVGIPVIRIEIALIPESMTYIVLDPFSLQCRLYSHNKEVKALEYETREII 410 
 
   HparA-R 
 
Fig. 3.15 Partial alignment of the putative ribosyltransferase proteins (“NeoA”-family) for the 
design of heterologous primers. Boxes mark the areas which were used to design the heterologous 
primers. The nucleotide sequences of HparA-F & HparA-R primers are listed in Tab. 2.5. The numbers 
indicate the position within the corresponding proteins. 
 
 
Possible heterologous primers were generally proposed via multiple sequence alignments of the 
already known amino acid sequences of the respective protein families using the Clustal W 
program (cf. Sect. 2.26). The areas with maximum conservation of the amino acid sequences of 
the “NeoC”, “NeoS”, “NeoB”, “NeoA” and “GenK” families of biosynthetic enzymes were 
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chosen (Figs. 3.12 - 3.16). To get the optimal nucleotide sequences for the heterologous primers, 
the selected amino acids were back translated into their corresponding codons taking into 
consideration the codon usage for actinomycetes (Bibb et al., 1984). The nucleotide sequences of 
the heterologous primers as well as the expected size for the respective PCR fragments obtained 
are listed in Tab. 2.5. Interestingly, it turned out to be very useful to design a pair of primers 
(HS2-F & HS2-R) that could distinguish between genes kanS1 from kanS2 (cf. Fig. 3.13; Tab. 
3.2). Detection of the respective genes via PCR using the genomic DNA of the respective strains 
as a template and the heterologous primers is summarized in Tab. 3.2. 
 
       HKL1-F  
 
ForK        ------MSTRTDTGVTRVLLIKPPIRACMIEIGRHMPIGLAYLAAQLRNSGMEVDIFDSL 54 
GenK        MNALVAAPSVTEGNQVKVFLVKPPIRGCMVEIGRHVPIGLAYVSSALRAAGHETEIFDSL 60 
 
 
ForK        TATLITSRGCPFSCSFCTVHATVGKKFRARAPENVVDEIEHYVTEHGIRRFFIEDDNFTF 293 
GenK        AVTLITSRGCPFSCSFCTVHATVGKQFRARDPQRVVDEIEHYVNVHGVRRFLVEDDNFTF 300 
         HKL1-R 
 
Fig. 3.16 Partial alignment of the putative 6’-C-methyltransferase proteins (“GenK”-family) for the 
design of heterologous primers. ForK from M. olivasterospora and GenK from M. echinospora were 
aligned using Clustal W program (Sect. 2.26). Boxes mark the areas which were used to design the 
heterologous primers. The nucleotide sequences of HKL1-F & HKL1-R primers are listed in Tab. 2.5. 
The numbers indicate the position within the corresponding proteins. 
 
 
Tab. 3.2 Detection of biosynthetic genes in genomic DNA using heterologous primers 
 
Primer pairs 
Strain 
 
HC-F/ 
HC-R 
 
HS1-F/ 
HS1-R 
 
HS2-F/ 
HS2-R 
 
HB-F/ 
HB-R 
 
HparAF/ 
HparA-R 
 
HKL1-F/ 
HKL1-R 
S. kanamyceticus DSM 40500 + + + + - nt 
S. fradiae DSM 40063 + + - + + nt 
S. rimosus subsp. paromomycinus 
NRRL 2455 
+ + - + + nt 
S. tenebrarius DSM 40477 + + + + - nt 
S. hygroscopicus subsp. 
hygroscopicus DSM 40578 
+ + - + - nt 
M. echinospora DSM 43036 + + + + nt + 
M. olivasterospora DSM 43868 + + nt nt nt + 
S. ribosidificus NRRL B-11466 + + - + + nt 
S. lividus ATCC 21178 + + nt + nt nt 
S. tenjimariensis ATCC 31603 + + nt + nt - 
St. hindustanus DSM 44523 + + nt + nt nt 
+ = PCR product obtained (proven by DNA-sequencing); - = no PCR product obtained (in general no homologous 
gene present in the gene cluster); nt = not tested. 
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Tab. 3.3 Biosynthetic proteins encoded by genes conserved among the ACAGA gene 
clusters analysed 
_____________________________________________________________________________ 
Key enzyme    Members   pfam/COG Remarks/ 
(postulated function)        General function 
_____________________________________________________________________________ 
2-deoxy-scyllo-inosose synthase BtrC, NeoC, LivC, ParC,  pfam01761 cyclase in 2DOS 
 GenC, IstC, RibC, HygC,  COG0001 -pathway 
 AprC, TobC, KanC. 
 
L-glutamine (PLP): 2-deoxy-scyllo- BtrS, NeoS, LivS, ParS, pfam01041 putative bifunctional 
-inosose aminotransferase (AT-I) and RibS, HygS, AprS, TobS1, COG0399 ketocyclitol  
1-keto-2,3-deoxy-3-amino-scyllo- KanS1, GenS1, ForS, IstS  aminotransferase 
-inositol aminotransferase (AT-II)   (AT type IV) 
 
aminocyclitol-1-dehydrogenase BtrE, NeoE, LivE, ParE, pfam00107 good evidence 
 RibE, AprE, TobE, KanE, COG1063 
 GenE, ForE, IstE 
 
L-glutamine (PLP): neutral sugar  KanS2, TobS2, GenS2 pfam01041 AT type IV 
Aminotransferase; putative 3”-amino-  COG0399  
-transferase of the -1,6- glycosyl unit of 
Kan, Gen and Tob. 
 
-1,4-glycosyltransferase  BtrM, NeoM, LivM, ParM, pfam00534 -1,4- glycosyl 
(hexosaminyltransferase) RibM, AprM, TobM1, IstM, COG0438 transferase I 
 GenM1, ForM, IstM, KanM1, 
 
-1,6-glycosyltransferase KanM2, TobM2, GenM2 pfam00534 -1,6- glycosyl 
(neutral sugar transferase) COG0438  transferase II 
 
ribosyltransferase BtrL, NeoL, RibL, ParL,  COG1926  
 LivL 
 
ribosyltransferase  BtrA, NeoA, RibA, ParA,   
 LivA 
 
glycosyltransferase  NeoF, RibF, ParF, LivF COG0438 glycosyl transferase III 
(hexosaminyltransferase)    
     
6’-dehydrogenase (FAD)  BtrQ, NeoQ, RibQ, ParQ,  pfam05199 
   LivQ, AprQ, TobQ, KanQ,  COG2303 
   GenQ, ForD2, IstQ 
 
6’ or (6’’’)-aminotransferase BtrB, NeoB, LivB, ParB,  pfam00202 sugar aminotransferase 
   RibB, AprB, TobB, KanB,  COG0001 (AT type III) 
   GenB1, GenB2, GenB3,  
 ForB, GenB4, IstB 
 
(N-acetyl)- hexosaminyl- BtrD, NeoD, LivD, ParD,  pfam02585 either UDP-D-glucos- 
-deacetylase or other amidase    RibD, AprN, TobD1, KanD1, COG2120 -amine synthase or 
(LmbE-family)   ForD, GenL, IstD  deacetylating amidase 
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3’-dehydratase    LivY, AprD3, GenD3  pfam00106 3’-dehydroxylation 
         COG1028  
      
3’-oxidoreductase   LivW, AprD4   COG1032 3’-dehydroxylation 
(Fe-S) oxidoreductase          
 
3’’-dehydrogenase (NAD)   TobD2, KanD2, GenD2, pfam1408 keto-sugar/cyclitol 
     ForC    COG0673 dehydrogenase 
 
(Fe-S)-oxidoreductase (SAM) BtrN, RibN, ParN, LivN,  pfam04055 dehydrogenases or  
ForL, IstL, IstL2, LivA, COG0535 epimerases 
ForO    
 
6’-C-methyltransferase (SAM)  GenK, ForK   pfam04055 only in GM and FM 
smart00729  
 
6’/7’-N-methyltransferase (SAM) ForG, IstG, AprI, GenN pfam06325 N-methyltransferase 
         COG0500 
 
3-O-methyltransferase   ForN, IstN   pfam05711 O-methyltransferase 
 
sugar-phosphate-   BtrP, NeoP, ParP, LivP, COG0406 ForA: D-myo-inositol- 
-phosphatase     RibP, AprZ, HygU, ForA   -3-phosphate- 
           -phosphatase 
 
NDP-heptose/hexose dehydrogenase HygK, AprD1   pfam01370 unknown oxidoreductase 
/epimerase        COG1087 
_____________________________________________________________________________________ 
 
 
Tab. 3.4 Transporter proteins encoded by genes conserved among the ACAGA gene 
clusters analysed 
_____________________________________________________________________________ 
Key enzyme    Members   pfam/COG Remarks/ 
(postulated function)        General function 
_____________________________________________________________________________ 
AGA-exporter NeoT, RibT, ParT, LivT, pfam00664 ABC-transporter 
 HygV, AprV COG1132 (ATP) 
 
AGA-exporter NeoU, RibU, ParU, LivU, pfam00005 ABC-transporter 
 HygW, AprW  (ATP) 
 
AGA-exporter GenY, ForY, FosD, KanX pfam00999 efflux protein 
  COG0475 antiporter 
 
AGA-exporter (permease) TobT, KanT, GenT, IstI COG0477 efflux protein 
 
AGA-exporter GenI, GenH, ForJ, ForH,  COG2271 efflux protein 
 ForI, IstJ, IstH 
 
AGA-exporter KanZ pfam00083 efflux protein 
  COG4932 
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Tab. 3.5 Regulatory proteins encoded by genes conserved among the ACAGA gene clusters  
analysed 
_____________________________________________________________________________ 
Key enzyme Members pfam/COG Remarks/ 
(postulated function)   General function 
_____________________________________________________________________________ 
response regulator system  NeoI, RibI, ParI, LivI, cd00093.1 possible component of 3 
(DNA-binding protein) HygI, KanI CAD60534 component sensor/response 
    regulator system; 
    similar to Cinorf12 
 
response regulator system  NeoH, RibH, ParH, LivH, CAD60535 possible component of 3 
(sensor kinase) HygH, KanH   component sensor/response  
    regulator system;  
   similar to Cinorf13 
 
response regulatory system  NeoG, RibG, ParG, LivG, CAD60536 possible component of 3 
(trans-membrane protein HygG, KanG   component sensor/response 
of sensor complex)    regulator system; 
    similar to Cinorf14 
 
regulatory proteins NeoX, RibX, ParX, LivX  weak evidence 
 
regulatory proteins NeoR, AprR1, AprR2, KanR,   weak evidence 
 GenU, IssC, KanU 
_____________________________________________________________________________________ 
 
 
 
Tab. 3.6 Resistance proteins encoded in the ACAGA gene clusters analysed 
_____________________________________________________________________________ 
Key enzyme Members pfam/COG Remarks/ 
(postulated function)   General functions 
_____________________________________________________________________________ 
APH(3’) AphA, Rph, GenP, pfam01636 AphA inactivate ACAGAs  
 ForP, IstP COG3281 inside the cells; GenP, ForP, 
    IstP are biosynthetic enzymes 
   (3’-deydroxylation) 
 
APH(7’’) AGA resistance HygA pfam01636 inactivate ACAGAs inside 
  COG3281  the cells 
 
AAC(3) AGA resistance AacC8 (SfrF04.15c), pfam02522 inactivate ACAGAs inside 
 AacC (SribP10.14) COG2746 the cells 
 AacC7 (SriA13.2) 
 
AAC(6’) AGA resistance KanA,  pfam00583 inactivate AGA inside 
 AacA (SriA13.3) COG2746 the cells 
 
16S rRNA methyltransferases KamB, Kmr, GmrA, GmrB,  pfam07091 modify target site 
 FmrR, FmrO, FmrP, FmrB,  COG1670 
 ImrA 
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Tab. 3.7 Transposase proteins encoded in the ACAGA gene clusters analysed 
_____________________________________________________________________________ 
Key enzyme Members pfam/COG Remarks/ 
(postulated function)   General functions 
_____________________________________________________________________________ 
transposase SribP10.8c pfam1609 All are either 
neighbouring  
    or inserted in AGA gene 
    clusters; some might be 
    non-functional 
   (fragmentary ORFs) 
transposases SribP10.9c, ShyG17.8, COG3293  
 SteO08.8c, (TatA),  
 SteO08.9c (TatB),  
 SteO08.10c (TatC) 
 
transposase ShyG17.31c (HygZ) pfam00665  
  COG2826 
  
transposase MolI14.2c COG3415 
  
transposases SribL03.10c, SteK17.29 
_____________________________________________________________________________________ 
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B Studies on some selected ACAGA biosynthetic enzymes 
 
3.4 Identification of the enzymes involved in the biosynthesis of 2DOS 
Following the analysis and comparison of the studied ACAGA biosynthetic gene clusters, an 
attempt was made for expression, characterization and biochemical study of some key enzymes 
which are expected to be involved in the formation of the aminocyclitol (2DOS) moiety. 
Starting from G-6-P, four enzymatic steps would be necessary to form 2DOS (Fig. 3.17): i-
conversion of G-6-P to 2-deoxy-scyllo-inosose; ii- transamination of 2-deoxy-scyllo-inosose to 2-
deoxy-scyllo-inosamine; iii- oxidation of 2-deoxy-scyllo-inosamine at the 1- position to form 1-
keto-2,3-deoxy-3-amino-scyllo-inositol; iv- transamination of this keto intermediate to 2DOS. 
Therefore, the enzymes KanC (2-deoxy-scyllo-inosose synthase), KanS1 (putative bifunctional 
enzyme; L-glutamine (PLP): 2-deoxy-scyllo-inosose aminotransferase [AT-I] and 1-keto-2,3-
deoxy-3-amino-scyllo inositol aminotransferase [AT-II]) and KanE (putative aminocyclitol 1-
dehydrogenase) encoded by the kan-cluster of S. kanamyceticus were analyzed. Of these 
enzymes, the enzymes related to KanC (Kudo et al., 1999a; Ota et al., 2000; Kharel et al., 2004) 
and KanS1 (Lucher et al., 1989; Walker, 1995; Ahlert et al., 1997; Tamegai et al., 2002b) had 
been previously studied enzymatically in part. It was presumed that KanS1 was a bifunctional 
enzyme on the evidence presented by Lucher et al. (1989) and Walker (1995) that the 
aminotransferase steps in 2DOS biosynthesis are catalysed by a bifunctional, L-glutamine 
dependent aminotransferase and only one KanS1 homolog was conserved in all the 2DOS-
ACAGA gene clusters analyzed. Only in the KM group, two homologues (KanS1, KanS2 and the 
related proteins) were found (see Sect. 3.2.2). 
Furthermore, the analysis of ACAGAs gene clusters revealed the presence of only one conserved 
gene for a putative dehydrogenase (kanE and the related genes; Tab. 3.3). Therefore, it was 
predicted that the KanE and related proteins were involved in the 1-dehydrogenation of 2-deoxy-
scyllo-inosamine. In order to reconstitute the 2DOS pathway, the three enzymes KanC, KanS1 
and KanE were expressed individually and their enzymatic roles in aminocyclitol biosynthesis 
were studied.  
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Fig. 3.17 Biosynthetic pathway for the formation of 2DOS in S. kanamyceticus DSM 40500. 
 
3.5 Heterologous expression of the KanC, KanS1 and KanE proteins 
 
3.5.1 The general strategy for the overexpression of the selected Kan-proteins 
For overexpression, the individual genes were firstly amplified by PCR from the chromosomal 
DNA of S. kanamyceticus DSM 40500 using the appropriate primers and PCR conditions (cf. 
Tab. 2.4; Sect. 2.15). The forward primers were generally designed for the introduction of an 
NdeI site, changing the sequence at the natural start codon for the ability to create start codon 
fusion of these genes into the promoter/ribosome-binding site cassettes of suitable expression 
vectors. On the other hand, the reverse primers were designed for the introduction of an alternate 
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restriction site located immediately downstream of the natural stop codon in order to allow 
orientated cloning into the expression vectors. The amplified DNA fragments were cloned into i- 
pET16b (N-terminal His-tagged fusion protein) or pET11a (native protein) expression vectors of 
E. coli under the control of the T7 promoter; ii- pUWL201PW E. coli-Streptomyces shuttle 
vector (native protein) under the control of the ermE up promoter. 
 
3.5.2 Heterologous expression in E. coli under T7 promoter 
A set of recombinant plasmids was constructed (cf. Tabs. 2.2 & 2.3) to express kanC, kanS1 and 
kanE genes in either of the E. coli BL21 (DE3), JM109 (DE3) or BL21 (DE3) Rosetta strain 
under the control of the T7 promoter as described in Sect. 2.17.1 (cf. Tab. 2.1). The cloning of 
the corresponding genes and the construction of the expression plasmids are described in Sect. 
2.4. The results of the expression of the three proteins under different conditions are summarized 
in Tab. 3.8. 
 
Tab. 3.8 Summary of expression of KanC, KanS1 and KanE proteins 
 
Protein Vector (Promoter) Host strain Culture 
condition, time 
of induction 
cMW 
(kDa) 
Solubility a 
pKC16b1 (T7) E. coli BL21 (DE3) LB, 37°C, 6 hrs 43,401 ± 
pKC16b1 (T7) E. coli BL21 (DE3) LB, 37°C, 6 hrs 43,401 ± 
pKC16b1 (T7) E. coli BL21 (DE3) LBS, 30°C, 
 12 hrs 
43,401 + (WB) 
 
KanC 
 
pKC16b1 (T7) E. coli JM109 (DE3) LBS, 30°C,  
12 hrs 
43,401 + (WB) 
pKS16b1 (T7) E. coli JM109 (DE3) LB, 37°C, 4 hrs 47,709 - (WB) 
 
KanS1 pKS16b1 (T7) E. coli JM109 (DE3) LB, 30°C, 4 hrs 47,709 + (WB) 
pKE16b1 (T7) E. coli BL21 (DE3) LB, LBS, 30°C,  
2 hrs 
37,654 - 
pKE16b1 (T7) E. coli JM109 (DE3) LB, LBS, 30°C,  
2 hrs 
37,654 - 
pKE16b1 (T7) E. coli Rosetta LB, 37°C, 6 hrs 37,654 - 
pKE16b1 (T7) E. coli Rosetta LBS, 30°C,  
12 hrs 
37,654 + (WB) 
pKE11a-4 (T7) E. coli Rosetta LBS, 30°C, 2, 4 
and 12 hrs 
35,881 no 
 
KanE 
pKEW1-2 (ermE) S. lividansTK23 YEME, 30°C, 48 
hrs 
35,881 + 
a: + = soluble, - = insoluble, ± = partially soluble; no = not observed; (WB) = detection in Western blot assays; cMW 
= calculated molecular weight; LBS = LB medium supplemented with 1 M sorbitol and 2.5 mM betaine. Extracts 
from the strains underlined were used for enzyme assays. 
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           A          B 
Fig. 3.18 SDS-PAGE analysis of the production of the KanC, KanS1 and KanE proteins in different E. 
coli strains. Only the soluble proteins were analyzed on 12% PAA gels. A: The production of KanC in E. coli 
JM109 (DE3; lanes 1-4) and in E. coli BL21 (DE3; lanes 5-8). The cell-free extracts were obtained from strains 
harboring the following plasmids: pET16b (control; lanes 2, 4, 6 & 8); pKC16b1 (KanC; lanes 1, 3, 5, & 7); 
lanes 3, 4, 7 & 8 were 6 hrs after induction; lanes 1, 2, 5 & 6 were 12 hrs after induction. B: The production of 
KanS1 in E. coli JM109 (DE3). The cell-free extracts were obtained from strains harboring the following 
plasmids: pET16b (control; lanes 3 & 4); pKS16b1 (KanS1; lanes 1, 2, 5 and 6); lanes 1, 3 and 5 were before 
induction; lanes 2, 4 and 6 were 4 hrs after IPTG induction. The arrows mark additional bands corresponding 
to the expected size of proteins. 
 
                      1    2   3   4    5   M   6    7      1         2           M                 3  
 
   A       B 
Fig. 3.19 Detection of the His-tagged proteins KanC, KanS1 and KanE by Western Blotting. The Western 
blotting was carried out as described in Sect. 2.20. A: Detection of N-terminal His-tagged KanE protein: 
Soluble cell-free extracts were from E. coli BL21 (DE3) Rosetta harboring the following plasmids: pET16b 
(control; lanes 1 & 6); pKE16b1 (KanE; lanes 2, 3, 5 & 7); and pKE16b1 (KanE; crude extract; lane 4). B: 
Detection of N-terminal His-tagged KanS1 protein: soluble cell-free extracts were from E. coli JM109 (DE3) 
harboring the following plasmids: pET16b (control; lane 2); pKS16b1 (KanS1; lane 3); and pKC16b1 (KanC; 
lane 1). The molecular masses of the marker proteins (lane M) are indicated in kDa. 
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KanC was overproduced as a soluble N-terminal His-tagged protein in both E. coli BL21 (DE3) 
and JM109 (DE3): An additional band of about 43 kDa present in the soluble fraction of the cell-
free extract corresponded in size to the expected molecular mass (43.4 kDa) of the His-tagged 
KanC protein was detected. The maximal overexpression of the soluble KanC protein was 
obtained using LB medium with 1 M sorbitol and 2.5 mM betaine at 30°C and 12 hrs after IPTG 
induction. Also KanS1 was overproduced as a soluble N-terminal His-tagged protein in E. coli 
JM109 (DE3) where an additional band of about 47 kDa present in the soluble fraction 
corresponded in size to the expected molecular mass (47.7 kDa) of the KanS1 protein (cf. Fig. 
3.18). The maximal overproduction of the soluble KanS1 protein was obtained 4 hrs after IPTG 
induction using LB medium at 30°C. The presence of multiple His residues in the overexpressed 
N-terminal His-tagged KanC and KanS1 proteins were also demonstrated by Western blot assays 
(Fig. 3.19). On the other hand, KanE was constantly produced in insoluble form (inclusion 
bodies) in the crude extract of the three selected E. coli strains using LB medium and various 
incubation temperatures. An additional band that corresponded to the deduced molecular mass of 
KanE protein (37 kDa) was only observed in the crude extract and not in the cell-free extract; 
also no positive signal could be detected in a Western blot assay. Nevertheless, KanE was 
successfully overexpressed as soluble N-terminally His-tagged protein in E. coli Rosetta cells 
using LB medium supplemented with 1 M sorbitol and 2.5 mM betaine at 30°C and 12 hrs after 
IPTG induction (cf. Tab. 3.8). The soluble KanE could also be detected by a Western blot (cf. 
Fig. 3.19). 
 
3.5.3 Heterologous expression of KanE in S. lividans TK23  
The recombinant plasmid pKEW1-2 was constructed for the expression of KanE in S. lividans 
TK23 as a native protein under the control of the ermE up promoter. KanE was successfully 
overproduced as a soluble native protein. An additional band of about 35 kDa, corresponding in 
size to the expected molecular mass (35.8 kDa) of the KanE protein was observed in the soluble 
fraction of the cell-free extract S. lividans TK23/pKEW1-2. Maximum expression of KanE in S. 
lividans TK23 was noted after 2 days of incubation at 30°C (Fig. 3.20). 
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Fig. 3.20 SDS-PAGE analysis of the production of KanE in S. lividans TK23. Protein separation was 
done on 12% PAA gel. Cell extracts were obtained from S. lividans TK23 harboring the following 
plasmids: pUWL201 (control; lanes 2, 4, 6 and 9), pKEW1-2 (KanE; lanes 1, 3, 5, 7, and 8). Lanes 1, 2, 7, 
8, and 9 contained cell-free extracts (soluble proteins); lanes 3, 4, 5, and 6 contained crude cell extracts. 
The molecular masses of the marker proteins (lane M) are indicated. The arrows mark a protein band 
corresponding to the molecular mass of the native KanE protein. 
 
 
 
3.6 Biochemical characterization of the KanC, KanS1 and KanE proteins 
 
3.6.1 Biochemical analysis of the KanC protein 
Because of the stability, solubility and purification problems of the first intermediate/enzyme 
substrate, 2-deoxy-scyllo-insose as provided by chemical synthesis, as well as the absence of 
commercial supply, an enzymatic preparation process for synthesizing this substance seemed 
best fitting the purpose. Such performing a KanC-catalysed reaction was not only carried out to 
prove again its enzymatic function but also to provide the natural substrate for the next enzymatic 
steps preparatively. 
The soluble fractions containing His-tagged KanC protein from either E. coli BL21 (DE3) or E. 
coli JM109 (DE3) were used for this purpose (cf. Tab. 3.8). 2-deoxy-scyllo-inosose synthase 
(KanC) was tested as described in Sect. 2.23. Conversion of G-6-P into 2-deoxy-scyllo-inosose 
was detected on both TLC and HPLC (Sects. 2.21 and 2.22). 
26.6 
36.48 
42.7 
55.5 
66.4 
RESULTS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
81 
 
 
 
Fig. 3.21 TLC analysis of KanC catalysed formation of 2-deoxy-scyllo-inosose. Relevant substances 
were visualized using the Cer-reagent (Sect. 2.3.10). The following samples were applied to the TLC: lane 
1: G-6-P; lane 2: E. coli BL21 (DE3)/pKC16b1 (KanC) with G-6-P; lane 3: E. coli BL21 (DE3)/pET16b 
(control) with G-6-P; lane 4: assay with cooked cell-free extract (100°C for 3 min) of E. coli BL21 
(DE3)/pKC16b1 (KanC) with G-6-P; lane 5: E. coli BL21 (DE3)/pKC16b1 (KanC) in absence of G-6-P; 
lane 6; E. coli BL21 (DE3)/pET16b (control) in absence of G-6-P; lane 7: D-glucose; lane 8: standard 2-
deoxy-scyllo-inosose. 
 
 
A new spot on the TLC with an Rf-value (0.46) corresponding to the migration of the standard 2-
deoxy-scyllo-inosose was observed in those enzyme reactions which contained soluble His-
tagged KanC protein. In all the control reactions used, no conversion of G-6-P to 2-deoxy-scyllo-
inosose was ever observed (Fig. 3.21). 
In a HPLC separation, also a new peak with a retention time (6.4 -6.7 min) to that obtained with 
standard 2-deoxy-scyllo-inosose was seen in the same enzyme reaction mixture (Fig. 3.22). 
Again, this new peak did not occur in the control assays. Maximal conversion (about 80%) of G-
6-P to 2-deoxy-scyllo-inosose was observed when the KanC reaction was incubated for 12 hrs at 
30°C. It was also noticed that presence of the cofactors Co++ and NAD was essential in the KanC 
enzyme reaction. This proved that KanC expressed from the plasmid pKC16b1 in E. coli in fact 
had a 2-deoxy-scyllo-inosose synthase activity. 
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Fig. 3.22 HPLC analysis of 2-deoxy-scyllo-inosose formation by KanC. HPLC run was carried out as 
described in Sect. 2.22. A: standard 2-deoxy-scyllo-inosose (10 mM); B: standard: scyllo-inosose (8 mM); 
C: standard G-6-P (15 mM); D: E. coli BL21 (DE3)/pKC16b1 (KanC) without G-6-P; E: E. coli BL21 
(DE3)/pET16b (control) without G-6-P; F: E. coli BL21 (DE3)/pET16b (control) in presence of G-6-P; G: 
E. coli BL21 (DE3)/pKC16b1 (KanC) in presence of G-6-P. Arrows indicate the peak for each substance 
and retension time are given between brackets. 
 
2-deoxy-scyllo-inosose (6.3 min)  
scyllo-inosose (5.2 min) 
G-6-P (21.5 & 27.5 min) 2-deoxy-scyllo-inosose 
(7.3 min) G-6-P (21.5 & 27.5 min) 
G-6-P (21.5 & 27.5 min) 
D 
C 
B 
G 
F 
E A 
substrate-free control assay 
substrate and enzyme-free control assay 
enzyme-free control assay 
RESULTS   
_____________________________________________________________________________________________ 
Dissertation, 2005  Aboshanab KM, BU Wuppertal 
83 
3.6.2 Biochemical analysis of the KanS1 protein 
The L-glutamine-dependent transamination of (2-deoxy-)scyllo-inosose to (2-deoxy-)scyllo-
inosamine is the second enzymatic step in 2DOS biosynthesis which was previously proven in 
extracts from various AGA producers (Lucher et al., 1989; Walker, 1995; Ahlert et al., 1997; 
Tamegai et al., 2002b). Two genes (kanS1 & kanS2) encoding related protein species belonging 
to this ketocyclitol aminotransferase family namely KanS1 (40% identity to BtrS from B. 
circulans; 54% identity to StsC from S. griseus) and KanS2 (32% identity to BtrS from B. 
circulans; 36% identity to StsC) proteins were present in the kan-cluster of S. kanamyceticus 
DSM 40500 (see Sect. 3.2.2). Since StsC and BtrS proteins were formerly characterized to be 
scyllo-inosose and 2-deoxy-scyllo-inosose aminotransferases, respectively (Ahlert et., 1997; 
Tamegai et al., 2002b), it was expected that the KanS1 protein represented the bifunctional 
ketocyclitol aminotransferase involved in the biosynthesis of 2DOS (Figs. 3.17 & 3.23). 
According to this hypothesis, KanS2 was expected (and had to be proven) not to be involved in 
2DOS biosynthesis. This transamination process would be carried out in the presence of PLP as a 
coenzyme as well as L-glutamine as an aminodonor substrate. The cell-free extract (soluble 
fractions) of E. coli JM109 (DE3) harboring the plasmid pKS16b1 (KanS1; cf. Tab. 3.8) was 
tested for 2-deoxy-scyllo-inosose aminotransferase activity. Because of stability problems with 
the chemically synthesized 2-deoxy-scyllo-inosose, a coupled assay of KanC and KanS1 was 
necessary. By this way, the 2-deoxy-scyllo-inosose enzymatically formed in the KanC reaction in 
the coupled assay acted as a substrate for the KanS1 enzyme (see Sect. 3.6.1).  
 
Fig. 3.23 First transamination reaction catalysed by the KanS1 enzyme using L-glutamine as 
aminodonor and 2-deoxy-scyllo-inosose as aminoacceptor. 
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Fig. 3.24 TLC detection of 2-deoxy-scyllo-inosamine formed from G-6-P and L-glutamine in the 
coupled reaction catalysed by KanC and KanS1. The enzyme reactions were performed with cell-free 
extracts (Tab. 3.8) as described in Sect. 2.23. TLC was developed as described in Sect. 2.21. Spots were 
visualized using ninhydrin solution (Sect. 2.3.10). Lane 1: L-glutamine; lane 2: 2DOS; lane 3: 2-deoxy-
scyllo-inosose and E. coli JM109 (DE3)/pKS16b1 (KanS1); lane 4: E. coli BL21 (DE3)/pKC16b (KanC) 
and E. coli JM109 (DE3)/pET16b (KanS1-free control); lane 5: E. coli BL21 (DE3)/pKC16b1 (KanC) 
and E. coli JM109 (DE3)/pKS16b1 (KanS1) without G-6-P; lane 6: E. coli BL21 (DE3)/pET16b (KanC-
free control) and E. coli JM109 (DE3)/pKS16b1 (KanS1) without G-6-P; lane 7: E. coli BL21 
(DE3)/pKC16b1 (KanC) and E. coli JM109 (DE3)/pKS16b1 (KanS1) without L-glutamine (substrate-free 
control); lane 8: E. coli BL21 (DE3)/pKC16b1 (KanC) and E. coli JM109 (DE3)/pKS16b1 (KanS1); lane 
9: BL21 (DE3)/pKC16b1 (KanC) plus L-glutamine but in the absence of E. coli JM109 (DE3)/pKS16b1 
(KanS1-free control).  
 
 
 
As shown in Figs. 3.24 and 3.25, both 2-deoxy-scyllo-inosamine and -keto-glutaramate were 
detectable on the TLC plates only from the coupled assays including active KanC and KanS1 
enzymes in the presences of G-6-P, L-glutamine and all the co-factors necessary. In these 
separations, the Rf-value for 2-deoxy-scyllo-inosamine was 0.54 and that for -keto-glutaramate 
was 0.83. Maximum conversion of 2-deoxy-scyllo-inosose to 2-deoxy-scyllo-inosamine by 
KanS1 was observed when the reaction was incubated at 37°C for 12 hrs. In addition, -keto-
glutaramate is unstable intermediate which easily cyclizes to 2-pyrrolidone-5-hydroxy-5-
carboxylic acid (Fig. 2.23; Alert et al., 1997). A new peak with a retention time of 13.9 min was 
observed by HPLC analysis of the KanC/KanS1 reaction assays (Fig. 3.26).  
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Fig. 3.25 TLC detection of -keto-glutaramate formed in the coupled reaction catalysed by KanC 
and KanS1. The enzyme reactions were performed with cell-free extracts (Tab. 3.8) as described in Sect. 
2.23. The TLC plate was developed as described in Sect. 2.21. Spots were visualized using the Ehrlich 
reagent (Sect. 2.3.10). lane 1: E. coli BL21 (DE3)/pKC16b1 (KanC) and E. coli JM109 (DE3)/pKS16b1 
(KanS1); lane 2: E. coli BL21 (DE3)/pKC16b1 (KanC) and E. coli JM109 (DE3)/pKS16b1 (KanS1) 
without L-glutamine; lane-3: E. coli BL21 (DE3)/pET16b (control) and E. coli JM109 (DE3)/pKS16b1 
(KanS1); lane 4: L-glutamine. The position of -keto-glutaramate is indicated by the arrow. 
 
 
 
In control assays lacking either one of the enzymes or one of the two substrates, this peak was 
not produced (Fig. 3.26). It was assumed that this peak represented -keto-glutaramate. Because 
of its instability, -keto-glutaramate is not available commercially and could not be used as a 
standard for the HPLC analysis. 
Furthermore, the KanS1 activity was also measured spectrophotometrically as described in Sect. 
2.24 with L-alanine as an aminodonor and measuring the decrease of NADH catalysed by L-
lactate dehydrogenase (Fig. 3.27). A significant decrease in the absorbance in the reaction 
containing KanS1 protein and all the other co-substrates in comparison to the other controls was 
observed (Fig. 3.27). The specific activity of KanS1 was calculated to be 0.27 U/mg protein (cf. 
Sect. 2.24). 
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Fig. 3.26 HPLC analysis of the KanC/KanS1 assays for the production of 2-deoxy-scyllo-inosamine. 
The enzyme reaction was performed using cell-free extracts (Tab. 3.8) as previously described in Sect. 
2.24. The HPLC run was carried out as described in Sect. 2.22. A: standard L-glutamine (30 mM); B: 
Tris-HCL, pH 7.5 (30 mM) + 1 mM PLP; C: E. coli BL21 (DE3)/pKC16b1 (KanC) without G-6-P and E. 
coli JM109 (DE3)/pKS16b1 (KanS1); D: E. coli BL21 (DE3)/pET16b (control) without G-6-P and E. coli 
JM109 (DE3)/pKS16b1 (KanS1); E: E. coli BL21 (DE3)/pET16b (control) and E. coli JM109 
(DE3)/pKS16b1 (KanS1); F: E. coli BL21 (DE3)/pKC16b1 (KanC) and E. coli JM109 (DE3)/pKS16b1 
(KanS1). Arrows indicate the peaks corresponding to each substance (indicated by small letters) with its 
retention time (min; inbrackets). Small letters indicate; a- L-glutamine (30 mM), b- Tris-HCL (30 mM, 
pH 7.5 + 1 mM PLP), c- G-6-P (20 mM), d- -keto-glutaramate. 
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Fig. 3.27 Spectrophotometric assay for (NADH consumption) measurement of the KanS1 activity. 
The enzyme assay was performed as described in Sect. 2.24 using cell-free extracts (soluble fractions) of 
E. coli JM109 (DE3)/pKS16b1 (KanS1) and or of E. coli JM109 (DE3)/pET16 (enzyme-free control). 
 
 
3.6.3 Biochemical analysis of the KanE protein 
The determination of the KanE activity (putative 3-aminocyclitol 1-dehydrogenase) was carried 
out as described in Sect. 2.25. However, the lack of 2-deoxy-scyllo-inosamine as a pure substrate 
made the quantification of this assay difficult. Therefore, an assay containing KanE besides 
KanC and KanS1 was carried out starting from G-6-P as a substrate. 
A weak spot on TLC with similar Rf value (0.42) to the standard 2DOS was only observed in the 
complete three enzyme assay, i.e. when extract of S. lividans TK23 harboring the plasmid 
pKEW1-2 (native KanE) was included (Fig. 3.28; lane 7). This spot was absent when the same 
reaction was done in absence of ZnCl2 (cf. Fig. 3.28) or when the N-terminally His-tagged KanE 
protein was added instead of the native one. Additionally, spectrophotometeric measurement of 
NAD(P)H generation was tried for detecting the KanE activity (cf. Sect. 2.26). However, the 
activity could not be detected in the extracts because of a high background of NAD consumption 
which made the measurement of KanE activity impossible. 
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Fig. 3.28 TLC detection of 2-deoxystreptamine (2DOS) formed by the 3-enzymes catalysed reaction. 
The coupled enzyme reaction for KanC, KanS1 and KanE was performed using cell-free extracts (Tab. 
3.8) as previously described in Sect. 2.25. TLC was developed as described in Sect. 2.21. Spots were 
visualized using the ninhydrin solution (Sect. 2.3.10). Lane 1: KanC/KanS1 (Sect. 2.24) without L-
glutamine; lane 2: E. coli BL21 (DE3)/pET16b (vector control) and E. coli JM109 (DE3)/pKS16b1 
(KanS1); lane 3: KanC/KanS1 without G-6-P; lane 4: standard 2DOS; lane 5: KanC/KanS1 and S. 
lividans TK23/pUWL201 (KanE-free control); lane 6: KanC/KanS1 and S. lividans TK23/pKEW1-2 
(native KanE; complete assay) without ZnCl2; lane 7: KanC/KanS1 and S. lividans TK23/pKEW1-2 
(native KanE; complete assay) in presence of ZnCl2; lane 8: standard L-glutamine. The positions for L-
glutamine, 2DOS and 2-deoxy-scyllo-inosamine are indicated by arrows. 
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4 Discussion 
 
4.1 General structure and genomic location of the ACAGA biosynthetic gene 
clusters  
 
The major objective of this work was to elucidate the genetics and use their comparison to set up 
proposals for the hypothetical pathways for the production of the major groups of 2DOS and 
related ACAGAs in their producing strains (cf. Tab. 3.1). The immediate interpretation of the 
structures and locations of the respective gene clusters analysed can be summarized as follows: 
(i) for the NM group, the four streptomycetes clusters (i.e. the neo-, rib-, par- and liv-clusters) 
are homogenous in both DNA composition (G+C content between 72.1% [rib] and 76.8% [neo]) 
and order of the genes (cf. Fig. 3.2). However, the btr-cluster from B. circulans largely deviates 
from this pattern (G+C content 50.3%; cf. Fig. 3.2); (ii) for the KM group, the three kan-, tob- 
and gen-clusters show also homogenous DNA composition (G+C content between 69.7% [gen] 
and 72.8% [tob]). However, the order of genes inside the clusters is only conserved in part; e.g. 
the subclusters kan/tobS1CD2M2D1S2 are related to genS1CD2M2D1S2 and the subcluster 
tobEBQ is related to kanEBQ (cf. Fig. 3.5); (iii) the genes for the two apr-clusters are highly 
conserved in their order, number of ORFs and their sequence identity is higher than 90% (G+C 
content 73.3%; cf. Fig. 3.7); (iv) the hyg-cluster contains a mixture of genes with a few 
similarities with several other ACAGA gene clusters or other sources of genes involved in rare 
sugar or oligosaccharide biosynthesis. The hyg-cluster is flanked by a transposase gene and 
contains three genes with good similarity to corresponding ones in the spc-cluster, i.e. hygFMF 
related to spcFMY (cf. Fig. 3.9); (v) the for- and ist-clusters share gene similarities to each other; 
however, the order of genes is not retained (cf. Fig. 3.11). As well, both clusters share the gene 
sets for/istHJ which correspond to genHJ; (vi) the surrounding genomic regions of all the 
clusters studied obviously are not conserved at all however, these regions are enriched with 
ORFs which are highly conserved in both the completely analysed streptomycete genomes 
(Bentley et al., 2002; Ikeda et al., 2003); (vii) the gene clusters for nearly all of the postulated 
biosynthetic pathways for the individual ACAGAs treated putatively contain all the necessary 
biosynthetic genes, except for BU and TM (cf. Figs. 3.2 & 3.5); (viii) the gene clusters analysed 
obviously are not located in a commonly conserved region on the respective linear chromosomes 
of their producer strains. There is evidence that all the gene clusters reside in the arms (i.e. the 
neo-, liv-, par- and rib-clusters seem to be located on a common area of one of the variable arms) 
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or close to their boundary with the core of the respective genome (e.g. kan-cluster). (ix) There is 
no clear evidence that any of the cluster is located in one of the conserved core regions of the 
respective linear chromosomes; the presence of an rRNA operon (rrnE) in close vicinity to the 
gen-cluster in M. echinospora does not contradict this suggestion, since also in the two 
completely analysed streptomycete genomes, two to three of the six rRNA operons lie outside 
the core regions (Bentley et al., 2002; Ikeda et al., 2003).  
 
4.2 Proposed biosynthetic pathways for the major groups of 2DOS and related 
ACAGAs 
 
4.2.1 Biosynthesis of 2DOS and related diaminocyclitols 
Biosynthesis of 2DOS and related 3,6-diaminocyclitol intermediates is considered the first target 
during the biosynthesis of the 2DOS-ACAGAs (i.e. paromamine and non-paromamine 
containing ACAGAs) and IM (i.e. 2-deoxyfortamine-containing ACAGAs), respectively. Only, 
the first two biosynthetic steps in the biosynthesis of 2DOS had been biochemically analysed by 
identifying the BtrC-related enzymes (2-deoxy-scyllo-inosose synthases or cyclases; Kudo et al., 
1999a; Ota et al., 2000; Kharel et al., 2004) and the BtrS-related cyclitol aminotransferases (L-
glutamine: ketocyclitol aminotransferases I and II; Lucher et al., 1989; Walker, 1995; Tamegai 
et al., 2002b). Analysis of the gene clusters of the 2DOS-ACAGAs revealed the conserved 
presence of a gene for a likely candidate aminocyclitol dehydrogenase (KanE and the related 
proteins); this lead to the prediction for this protein to be involved in the third step of 2DOS 
biosynthesis. As well, evidence was presented in the present study that KanE is involved in the 
dehydrogenation of the 2-deoxy-scyllo-inosamine to form the keto intermediate (1-keto-2,3-
deoxy-3-amino-scyllo-inositol) which is then transaminated a second time by the same 
ketocyclitol aminotransferase (KanS1 and related proteins; bifunctional enzymes; cf. Fig. 3.17) 
to form 2DOS. The proposed biosynthetic pathway for 2DOS is illustrated in Fig. 4.1. 
Both FTM and IM contain a 3,6-diaminocyclitol as basic cyclitol unit (cf. Fig. 1.5); however this 
cyclitol unit in each antibiotic originates from different routes of biosynthesis (cf. Figs. 1.8 and 
4.6 below). Analysis of the respective clusters revealed the presence of genes that encode 
putative enzymes needed for the biosynthesis of this aminocyclitol: 1) In case of FTM: (i) two 
further enzymes are found, ForA (putative D-myo-inositol-3-P-phosphatase) and ForC (putative 
myo-inositol-3-dehydrogenase), are required to link the biosynthetic pathway of D-myo-inositol-
3-P to the production of scyllo-inosose, the ketocyclitol substrate for the first aminotransferase 
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(ForS) to form scyllo-inosamine (the myo-inositol-derived scyllo-inosamine pathway); (ii) D-
myo-inositol-3-P is a common primary metabolite in actinomycetes, where it is essential for the 
synthesis of the major thiol, mycothiol, and cell wall phospholipids (Newton et al., 2000; 
Piepersberg et al., 2002; Movahedzadeh et al., 2004); (iii) Another putative scyllo-inosamine-6-
dehydrogenase (ForE; related to KanE) is also present; however, the difference is that the ForE 
enzyme does not act on the monomeric substrate, like the related enzymes in the 2DOS pathways 
(i.e. KanE). Rather it acts on a pseudodisaccharide (FTM-FU-10) to form the substrate for the 
next aminotransferase step, probably also being a bifunctional enzyme (ForS; see below Fig. 
4.6). Whether the ForS aminotransferase is a bifunctional enzyme as yet has to be proven in 
future, e.g. by mutant and biochemical studies; 2) In case of IM: (i) this cyclitol unit is derived 
from a 2-deoxy-scyllo-inosamine intermediate, like in the 2DOS pathways, where IstC and IstS 
are involved in its formation; (ii) the following biosynthetic steps would be similar to those in 
the FTM pathway, where IstE (putative 2-deoxy-scyllo-inosamine-3-dehydrogenase) and IstS 
(bifunctional aminotransferase) act on the a pseudodisaccharidic intermediate (IST-FU-10; see 
below Fig. 4.6). 
 
4.2.2 Biosynthesis of paromamine 
The biosynthesis of the pseudodisaccharidic intermediate, paromamine starts with a 
glycosyltransfer reaction coupling a D-glucosamine unit glycosidically to the 2DOS unit. A gene 
for a conserved putative glucosaminyltranferase enzyme (NeoM and related proteins; cf. Tab. 
3.3) is found in all the paromamine-containing ACAGAs producers, with high likeliness to be 
involved in this glycosylation process. In addition, the likely activated sugar as a cosubstrate for 
this glycosyltransfer reaction could be either UDP-D-glucosamine or UDP-N-acetyl-D-
glucosamine. As recently suggested by Kudo et al. (2005), UDP-D-glucosamine could be this 
activated sugar because its formation is claimed to be catalysed by BtrD protein, encoded by a 
conserved gene in most of the ACAGA producers. This suggestion made by Kudo et al. (2005) 
still questionable since: i) the BtrD and related proteins show significant similarity to the 
MitE/LmbE family of possible N-acetylhexosamine deacetylases (pfam02585; COG2120) and 
other amidases (e.g. mycothiol conjugate amidase; NP215598). Especially, this deacetylating 
function would fit to the biosynthetic pathway of the respective ACAGAs; ii) the nature of the 
enzymatic function of the BtrD/LmbE/MitE family of proteins (COG2120) is different from that 
of the nucleotidyltransferses (or UDP-D-glucosamine synthases). All other NDP-sugar synthases 
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(pyrophosphorylases) are strongly similar to each other but in a totally different protein family 
unrelated to the BtrD-like protein. However, both functions could be required during the 
biosynthesis of the respective ACAGAs; iii) they tried to clarify this nucleotidyl transferase 
function for the BtrD protein via using a protein model structure of MshB protein (1-D-myo-
inosityl-N-acetyl-D-glucosamine deacetylase) which is involved in a completely different 
catalytic function. The three-dimensional structures of MshB enzyme was completely analysed 
to be a zinc dependant hydrolyase as previously pointed out by Maynes et al. (2003). A protein 
model structure of a BtrD protein has to be used instead in order to establish a precise structural 
model; iv) Kudo et al. (2005) also made some attempts to test for the BtrD deacetylase activity 
by using UDP-GlcNAc a substrate. However, it has been reported that these type of LmbE-
related enzymes act only on GlcNAc-containing conjugates and not on monomeric substrate 
(Newton et al., 2000). In our case, 2’-N-acetylparomamine could be the high likely substrate for 
the “D” enzymes and should be used for testing the deacetylating activity of these enzymes.  
For these reasons, the predicted catalytic functions attributed to this conserved protein (BtrD-like 
protein) could be either a deacetylase or deaminase: a) a deacetylase for the N-acetyl-D-
glucosamine (GlcNAc)-containing conjugates (e.g. 2’-N-acetylparomamine), if NDP-N-acetyl-
D-glucosamine would be the donor substrate for the “M” enzymes. This predicted function is 
supported by the occurrence of a good similarity of “D” enzymes to the 1-D-myo-inosityl-N-
acetyl-D-glucosamine (GlcNAc-Ins) deacetylase (MshB) from Mycobacterium tuberculosis, 
which is involved in the biosynthesis of mycothiol (MSH; Newton et al., 2000; Maynes et al., 
2003). This deacetylating function of the BtrD protein would also fit to the biosynthetic 
pathways of the respective antibiotics, particularly in the formation of paromamine or 
paromamine-like intermediates. The involvement of BtrD like proteins in the formation of 
paromamine (in this case by its deacetylating activity) would also correlate to the data obtained 
with blocked mutants and biochemical feeding studies by Kudo et al. (2005). They disrupted the 
btrD gene in the wild type strain and the resulted btrD mutant showed no antibiotic production 
which confirmed that the btrD gene product is involved in the biosynthesis of BUs antibiotics. In 
order to determine which biosynthetic step was blocked, they carried out biochemical feeding 
studies for this mutant strain with various biosynthetic intermediates, such as 2-deoxy-scyllo-
inosamine, 2DOS and paromamine. They found that only with paromamine, the btrD mutant 
strain was able to recover antibiotic production which proves the involvement of the BtrD 
enzyme in the production of paromamine; b) a deaminase for -ketoglutaramate, where it 
converts the -ketoglutaramate (unavoidable and unstable by product of the two L-glutamine  
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Fig. 4.1 A proposal for the biosynthetic route to paromamine in the producers of the major classes 
of 2DOS-ACAGAs. The bracketed letters in bold in the figure indicate the possible protein families 
encoded by the respective ACAGA gene clusters that could catalyse the respective reactions: C = BtrC, 
NeoC, LivC, ParC, RibC, HygC, AprC, TobC, KanC, GenC, IstC; S = BtrS, NeoS, LivS, ParS, RibS, 
HygS, AprS, TobS1, KanS1, GenS1, IstS; E = BtrE, NeoE, LivE, ParE, RibE, AprE, TobE, KanE, GenE, 
IstE; D = BtrD, NeoD, LivD, ParD, RibD, AprN, TobD1, KanD1, GenL, ForD, IstD; M = BtrM, NeoM, 
LivM, ParM, RibM, AprM, TobM1, KanM1, GenM1, IstM. NM = neomycin; KM = kanamycin.  
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dependant transamination steps of the 2DOS pathways; cf. Fig. 3.17) to -ketoglutarate, before 
being spontaneously cyclised to 2-hydroxy-5-keto proline, a likely toxic metabolic compound. 
However this putative  function is contradicted by the absence of the equivalent gene in the hyg-
cluster. In addition, the BtrD protein could also act as a bifunctional enzyme 
(nucleotidyltransferase and 2’-N-acetylparomamine deacetylase) or maybe involved in another 
still unknown reaction. 
 
4.2.3 4,5-glycosylated 2DOS-ACAGAs (NM group) 
4.2.3.1 Biosynthesis of the NM-related ACAGAs 
The similarities in the chemical structures of the members of this group are mirrored by the 
greater similarity in the respective actinomycete gene clusters, gene content and sequence 
similarity in the individual genes/enzymes (cf. Fig. 3.2). The set of postulated enzymes encoded 
by the respective clusters are putatively complete for the biosynthesis of the individual ACAGAs 
except for BU. All the respective members of this group share the common intermediate 
paromamine and all the enzymes needed for this purpose are conserved in the producers of this 
subgroup (cf. Fig. 4.1). All the respective NM-related ACAGAs contain a ribosyl unit attached 
via a glycosidic link at position 5 of the cyclitol residue which distinguishes this group from the 
other subgroups of 2DOS-ACAGAs (cf. Fig. 1.2). Therefore, glycosylation of paromamine with 
an activated ribosyl unit would be expected to occur in order to form the common 
pseudotrisaccharidic intermediate (5-ribosylparomamine; Fig. 4.2). A pair of genes (neoA, neoL 
and related genes) is conserved only in this subgroup with a relatively good likeliness to encode 
proteins involved in the activation and transfer of this ribosyl unit. However, the enzymatic 
mechanism of this process still unknown. We expected that NeoA and NeoL (and related 
proteins) would be involved in the ribosyl activation and transfer, respectively, since: (i) NeoL 
shares some aa similarity with other phosphoribosyltransferase proteins and other 
glycosyltransferases (NP752321, 32% identity in 152 aa overlap; ZP00166262, 43% identity in 
57 aa overlap; NP248665, 47% identity in 57 aa overlap); (ii) the type of activation of the ribose 
residue for this unique biosynthetic step should be completely new since the normal activated 
ribose in the cell is 5-P-ribose-1-pyrophosphate (PRPP), which is needed or the biosynthesis of 
nucleotides at several stages and hence no conserved domains with other known proteins for the 
NeoA protein was found in the data base; (iii) both proteins are only present in the producers of 
this subgroup of ACAGAs and absent in others; (iv) both proteins are also conserved in both RM 
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and BU producers (pseudotrisaccharidic ACAGAs) and contain a ribosyl unit which means that 
these two proteins would have nothing to do with the third glycosylation process as in the 
pseudotetrasaccharidic ACAGAs (i.e. NM, PM and LM). 
After formation of the 5-ribosylparomamine, a need for reactions catalysed by a 6’-
dehydrogenase and a transaminase would be necessary to produce the pseudotrisaccharide RM 
which seems to be the end product in S. ribosidificus (Fig. 4.2). A pair of genes (neoQ and neoB) 
is found to be conserved in all gene clusters for the 2DOS and related ACAGAs except in the 
hyg-cluster. These two genes are postulated to encode the Q- and B-proteins (an oxidoreductase 
and a type III aminotransferase; see Tab. 3.3) for performing these two biosynthetic steps. The 
reasons attributed for this hypothesis are: (i) the two amino groups in the cyclitol moiety are 
produced by the NeoS (and related proteins) as previously analysed (Sect. 4.2.1; cf. Fig. 4.1); (ii) 
the 2’-amino group originates from the (N-acetyl-)D-glucosamine precursor which is a regular 
metabolite inside each cell; (iii) both proteins are also encoded by the rib-cluster where RM (end 
product) contains only one possible site for these two candidate enzymes (the 6’-OH group); (iv) 
the NeoQ (and related proteins) share putative conserved domains to other alcohol 
dehydrogenases from the pfam05199 (COG2303); (v) a protein homologous to NeoQ is not 
encoded by the hyg-cluster and HM-B lacks a 6’-amino residue or an equivalent one; (vi) NeoB 
(and related proteins) shares a conserved domain structure to other aminotransferases type III 
(pfam00202; COG0001) with good identity to a glutamate-1-semialdehyde aminotransferase-like 
protein (CAF34036). Both the Q- and B-related characterised enzymes are generally involved in 
the oxidoreduction/transamination of primary alcoholic/aldehyde groups (rather than ring 
positioned hydroxyl or keto groups).  
Interestingly, only one pair of homologous proteins (ParQ/LivQ and ParB/LivB) is encoded by 
the par- and liv-clusters. However their end products (PM-I and LM) lack a 6’-amino group. 
Furthermore, the non-functionality of the respective enzymes necessary for fulfilling a similar 
job in PM/LM is not evident from their primary structures. The presumed reasons for that are: (i) 
both enzyme pairs encoded by the par- and liv-clusters show different protein folding and hence 
their 3-dimensional structures are different from the other homologous proteins encoded by the 
neo-, rib- or btr-clusters; (ii) the presence of this gene pair in the par- and liv-clusters could 
mean that they are also responsible for introduction of the 6’’’-amino group (Fig. 4.2); (iv) a 
phylogram of BtrB homologous shows the closer relatedness of ParB/LivB and their divergence 
from the rest of the homologous proteins (NeoB, RibB, BtrB, etc.; cf. Fig A.7) which again 
could underline their separate substrate specificity. Therefore, it is postulated that the ParQ/B, 
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LivQ/B protein pairs act only on the pseudotetrasaccharidic substrate for the introduction of the 
6’’’-amino group and on the other hand, the NeoQ/B pair alone acts as a pair of bifunctional 
enzymes on both the pseudotrisaccharidic and pseudotetrasaccharidic intermediates for the 
introduction of both the 6’- and 6’’’-amino groups. 
Another surprising phenomenon of unexpected occurrence in the rib-cluster is the ribF gene, the 
equivalents of which putatively encode the second hexosaminyltransferase in the NM, PM and 
LM pathways. Furthermore, both the rib- and neo-clusters are highly conserved and the only 
major difference found was that in the rib-cluster, a natural frame shift mutation created by two 
compensating frame shifts (+1 bp in position 544 and -1 in position 771) was seen in the ribN 
ORF (encoding a putative 5’’’-epimerase). Since frame-shifts of this kind can also occur as 
artefacts via either reading errors during automatic analysis of DNA sequences or via mutational 
alteration in heterologous genetic backgrounds after cloning of the DNA, we analysed the 
particular DNA sequence twice again from independently isolated fragments obtained directly by 
PCR-amplification from the genomic DNA of S. ribosidificus, which confirmed the frame shifts. 
These results can be interpreted by either one or a combination of the following possibilities: (i) 
the RibF protein has lost its function; however, its production can not be excluded because there 
are no features to be seen in the DNA sequence which would indicate its exclusion from 
transcription or translation; (ii) the natural frame-shifts occurring in the ribN ORF lead to an 
inactive RibN protein which could negatively affect this glycosylation process (RibN could be 
involved in other as yet unknown accompanying function(s), so that causing fidelity of the third 
glycosylation step); (iii) the trisaccharidic nature of RM could be a favourite substrate for the 
exporter system (RibT/U) and therefore, compete with the third glycosylation (RibF) which leads 
to pumping of RM outside the cell before being further glycosylated. 
Another pair of ORFs (livY/W) are only found in the liv-cluster with a good reclamation to 
encode proteins (LivY and LivW) having putative 3’,4’-dehydratase and 3’,4’-oxidoreductase 
activities, respectively. Both enzymes are anticipated to be necessary for the 3’-dehydroxylation, 
the unique biosynthetic step during biosynthesis of LM. The reasons attributed for that are: (i) 
both genes are found only in the liv-cluster and are absent in the other clusters of this subgroup; 
(ii) both proteins show similarities to other protein families encoding dehydratase and/or 
oxidoreductase functions summarized under the data base entries pfam00106 (COG1028) for 
LivY and COG1032 for LivW; (iii) both proteins exhibit good identities to related ones in the 
apr-cluster, putatively involved in the same type of catalytic function (3’-dehydroxylation) in the  
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Fig. 4.2 Proposal of a general pathway design for the biosynthesis of the 4,5-glycosylated 2DOS-
ACAGAs starting from paromamine. The ACAGAs given in bold are the main end products in their 
corresponding ACAGAs producers (cf. Tab. 2.1). AT = aminotransferase; AHB = -hydroxy--
aminobutyryl residue; DH = dehydrogenase; DT = dehydratase; EP = epimerase; GT = 
glycosyltransferase; OR = oxidoreductase. 
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apramycin pathway (LivY, 58.4% identity in 229 aa overlap with AprD3; and LivW, 85.3% 
identity in 458 aa overlap with AprD4; cf. Figs. A.9 and A.10; cf. Tab. 3.3). 
 
4.2.3.2 Resistance mechanisms for the NM-related ACAGAs 
The producers of NM-related ACAGAs rely on aminoglycoside modification, O-
phosphorylation or N-acetylation, as resistance mechanisms for their self-protection (Cundliffe, 
1989; Shaw et al., 1993; Piepersberg, 1997). The gene clusters reported contain at least one 
resistance gene (generally aphA-derivatives) in the cases of the neo-, rib-, and par-clusters; 
however, none so far was detected in the liv-cluster and the DNA segments covering at least the  
larger part of the btr-cluster. However, a BU phosphotransferase gene (aphA-family) is located 
probably outside the btr-cluster (Herbert et al., 1986). The neo- and rib-clusters were found to be 
flanked by two resistance genes (aphA and aacC); the par-cluster contained only one resistance 
gene (aphA) at one side of the cluster however, the aacC gene and a putative aac6’-IIc gene are 
located outside the par-cluster (see Sect. 3.2.1; cf. Figs. 3.5 &. 3.3). Some of these genes had 
already been described in earlier studies (Thompson and Gray, 1983; Hoshiko et al., 1988; 
Lopez-Cabrera et al., 1989; Salauze et al., 1991). Because LM is the only antibiotic which lacks 
the 3’-OH group (target site of AphA enzyme), it can therefore, not be 3’-phosphorylated as a 
resistance mechanism and hence the aphA gene became deleted from the liv-cluster during 
evolution. Since, in the liv-cluster, the sole case among the respective clusters, livZ is present 
which putatively encodes an extracellular alkaline phosphatase similar to the StrK from the 
streptomycin producer S. griseus (Mansouri and Piepersberg, 1991; cf. Fig. 3.5 and Tab. A.5). 
This strongly implies that LM, like streptomycin and the other NMs is phosphorylated inside the 
cells and that, after secretion, it becomes dephosphorylated in the medium. This additionally 
implies that another (non-aphA-like) LM phosphotransferase gene occurs in S. lividus, but 
outside the liv-cluster. However, AGA phosphotransferases modifying NM-like 2DOS-ACAGAs 
in other positions are not known so far. Furthermore, another additionally conserved gene (neoP 
and related genes) which encodes a putative sugar phosphate phosphatase could also be involved 
in the 3’-dephosphorylation of the respective phosphorylated-ACAGAs outside the cells (cf. Fig. 
3.2). 
Also, a pair of genes was found to be highly conserved among the respective gene clusters 
(neoT, U and related genes) which encodes two transporter proteins (NeoT/U; cf. Tab. 3.4). 
These two proteins show a significant similarity to classical, two-components ABC transporters 
(e.g. NP823966 and NP823967), which are mostly encoded by two adjacent genes in an operon 
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(cf. Fig. 3.2). Presumably, both enzymes may be involved in the export for of the respective 
ACAGAs outside the cells (cf. Fig. 3.2 and Tab. 3.4) and therefore, could contribute to the 
resistance phenotype of the producer cells as drug exporters. Future investigations will have to 
clarify these open questions. 
 
4.2.3.3 Possible sensor/response regulatory system 
The presence of the three conserved genes neoG, H, I (and the related genes) among the 
actinomycete genes clusters of the NM-family (neo-, par-, liv-, and rib-) gave an expectation that 
their gene products could play a role in the regulation of the produced metabolites (cf. Fig. 3.2). 
From our lab discussion, there was a conclusion that, the respective three conserved gene 
products (G/H/I) would possibly act as a new type of sensor/response regulatory system for 
transmitting signals via the cytoplasmic membrane and hence control the pathway-specific gene 
expression (Galperin, 2004). Some reasons which lead to that conclusion are: i) the equivalent 
gene products are also encoded by hyg- and kan-clusters as well as by the cin-cluster 
(cinnamycin gene cluster of S. cinnamoneus subsp. cinnamoneus DSM 40005; Cinorf12, 13 and 
14; Widdick et al., 2003). In all cases, the three conserved genes are present in a common operon 
except in the par-cluster (cf. Figs. 3.2, 3.5 and 3.9). Equivalent genes are absent in the other 
related gene clusters (i.e. gen-, for-, tob-, ist- and apr-clusters; cf. Figs. 3.5, 3.7 and 3.11). This 
means that the presence of these genes does not correlate with the nature and structure of 
metabolic products formed by the respective clusters. In addition, they are not required for any 
other metabolic functions such as, biosynthesis, transport or resistance; ii) regarding the 
structural analysis of the respective protein sets, the NeoI-related proteins are in the range of 
160-175 aa long having a possible helix-turn-helix (HTH) DNA-binding motif at positions 51-90 
(see Fig. A.11). The NeoH-related proteins are in the range of 168-195 aa long containing a 
strongly conserved hydrophilic and histidine-rich residues at positions 89-100 and possibly 
contain a single trans-membrane helix at positions 42-62 (see Fig. A.12). The NeoG-related 
proteins are in the range of 382-431 aa long having 6 or 7 trans-membrane helices (in the first 
230-250 aa; see Fig. A. 13). Presumably, the NeoG/H-related proteins would interact on the 
cytoplasmic side of the membrane forming a trans-membrane/sensor kinase complex. When 
signals come via the membrane, the NeoG/H complex would become active which in turn 
activate the postulated transcription regulator (NeoI-related proteins) leading to a control 
pathway-specific gene expression. Future physiological analysis in wild type and knock-out 
mutant strains will help to clarify this working hypothesis. 
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4.2.4 4,6-glycosylated 2DOS-ACAGAs (KM group) 
Biosynthetic feeding studies with isotope labeled precursors, induction of series of blocked 
mutants and their crossfeeding with accumulated intermediates was carried out extensively for 
the GMs and FTMs (Kase et al., 1982; Hasegawa, 1992). In their biosynthetic pathways 
proposed on the basis of such results, the two families, KMs and GMs share the intermediate 
formation of the pseudodisaccharide paromamine (D-glucosamine-alpha-1,4-2DOS) with the 
NM group (see Sect. 3.2.2). KMs (including TM) are structurally differentiated from GMs by 
some additional modifications, the latter share with the FTMs, not belonging to the 2DOS class 
(Rinehart, 1979; Kase et al., 1982; Umezawa et al., 1986; Hasewaga, 1992; Piepersberg, 1997). 
Thus KMs and GMs are both 3’’-aminated during the later stages of modification in the neutral 
sugar unit attached to the 6-hydroxyl group of the 2DOS aminocyclitol. In turn, the GMs and 
FTMs share typical 6’-C-methylation and 3’,4’-didehydroxylations (cf. Figs. 1.3 & 1.5). 
Recently, two other groups have sequenced the kan-cluster of S. kanamyceticus (AJ582817, a 
segment of 47050 bp; Kharel et al., 2004b) or part of it (AB164642; a segment of 25467 bp; 
Yanai and Murakami, 2004). The submitted sequence of the group of Kharel et al. (2004b) was 
found to be different from position 44915 (equivalent to position 41573 bp of our sequence) up 
to the end of their sequence compared to our sequence. The difference is created by a 
recombination in a Sau3AI recognition site (GATC) in our submitted sequence (SkaJ15.18). This 
in turn means that, the DNA segment (21314 bp) downstream to this recombinant site is not 
located adjacent to upstream region harboring the kan-cluster. However, both DNA segments 
were ligated during construction of the cosmid bank. In addition, the same group of Kharel has 
recently submitted part of the tob-cluster (AJ579650; a segment of 13802 bp; Kharel et al., 
2004a) where the overlapping sequences to our submission was found to be identical. Also 
Kharel group (AJ575934; 32668 bp; Kharel et al., 2004a) and another group (AY524043; 38146 
bp; Unwin et al., 2004) have partially sequenced the gen-cluster from M. echinospora ATCC 
15835. The overlapping sequences of these clusters were identical to our submission. 
Analyses of the kan-, tob- and gen-clusters revealed two characteristic features, (1) some of the 
centrally located genes are duplicated or even multiplied most probably to encode proteins 
responsible for unique biosynthetic purposes. This phenomenon could be explained as follows: 
a) presence of an amino group at position 3’’of the respective ACAGAs could explain the 
duplication of the S-like genes (kanS1/S2 and the related gene pairs). The hypothesis on which 
this conclusion is based are : i) only one related gene is required [like in the neo- and other gene 
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clusters; also on the evidence formerly provided by Lucher et al. (1989) and Walker (1995)] to 
encode a bifunctional aminotransferase needed for the introduction of the two amino groups into 
the 2DOS cyclitol ring; ii) the KanS2 would act on 3’’-keto-intermediate originated from the 
secondary sugar hydroxyl group which resemble to certain degree the structures of the 
ketocyclitol intermediates (substrate of KanS1); iii) the presence of kanD2 (and related genes) 
only in these gene clusters which putatively encode 3’’-dehydrogenase complements this 
hypothesis; b) duplication of M-like genes (kanM1/M2 and the related genes), suggests that the 
second glycosylation step (probably catalysed by KanM2 and the related proteins; 6-
glycosylation of 2DOS) needs a very similar enzyme and cosubstrates during the biosynthesis of 
KMs and GMs (UDP-D-glucosamine or UDP-xylose, respectively); c) the four fold occurrence 
of a B-type aminotransferase gene in the gen-cluster only (genB1/B2/B3/B4) is still enigmatic 
and needs particular investigation. At present the most likely explanation for this phenomenon is 
that the encoded pyridoxal phosphate-dependant enzymes are not only involved in the 6’-
transamination steps. Rather, at least in part in the stereoisomerization of the 6’-C-atom to yield 
the various variants and branching alternatives of GM family intermediates/end products. Future 
biochemical studies of the encoded proteins as well as knock-out mutants of the respective genes 
would give more clear knowledge about their precise catalytic functions. 
(2) Analyses of the tob-cluster in comparison to the related kan-cluster revealed the following: a) 
absence of some genes that would encode proteins required for the 3’-dehydroxylation processes 
during the biosynthesis of TM. However, the only hypothesis related to that observation is that, 
this unique biosynthetic step could be catalysed by the two proteins encoded by the co-existing 
apr-cluster in the same producer (AprD3 and AprD4; Sect. 4.1.2); b) no resistance genes were 
detected in the tob-cluster however, it is also assumed that the kamB resistance gene (Holmes et 
al., 1991) found in the apr-cluster would also counter resistance to TM; c) presence of the two 
genes, kanK (putatively encodes 2’-deaminase) and kanJ (putatively encodes 2’,3’-
oxidoreductase/reductase) only in the kan-cluster would explain their necessity for the 
conversion of KM-B to KM-A (the two main end products) in S. kanamyceticus. This prediction 
is made on the following arguments: i) both kanJ and kanK genes are unique to the kan-cluster; 
ii) absence of these two genes from the tob-cluster, since these catalytic functions are not needed 
for TM (only one end product; TM = 3’-deoxykanamycin B); iii) UDP-(N-acetyl)-D-
glucosamine is the precursor required for the first glycosylation step (KanM1); therefore, the 
hypothesis that UDP-D-glucose could act as an alternative precursor to form KM-A seems to be 
high unlikely;  
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Fig. 4.3 Proposal of a general pathway design for the biosynthesis of the 4,6-glycosylated 2DOS-
ACAGAs starting from paromamine. ACAGAs given in bold are the main products in their 
corresponding producers (Tab. 2.1). AT = aminotransferase; DA = deaminase; DH = dehydrogenase; DT 
= dehydratase; MT = methyltransferase; OR = oxidoreductase ; PL = phospholyase. 
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iv) KanJ has significant similarity with the MmcH protein (mitomycin biosynthetic protein; 31% 
identity in 204 aa overlap; COG5285) from S. lavendulae which could have a similar 
biosynthetic function (deaminase); v) KanK has a significant similarity (43% identity in 61 aa 
overlap; NP626465) with a putative reductase. Certain genes encoding proteins needed for 
unique biosynthetic functions in GMs were present only in the gen-cluster: putative 6’/(4’’)-C-
methyltransferase (GenK), which is closely related to a characteristic enzyme encoded by the 
for-cluster (ForK; Kuzuyama et al., 1995); and the putative 6’-N-methyltransferase (GenN) 
which was also found to be conserved in the ist-cluster (cf. Figs. 3.5 & 3.11). A proposal for the 
biosynthetic pathways for the three ACAGAs starting from the paromamine intermediate is 
outlined in Fig. 4.3. It was known before that the producers of KM-related ACAGAs rely on 
modification of the target site (16S rRNA methyltransferase) as a resistance mechanism 
(Kelemen et al., 1991; Shaw et al., 1993; Piepersberg, 1997; Demydchuk et al., 1998). Two 
resistance genes were found in both the kan- and gen-clusters (cf. Fig. 3.5). In case of the 
producer strain S. kanamyceticus, the genes kmr (CAA75800.1; encoding 16S rRNA 
methyltransferase) and kanA (AB164230.1; encoding aminoglycoside 6'-acetyltransferase) were 
known from earlier studies (Murakami et al., 1983; Demydchuk et al., 1998). Both genes were 
found in our data set and turned out to be identical with those submitted to the data base earlier. 
In the gen-cluster, gmrA and gmrB (both encoding 16S rRNA methyltransferases) were detected; 
however, only the gmrA gene was already known from earlier analyses and data base 
submissions (Kelemen et al., 1991; M55520). The kan-, tob- and gen-clusters contained genes 
which encoded putative efflux proteins that could play a role in the export system of the 
respective antibiotics (cf. Sect. 3.2.2). Out of these, a kanT-related gene was conserved in all the 
clusters (kanT, tobT and genT), however, a kanX-related gene was conserved only in the gen-
cluster (cf. Fig. 3.5). 
Analysis of the gen-, kan- and for-clusters revealed evidences that the gen-cluster could have 
basically originated from a fusion of a kan- and a for-cluster. Comparison of the DNA and 
protein sequences showed a significant similarity between the gen- and kan-clusters as well as 
between the gen/for-clusters. However, no significant similarity could be detected between the 
kan- and for-clusters. The flanking segments of the gen-cluster showed a strong similarity (55 to 
95% sequence identity) to the for-cluster. Especially in most of the genes which are not present 
in any other of the analysed ACAGA gene clusters, i.e. forHIJ/genHJ, forQ/genQ, 
forPBK/genB4PB3K, forT/genI, fosC/genW as well as for several truncated (obviously non-
functional) ORFs. The opposite of that was found between the kan- and gen-clusters where the 
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central part of the gen-cluster showed a strong similarity to the kan-clusters. Especially in most 
of the genes conserved among the majority of the 2DOS-ACAGA gene clusters, which share the 
pseudodisaccharidic intermediate, paromamine in their biosynthesis (Okuda and Ito, 1982; 
Piepersberg, 1997). Examples of these gene sets are: kanBQ/genBQ, 
kanS1CD2M2/genS1CD2M2, kanE/genE, kanS2/genS2, kanM1/genM1. Structural comparison of 
GM-C1, KM-B and FTM-A with regard to their biosynthetic origin and evolution of a hybrid 
pathway is presented in Fig. A. 14. 
 
4.2.5 4-glycosylated 2DOS-ACAGAs (Apr group) 
Apr is the only important product in this group and is produced by various different 
actinomycetes, e.g. S. tenebrarius DSM 40477 and St. hindustanus DSM 44523. Organization 
and order of ORFs for the two apr-clusters derived from these two strains are highly conserved 
(cf. Fig. 3.7). This could mean that their occurrence in such distant organisms is the result of a 
rather recent event of horizontal gene transfer of the full length gene cluster. The postulated 
biosynthetic pathway for Apr starting from 2DOS is illustrated in Fig. 4.4. The genes encoding 
proteins (AprC, AprS and AprE) involved in the biosynthesis of the 2DOS moiety were 
conserved in both clusters (cf. Fig. 3.7). The first sugar unit in Apr could be formed via an 
(NDP-) octosamine sugar precursor probably derived from a C7- or C8- pentose phosphate 
pathway intermediate (heptoses and octoses are typical bacterial cell wall sugars). This 
octosamine unit would later undergo some intramolecular arrangement to form the stable double 
ring sugar unit attached to position 4 of the 2DOS unit. The genetic evidences in favour for this 
hypothesis are: (i) presence of the aprK gene that encodes a protein related to ADP-heptose 
synthases with good identity to other proteins from this family (e.g. ZP00291440 with 38% 
identity in 119 aa overlap). So, it seems that the AprK protein would putatively encode an 
octose- (or heptose-) or octosamine-activating enzyme which in presence of NTP forms an NDP-
activated precursor of an octosamine; (ii) presence of aprJ and aprD1 genes that encode proteins 
with good similarity to known phosphosugar mutases and NDP-sugar epimerases, respectively. 
These enzymes could also be involved in the formation and modification of the postulated NDP-
octosamine precursor; (iii) presence of a gene, aprH, for a putative glycosyltransferase (AprH; 
related to ZP00054179.1; 32% identity in 321 aa overlap; COG3980) which could be involved in 
4-octos(amin)yl transfer of the C8-sugar moiety.  
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Fig. 4.4 A proposal for a biosynthetic pathway for the 4-glycosylated 2DOS-ACAGAs (apramycins) 
starting from 2DOS. ACAGAs given in bold are the main products in the producing strains (cf. Tab. 
2.1). AT = aminotransferase; DH = dehydrogenase; DT = dehydratase; MT = methyltransferase; OR = 
oxidoreductase; PPP = pentose phosphate pathway. 
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However, the exact function and their placement in the pathway of both the AprJ- and AprD1-
catalysed steps are highly speculative at present, i.e. before or after the glycosylation to form the 
pseudodisaccharidic intermediate (see Fig. 4.4). Another conserved gene in the apr-cluster 
(aprM), putatively encodes a second glycosyltransferase (AprM), relatives of which are 
conserved in other ACAGA gene-clusters, which is likely to be involved in the second 
glycosylation step. Related activities were attributed above to the KanM2 and TobM2 proteins 
which are probable UDP-D-glucosyltransferases (cf. Tab. 3.3; see Fig. 4.3). Formation of a 
UDP-D-glucose precursor could be catalysed by the AprN (BtrD homolog) as discussed above 
(see Sect. 4.2.2). After formation of the pseudotrisaccharidic intermediate, introduction of an 
amino group at position 7’ followed by its methylation would be the next step in order to form 
the first byproduct, saccharocin or KA-5685 (see Fig. 4.4; Piepersberg, 1997). Therefore, the 
three genes (aprQ, aprL and aprI) encoding proteins with putative 7’-dehydrogenase, 7’-
aminotransferase and 7’-N-methyltransferase activities are expected to be involved in these 
biosynthetic steps.  
For the production of oxyapramycin (second byproduct) from saccharocin, a need for 
introduction of an amino group at position 4’’of the second neutral sugar is necessary. Therefore, 
both AprD2 (putative 4’’-dehydrogenase) and AprL (putative 4’’-aminotransferase) are expected 
to be involved in this conversion (cf. Fig. 4.4). Production of Apr (end product) does occur via 
3’-dehydroxylation of oxyapramycin in which we postulate that the enzymes AprD3 (putative 
3’,4’-dehydratase) and AprD4 (putative 3’,4’-oxidoreductase) are involved (see also Sect. 4.2.3). 
 
4.2.6 5-glycosylated 2DOS-ACAGAs (HM-B group) 
HM-B is at present the sole member of this group (cf. Fig. 1.4). The postulate on the biosynthetic 
pathway for HM-B is based on an interpretation of the gene products encoded by the hyg-cluster 
as illustrated in Fig. 4.5. It was also observed that the hyg-cluster could be located at the end of 
the respective chromosome because the last 2 ORFs (ShyG17.32c and ShyG17.33c) on the 
cloned DNA segment harboring the hyg-cluster are homologous to those (NP631871.1 and 
NP624364.1) at the end of the linear chromosome of the fully sequenced genome of S. coelicolor 
A3(2) (Bentley et al., 2002). The following proteins were assigned to biosynthetic functions in 
the HM-B: a) The biosynthesis of the aglycone and its modification: the conserved proteins 
HygC, HygS, HygE clearly are involved in 2DOS biosynthesis (cf. Fig. 4.1); HygM putatively 
represents a 3-N-methyltransferase due to its homology to the SpcM protein (AF145038) which  
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Fig. 4.5 Proposal of a biosynthetic pathway for the 5-glycosylated 2DOS-ACAGAs (HM-B) starting 
from 2DOS. AT = aminotransferase; DH = dehydrogenase; GT = glycosyltransferase; MT = 
methyltransferase; NDP = nucleotidyldiphosphate; P = phosphate. 
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was postulated to be responsible for a similar catalytic function in the biosynthesis of 
spectinomycin (see Sect. 3.2.4); b) The biosynthesis of the glycosidic units and their 
modifications: From the chemical structure of HM-B (cf. Fig. 1.4) as well as from the analysis of 
the hyg-cluster, it seems that both sugar units would likely be derived from a hexose and a 
heptose, respectively (Piepersberg, 1997). The hexose precursor seems to be a galactose rather 
than glucose. The heterocyclic ring formed between the first and second sugar, gives rigidity to 
the molecule and hinders the normal rotation and flexibility between the two sugar units in the 
disaccharidic molecule. Therefore, for molecular stability, the hydroxyl group at position 4 of the 
first hexose should be in an axial conformation and above the molecular plane, which is the case 
in galactose, and not in glucose. Presence of the hygJ gene, putatively encoding an NDP-hexose 
3’-epimerase (HygJ), which could be required to change the stereochemistry of the hydroxyl 
group at the position 3 of the hexose in order to facilitate formation of this heterocyclic ring. It is 
also expected that formation of this heterocyclic ring between the two sugars units occurs at one 
of the later steps during the biosynthesis of HM-B. HygF is a putative NDP-galactosyltransferase 
with good identity to a similar protein encoded in the spc-cluster (SpcF; Tab. A.13).  
It was predicted that sedo-heptulose-7-phosphate is the precursor of the second heptose sugar. 
Sedo-heptulose-7-phosphate is supposed to undergo several modifications, before being 
glycosylated by the putative 1,3-glycosyltransferase (HygD, 35% identity in 170 aa overlap to a 
glycosyltransferase from Methylococcus capsulatus; AAU92274) to the preformed disaccharidic 
intermediate. Modifications that are postulated to occur to the sedo-heptulose-7-phosphate 
precursor by use of the putative proteins HygP, HygN, HygU, HygO, and HygL are outlined in 
Fig. 4.5. Heterocycle formation is expected to be catalysed by one or more proteins, such as a 
1”,2’- or 1’’,3’-oxidase (HygY; a SpcY homolog is present in the spectinomycin producer where 
a similar heterocyclization process is involved in AGA biosynthesis) or maybe others, such as 
HygX. The gene product HygA, the APH(7’’) enzyme would be responsible for self resistance in 
the producing strain. HygA was already known from the earlier studies (Zalacain et al., 1986). 
The two genes hygV and hygW encode proteins putatively involved in the export of HM-B-7’’-
phosphate outside the cells and therefore could be relevant for the resistance phenotype. 
 
4.2.7 ACAGAs related to 2DOS-containing compounds (FTM/IM group) 
A preliminary overview about the partial structure of the for-(fms-) cluster was already published 
by Hasegawa and collaborators in the past (Odakura et al., 1984; Dairi et al., 1992a, b, c; Ohta et 
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al., 1992a, b; Kuzuyama et al., 1995). These studies were based on both the isolation of DNA-
fragments encoding purified biosynthetic enzymes or complementing several mutations blocked 
in FTM-A/dactimicin/sannamycin production in M. olivasterospora ATCC 21819 and in S. 
sannaensis IFO 14239 (producer of the FTM-related sannamycin). All gene loci had been 
mapped in a cluster located on a cosmid covering a larger genomic segment and carrying at least 
ten genes (fms1/forA, fms3/forM, fms4/forS, fms5/forE, fms7/forK, fms8/forP, fms10/forN, 
fms11/forL, fms12/forO, and fms13/forV; cf. Tab. A.10). Some of these genes had also been 
sequenced and/or functionally identified by these authors: fms7 (forK; encoding FTM-KL1 
methyltransferase), fms8 (forP; encoding FTM-KK1 3'-phosphotransferase), fms11 (forL; 
encoding 1-O-methyl-epimerase), fms13 (forV; encoding FTM-B glycyltransferase), fms14 (forZ; 
encoding FAD-dependent FTM-A oxidase or N-formimidoyl FTM-A [dactimicin] synthase). 
Previous studies on the biosynthesis of FTM (and the related pseudodisaccharidic antibiotics) 
gave indications that the second transamination step in the synthesis of the diamino-cyclitol unit 
took place on the disaccharidic intermediate, which is otherwise not the case in all the 2DOS-
ACAGAs biosynthetic pathways (cf. Figs. 4.1 & 4.6). Thus, it seemed likely that all producers of 
FTM-like aminoglycosides (including IM, etc.) contain highly related gene clusters (cf. Fig. 
3.11), originating from a common evolutionary source, with some minor modifications, such as 
the use of different gene sets for the formation of the alternative cyclitol precursors, (2-deoxy)-
scyllo-inosose (see proposed pathway in Fig. 4.6).  
Analyses of the blocked mutants and/or conversion studies with IM intermediates corresponding 
to the last five intermediates of the FTM pathway (cf. Fig. 4.6) in S. sannanensis and S. 
tenjmariensis supported this conclusion (Hotta et al., 1989a and b; Ohta et al., 1992a; Hotta et 
al., 1994). Analyses of genes present in both the for- and ist-clusters, were found to encode the 
proteins putatively required for the biosynthesis of FTM and IM, respectively (cf. Fig. 4.6). 
Moreover, the coupled 3’,4’-dehydroxylation is a tailoring biosynthetic process that does not 
only occur in the formation of FTM and IM, but also in that of GM (cf. Fig. 4.3). The 
biochemical tools and mechanisms used for this process, would include five subsequent steps 
namely, phosphorylation-phospholysis-reduction-dehydratation-reduction (cf. Fig. 4.6). The 
putatively proteins that are responsible for this dehydroxylation process are indicated in Fig. 4.6. 
The first step in 3’-phosphorylation would be catalysed by an AphA-related APH(3’) enzyme 
(ForP, IstP) encoded by the respective gene clusters, which means its involvement in a 
biosynthetic step rather than in the resistance phenotype.  
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Fig. 4.6 Proposal of a pathway for the biosynthesis of the FTM and IM group ACAGAs starting 
from G-6-P. ACAGAs given in bold are the main products in the producing strains (cf. Tab. 2.1). APH = 
aminoglycoside phosphotransferase; AT = aminotransferase; DH = dehydrogenase; DT = dehydratase; EP 
= epimerase; GCT = glycyltransferase; mI = myo-inositol; mIP = myo-inositolphosphate; MT = 
methyltransferase; OR = oxidoreductase;PL = phospholyase; sI = scyllo-inosose. 
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As previously indicated, methylation of the 16S rRNA is considered to be the main resistance 
mechanism in the producers of FTM and IM (Ohta and Hasegawa, 1993a & b). The three genes 
(forI, H, J and the related genes) that putatively encode proteins involved in the export of the 
respective antibiotics were also conserved in both clusters (cf. Tab. 3.4). The proposed 
biosynthetic pathways for both FTM and IM are mostly similar except for two particular 
biosynthetic phases: (i) the different cyclitol biosynthesis as described above (see Sect. 4.2.1); 
(ii) the 6’-C-methyltransfer in the FTM pathway (ForK; which also occurs in the GM pathway 
by GenK) and instead the 6’-N-methyltransfer in the formation of IM (ForU; cf. 4.6). 
 
4.3 Reconstitution of the 2DOS pathway in vitro 
The second main goal of this work was to test and elucidate the biosynthetic steps for the 
biosynthesis of 2DOS, the aglycone unit in all the 2DOS-ACAGAs. The first and second 
enzymatic steps had already been studied previously and characterized in part from other 
pathways (Lucher et al., 1989; Walker, 1995; Ahlert et al., 1997; Kudo et al., 1999a; Ota et al., 
2000; Tamegai et al., 2002b; Kharel et al., 2004; Kharel et al., 2005). After identification and 
analysis of most of the biosynthetic gene clusters for 2DOS-ACAGAs, three conserved genes 
were likely candidates to be involved in the biosynthesis of the 2DOS moiety (see Sect. 4.2.1 and 
Fig. 4.1). For achieving this, the respective three genes from the kan-cluster (kanC, kanS1, kanE) 
were selected for expressing them heterologously in several E. coli strains as well as in S. 
lividans TK23 and characterizing their catalytic activities. 
 
4.3.1 Heterologous expression of KanC, KanS1 and KanE proteins 
In order to overproduce the soluble proteins of KanC, KanS1 and KanE for enzyme assays, 
different expression systems in E. coli and in S. lividans as well as different expression 
conditions were tested. E. coli is the most frequently used prokaryotic expression system for the 
high level production of heterologous proteins (Hannig and Makrides, 1998; Binnie et al., 1997). 
Due to the high G+C content of the heterologous genes from Streptomyces to be expressed in E. 
coli, sometimes codon bias arises as an obstacle during expression (Novy et al., 2001). Codon 
bias leads to insufficient tRNA pools which could in turn lead to stalling, premature termination, 
frame shifting and amino acids misincorporation during translation. Overcoming the codon bias 
in E. coli for enhanced protein expression was achieved by using the E. coli Rosetta strain, 
because it harbors the pRARE plasmid, on which most of rare tRNAs are encoded (Novy et al., 
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2001). In this work, the soluble N-terminally His-tagged KanE protein was only achieved via 
heterologous expression in the E. coli Rosetta strain (cf. Tab. 3.8). 
 
4.3.2 Biochemical characterization of KanC, KanS1 and KanE proteins 
In order to reach the final goal, to reconstitute the 2DOS formation in a “one-pot-assay”, the 
heterologous expressed and soluble proteins, KanC (2-deoxy-scyllo-inosose synthase), KanS1 
(putative bifunctional enzyme, L-glutamine (PLP):2-deoxy-scyllo-inosose aminotransferase [AT-
I]; and 1-keto-2,3-deoxy-3-amino-scyllo inositol aminotransferase [AT-II]) and KanE (putative 
aminocyclitol 1-dehydrogenase) were at first tested individually for their enzymatic activities. 
Conversion of G-6-P to 2-deoxy-scyllo-inosose by KanC was confirmed (see Sect. 3.6.1). In all 
the control reactions, formation of 2-deoxy-scyllo-inosose was never detected which in turn 
delivered an additional detail to the substrate specificity of the KanC-catalysed reaction. Similar 
results were obtained by others with KanC homologous from other pathways (BtrC, Kudo et al., 
1999a; TbmA, Kharel et al., 2004). It was also confirmed that both Co++ and NAD are necessary 
for exhibiting KanC activity, since both cofactors were necessary not only for the enzyme 
reaction but also for stabilizing the 2-deoxy-scyllo-inosose synthase as pointed out by Kudo et 
al., (1999a). The mechanism as well as the stereochemistry of this reaction catalysed by the BtrC 
enzyme was previously illustrated by the group of Kakinuma and others in more detail (Kudo et 
al., 1999a; Nango et al., 2003; Nango et al., 2004). The BtrC enzyme catalyses intramolecular 
carbocyclization of G-6-P to 2-deoxy-scyllo-inosose via a multi-step process which includes the 
first oxidation at the C-4 position of G-6-P followed by elimination of the phosphate group from 
the activated ulose to form an enol or enolate intermediate. Subsequent reduction at C-4, 
followed by intramolecular aldol condensation between C-1 and C-6 gives rise to 2-deoxy-
scyllo-inosose. 
The next step in the 2DOS biosynthesis, the transamination of the keto group of 2-deoxy-scyllo-
inosose, was also confirmed to be catalysed by the KanS1 enzyme. This enzymatic step was 
previously analyzed by different KanS1 homologous from other producers of ACAGAs (Lucher 
et al., 1989; Walker, 1995; Ahlert et al., 1997; Tamegai et al., 2002b; Kharel et al., 2005). Lack 
of 2-deoxy-scyllo-inosose as a pure substrate forced the use of a coupled assay of KanC and 
KanS1 for testing this activity and delivered the first indication that a combined “one-pot-
system” could be achievable (see Sect. 3.6.3). In an L-alanine/NADH-coupled assay, the specific 
activity of KanS1 enzyme was calculated to be 0.27 U/mg protein in the cell free extract which is 
in a reasonable range for this aminotransferase activity (cf. Sect. 3.6.2). 
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The third enzymatic process during the biosynthesis of 2DOS, the oxidation (dehydrogenation) 
of the 2-deoxy-scyllo-inosamine at the C-3 position was postulated by us first to be catalysed by 
KanE-related oxidoreductases (see Fig. 3.17; Sect. 3.4; Tab. 3.3). KanE is a member of Zn++-
dependent alcohol dehydrogenases (pfam00107; COG1063). This reflected by the presence of 
two conserved histidine and three conserved cysteine amino acid residues in the same positions 
as in other members of this class that could play role in the attachment to Zn++ ions (cf. Fig. 
A.19). Accordingly, an attempt was made to prove these suggestions and also the dependence on 
Zn++ ions. However, absence of 2-deoxy-scyllo-inosamine as a pure substrate had brought an 
additional obstacle about performing this step in a single reaction. Despite of lacking of pure 2-
deoxy-scyllo-inosamine, an attempt was made to perform the KanE assay in coupling it with the 
KanC/KanS1-promoted reactions (see Sect. 2.25). However, it was previously indicated that 
BtrC (KanC homolog) activity was completely inhibited by the presence of Zn++ ions (Kudo et 
al., 1999a). Therefore, the complete “one-pot-system” was carried out in two separate stages, i.e. 
the KanC/KanS1-catalysed reaction was at first proceeded until 2-deoxy-scyllo-inosamine was 
formed and then the KanE/KanS1-catalysed reactions were started thereafter (cf. Sect. 2.25). In 
this case, inhibition of KanC by Zn++ ions could be avoided. Formation of 2DOS was 
demonstrated preliminary this way and gave an indication that the activity of KanE was 
necessary. It also proves that the second transamination in the 2DOS biosynthesis was again 
catalysed by the bifunctional KanS1 aminotransferase (see Sect. 3.4; Fig. 3.17).  
The reasons that 2DOS was detected only in the presence of KanE as a native protein, but not 
when using the soluble N-terminal His-tagged KanE protein (cf. Fig. 3.28) could be that the 
tagged His residues interact with and chelate Zn++ ions from the medium. In this case, either the 
protein changes to inactive conformation or Zn++ ions would be scavenged and no longer be free 
to play their role in the KanE-catalysed reaction. In order to better characterize KanE activity 
further in the future, the following prerequisites should be fulfilled: a) purification of the native 
KanE protein; b) preparation of 2-deoxy-scyllo-inosamine as a pure substrate; c) as well, kanE-
mutants should be carried out in the wild type strain.  
 
4.4 Prospective of this work 
This study gives good basis for the following aspects to be further investigated in future: 
1. Biosynthetic studies for these important ACAGAs; This item could be achieved by cloning 
and expression of all the genes that putatively involved in the biosynthesis and regulation of 
ACAGAs. This would be done by testing the biochemical activities of the resulted proteins and 
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hence get a detailed overview about their metabolic roles in the formation of these important 
metabolites. 
2. Evolutionary studies about the origin and relatedness of these important metabolites; This 
could also be achieved via checking both DNA and protein sequences encoded by the respective 
gene clusters. Phylogram of all the related proteins encoded by these gene clusters are also a 
useful tool for testing evolution and origin of these metabolites. 
3. Biocombinatorial formation of new ACAGAs; This approach now is considered one of the 
most important tool for getting new members of these valuable metabolites especially those 
conferring resistance to the clinically relevant pathogens.  
4. Finding new producers of natural, still unknown relatives of the known ACAGAs, e.g. 
isolation and screening various antibiotic-producing isolates from soil and testing them using the 
newly developed heterologous primers designed in this work (see Sect. 3.3). 
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6.1 Tables of proteins encoded in the genomic region covering the biosynthetic gene clusters of the ACAGAs analysed 
 
Tab. A.1 Proteins encoded in the genomic region covering the neo-cluster of S. fradiae DSM 40063 (accession code: AJ629247) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in NM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SfrA10.1  544  NP_823514.1 S. avermitilis MA-4680 HP 
SfrA10.2  311  NP_823513.1 S. avermitilis MA-4680 HP 
SfrA10.3  1793  NP_823512.1 S. avermitilis MA-4680 multidomain regulator (AfsR-family) 
SfrA10.4  82  NP_827553.1 S. avermitilis MA-4680 pectin esterase (fragment) 
SfrA10.5  180  NP_629028.1 S. coelicolor A3(2) membrane protein (fragment) 
SfrA10.6c  98  NP_828422.1 S. avermitilis MA-4680 HP (fragment) 
SfrA10.7c aphA 268 AphA AAA26699.1 S. fradiae NM phosphotransferase, APH(3’)-V, NM-resistance 
SfrA10.8c neoG 431 NeoG CAD60536.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SfrA10.9c neoH 173 NeoH CAD60535.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SfrA10.10c neoI 175 NeoI CAD60534.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SfrA10.11 neoE 340 NeoE CAE22477.1 S. tenebrarius aminocyclitol 1-dehydrogenase 
SfrA10.12 neoS 424 NeoS CAE22472.1 S. tenebrarius L-glutamine:ketocyclitol aminotransferase, AT-I + -II  
SfrF04.2 neoC 430 NeoC CAE22471.1 S. tenebrarius 2-deoxy-scyllo-inosose synthase (cyclase) 
SfrF04.3 neoM 421 NeoM BAD20768.1 S. kanamyceticus 2DOS 4-glucosaminyltransferase, GT-I 
SfrF04.4 neoT 666 NeoT NP_823966.1 S. avermitilis MA-4680 ABC transporter, ATP binding; NM(-P) export 
SfrF04.5 neoU 594 NeoU NP_629587.1 S. coelicolor A3(2) ABC transporter, ATP binding; NM(-P) export 
SfrF04.6 neoQ 541 NeoQ AAR98543.1 M. echinospora NM 6'-(6''-) dehydrogenase 
SfrF04.7 neoN 299 NeoN NP_623366.1 Thermoanaerobacter Fe-S oxidoreductase; (5''-epimerase or 6''-DH) 
     tengcongensis 
SfrF04.8 neoP 233 NeoP BAC41220.1 B. circulans sugar phosphate phosphatase (?) 
SfrF04.9 neoX 83 NeoX AAL18481.1 Photorhabdus luminescens cHP, (5''-epimerase ?) 
SfrF04.10 neoF 366 NeoF NP_630571.1 Nostoc sp. PCC 7120 glycosyltransferase, put. GT-III 
SfrF04.11 neoD 279 NeoD BAD20763.1 S. kanamyceticus TTP-D-glucosmamine synthase 
SfrF04.12c neoL 660 NeoL BAC41207.1 B. circulans unknown, poss. involved in ribosyltransfer (?) 
SfrF04.13 neoB 416 NeoB AAR98542.1 M. echinospora NM 6'-/6''-aminotransferase 
SfrF04.14 neoA 1293 NeoA AAL18480 Photorhabdus luminescens unknown, poss. involved in ribosyltransfer (?) 
SfrF04.15c aacC8 287 AacC8 AAA26685.1 S. fradiae aminoglycoside N-3-acetyltransferase, NM resistance 
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Tab. A.1 Proteins encoded in the genomic region covering the neo-cluster of S. fradiae DSM 40063 (accession code: AJ629247), continued 
__________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in NM pathway or else a 
design. symbol aa design. acc. code organism  
__________________________________________________________________________________________________________________________________ 
SfrF04.16c neoR 886 NeoR NP_822883.1 S. avermitilis MA-4680 put. regulator 
SfrF04.17 (neoY) 73 (NeoY) O53810 Mycob. tuberculosis cHP 
SfrF04.18  173  NP_631038.1 S. coelicolor A3(2) cHP 
SfrF04.19c  140  NP_631360.1 S. coelicolor A3(2) cHP 
SfrF04.20c  454  NP_628830.1 S. coelicolor A3(2) serine protease 
SfrF04.21c  316  NP_628831.1 S. coelicolor A3(2) regulator (lysR family) 
SfrF04.22 icdA 739  NP_828390.1 S. avermitilis MA-4680 isocitrate dehydrogenase 
SfrF04.23  629  NP_733614.1 S. coelicolor A3(2) heat shock protein 70 
SfrF04.24  113  NP_630232.1 S. coelicolor A3(2) HP  
SfrF04.25  152  NP_628193.1 S. coelicolor A3(2) membrane protein 
SfrF04.26  254  AAN85502.1 S. atroolivaceus HP 
SfrF04.27c  128  AAB71209.1 S. cinnamoneus  membrane protein (partial ORF)) 
__________________________________________________________________________________________________________________________________ 
a
 Abbreviations: AacC = aminoglycoside 3-N-acetyltransferase; acc. code = accession code; AphA = aminoglycoside phosphotransferase; Apr = apramycin; 
AT = aminotransferase; BU = butirosin; cl. = cluster; (c)HP = conserved hypothetical protein; CPS = cell wall polysaccharide; DH = dehydrogenase; 2DOS = 
2 deoxystreptamine; fam. = family; FTM = fortimicin; Glu = glutamine; GM = gentamicin; GT = glycosyltransferase; HM-B = hygromycin B; icdA = 
isocitrate dehydrogenase; IM = istamycin; KM = kanamycin; LM = lividomycin; Magnetospir = Magnetospirillum; Mycob. = Mycobacterium; MT = 
methyltransferase; NM = neomycin; OMe = O-methyltransferase; PM = paromomycin; pr. = protein; poss. = possible; put. = putative; RM = ribostamycin; 
SAM-d. = S-adenosylmethionin dependant; sim. = similar, sp. = species; syst. = system; THB = tetrahydrobiopterin; TM = tobramycin; try = tryptophane. 
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Tab. A.2 Proteins encoded in the genomic region covering the rib-cluster of S. ribosidificus NRRL B-11466 (accession code: AJ744850) 
_________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in RM pathway or else a 
design. symbol aa design. acc. code organism  
_________________________________________________________________________________________________________________________________ 
SribP10.1c  135  AAQ20787.1 S. hygroscopicus ketosyntase/methylmalonyl-CoA transferase 
SribP10.2c  105  ZP_733531.1 Pseudomonas fluorescens penicillin acylase related protein 
SribP10.3  288  NP_828769.1 S. avermitilis MA-4680 HP 
SribP10.4c  340  AAP20835.1 Oryza sativa HP 
SribP10.5  487  NP_942801.1 Ralstonia eutropha HP 
SribP10.6c  147  ZP_00081914.1 Geobacterium metallireducens HP 
SribP10.7  375  ZP_00058465.1 Thermobifida fusca Streptomycin 6-kinase 
SribP10.8c  206  NP_639614.1 S. coelicolor A3(2) transposase (partial ORF) 
SribP10.9c  151  NP_862085.1 S. lividans transposase (partial ORF) 
SribP10.10c  139  AAF26370.1 S. coelicolor A3(2) HP, probable transposition function 
SribP10.11c   80  NP639616.1 S. coelicolor A3(2) HP 
SribP10.12c  253  NP862083.1 S. lividans HP 
SribP10.13c  149  NP_862091.1 S. lividans helicase-like protein 
SribP10.14c aacC 287 AacC AAA26685.1 S. fradiae aminoglycoside 3-N-acetyltransferase; RM resistance 
SribP10.15c ribA 1242 RibA AAL18480.1 Photorhabdus luminescens unknown; poss. involved in ribosyltransfer 
SribP10.16c ribB 416 RibB AAR98542.1 M. echinospora RM 6'-aminotransferases (AT-III) 
SribP10.17 ribL 652 RibL BAC41207.1 B. circulans unknown; poss. involved in ribosyltransfer 
SribP10.18c ribD 278 RibD NP_634124.1 Methanosarcina mazei Goe1 TTP-D-glucosmamine synthase  
SribP10.19c ribF 352 RibF NP_630571.1 S. coelicolor A3(2) glycosyltransferase III (hexosamiyltransferase II) 
SribP10.20c ribX 82 RibX AAL18481.1 Photorhabdus luminescens cHP, (5''-epimerase ?) 
SribP10.21c ribP 223 RibP BAC41220.1 B. circulans sugarphosphate phosphatase (?) 
SribP10.22c ribN 299 RibN NP_578073.1 Pyrococcus furiosus Fe-S oxidoreductase; (5''-epimerase or 6''-DH ?) 
SribP10.23c ribQ 541 RibQ AAR98543.1 M. echinospora aminoglycoside 6'- (and 6''-)dehydrogenase (?) 
SribP10.24c ribU 594 RibU NP_629587.1 S. coelicolor A3(2) ABC transporter, ATP binding; RM(-P) export 
SribP10.25c ribT 617 RibT NP_823966.1 S. avermitilis MA-4680 ABC transporter, ATP binding; RM(-P) export 
SribP10.26c ribM 419 RibM AAR98545.1 M. echinospora UDP-(NAc)glucosamine:2DOS 4-glycosyltransferase; 
      GT-I or paromamine synthase 
SribP10.27c ribC 391 RibC CAE22471.1 S. tenebrarius 2-deoxy-scyllo-inosose synthase (cyclase) 
SribP10.28c ribS 424 RibS CAE22472.1 S. tenebrarius L-glutamine:ketocyclitol aminotransferase (AT-I and -II) 
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Tab. A.2 Proteins encoded in the genomic region covering the rib-cluster of S. ribosidificus NRRL B-11466 (accession code: AJ744850), continued 
_________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in RM pathway or else a 
design. symbol aa design. acc. code organism  
_________________________________________________________________________________________________________________________________ 
SribP10.29c ribE 340 RibE CAE22477.1 S. tenebrarius aminocyclitol 1-dehydrogenase 
SribP10.30 ribI 166 RibI CAD60534.1 S. cinnamoneus component of sensor/response regulator syst. 
SribP10.31 ribH 177 RibH CAD60535.1 S. cinnamoneus component of sensor/response regulator syst. 
SribP10.32 ribG 390 RibG CAD60536.1 S. cinnamoneus component of sensor/response regulator syst.  
SribL03.8 aphA 468 AphA AAC32025.1 S. ribosidificus aminoglycoside 3’-phosphotransferase, RM resistance 
SribL03.9  81  AAQ82565.1 S. sp. FR-008 polyketide synthase (partial ORF); outside rib-cluster 
SribL03.10c  107  NP_626990.1 S. coelicolor A3(2) transposase (partial ORF) 
SribL03.11  154  ZP_00047805.1 Magnetospir. magnetotacticum HP 
SribL03.12  103  XP_323407.1 Neurospora crassa HP 
SribL03.13  245  NP_733533.1 S. coelicolor A3(2) HP 
SribL03.14c   186  AAP92498.1 S. vinaceus type II thioesterase (partial ORF) 
SribL03.15c  1089  AAP92497.1 S. vinaceus nonribosomal peptide synthetase 
SribL03.16c  739  AAP92496.1 S. vinaceus nonribosomal peptide synthetase (partial ORF) 
___________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.3 Proteins encoded in the genomic region covering the par-cluster of S. rimosus subsp. paromomycinus NRRL 2455 (accession code: AJ749845) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in PM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SriG07.16c  79  NP_336806.1 Mycobact. tuberculosis P450 heme-thiolate protein 
SriG07.17c  413  AAN85514.1 S. atroolivaceus P450 hydroxlase 
SriG07.18c  1110  AAK57184.1 Stigmatella aurantiaca non-ribosomal peptide synthetase 
SriD03.11c  158  NP_628587.1 S. coelicolor A3(2) unknown 
SriD03.12  260  NP_627740.1 S. coelicolor A3(2) membrane protein 
SriD03.13  136  NP_531113.1 Agrobacterium S. C58 membrane protein 
SriD03.14  211  AAP21653.1 S. hygroscopicus subsp. unknown 
     yingchengensis 
SriD03.15c  372  ZP_00052846.1 Magnetosp. magnetotacticum amidinotransferase 
SriD03.16c  169  NP_625008.1 S. coelicolor A3(2) transcriptional regulator 
SriD03.17  80  NP_822222.1 S. avermitilis MA-4680 transcriptional regulator 
SriD03.18  304  NP_627627.1 S. coelicolor A3(2) unknown 
SriD03.19  271  NP_822224.1 S. avermitilis MA-4680 unknown 
SriD03.20 parE 339 ParE NP_385683.1 Sinorhizobium meliloti aminocyclitol 1-dehydrogenase 
SriD03.21 parS 424 ParS AAD45549.1 S. netropsis  L-glutamine:ketocyclitol aminotransferase (AT-I and -II) 
SriD03.22 parC 386 ParC BAA83344.1 B. circulans 2-deoxy-scyllo-inosose-synthase (cyclase) 
SriD03.23 parM 417 ParM CAC93943.1 pIJ6021 UDP-(NAc)glucosamine:2DOS 4-glycosyltransferase; 
    BAC41206.1 B. circulans  GT-I or paromamine synthase 
SriD03.24 parT 604 ParT NP_823966.1 S. avermitilis MA-4680 ABC transporter, ATP binding; PM(-P) export 
SriD03.25 parU 628 ParU NP_823967.1 S. avermitilis MA-4680 ABC transporter, ATP binding; PM(-P) export 
SriD03.26 parQ 546 ParQ NP_823106.1 S. avermitilis MA-4680 PM 6''-dehydrogenase (?) 
SriD03.27 parN 298 ParN AAD32720.1 S. lavendulae Fe-S oxidoreductase; (5''-epimerase or 6''-DH ?) 
SriD03.28 parP 231 ParP BAC41220.1 B. circulans sugarphosphate phosphatase (?) 
SriD03.29 parX  90 ParX AAL 18481.1 Photorhabdus luminescens cHP, (5''-epimerase ?) 
SriD03.30 parF 367 ParF NP_826550.1 S. avermitilis MA-4680 put. glycosyltransferase III (hexosaminyl GT-II) 
SriD03.31 parD 253 ParD BAC41211.1 B. circulans TTP-D-glucosmamine synthase  
SriD03.32 parL 637 ParL BAC41207.1 B. circulans unknown; poss. involved in ribosyltransfer 
SriD03.33 parB 417 ParB BAC41209.1 B. circulans PM 6''-aminotransferase 
SriD03.34 parA 1302 ParA BAC41208.1 B. circulans unknown; poss. involved in ribosyltransfer 
APPENDIX         
 
 
136 
Tab. A.3 Proteins encoded in the genomic region covering the par-cluster of S. rimosus subsp. paromomycinus NRRL 2455 (accession code: AJ749845), continued 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in PM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SriL03.20c parZ 455 ParZ AAP92510.1 S. vinaceus extracellular PM-phosphate phosphatase 
SriL03.19 parI 163 ParI CAD60534.1 S. cinnamoneus component of sensor/response regulator system 
SriL03.18 aphA 262 AphA AAA26699.1 S. fradiae paromomycin phosphotransferase; Aph(3’)-V 
SriL03.17c parY 229 ParY ZP_00004610.1 Rhodobacter sphaeroides cHP; unknown 
SriL03.16c parG 400 ParG ZP_00110163.1 S. cinnamoneus component of sensor/response regulator system 
SriL03.15c parH 184 ParH NP_828190.1 S. cinnamoneus component of sensor/response regulator system 
SriL03.14c (pasA) 76 (PasA) AAF10386.1 Deinococcus radiodurans UDP-N-acetylglucosamine synthase; outside par-cluster  
SriL03.13 (pasB) 775 (PasB) NP_630071.1 S. coelicolor A3(2) chitinase; outside par-cluster 
SriL03.12 (pasC) 284 (PasC) ZP_00227284.1 Kineococcus radiotolerans NDP-sugar epimerase; outside par-cluster 
SriL03.11 (parR1) 209 (ParR1) ZP_00226580.1 Kineococcus radiotolerans transcriptional regulator; outside par-cluster 
SriL03.10 (parR2) 292 (ParR2) NP_824491.1 S. avermitilis MA-4680 transcriptional regulator; outside par-cluster  
SriL03.9 (pasD) 285 (PasD) ZP_00201781.1 Methylobacterium flagellatus oxidoreductase, DH; outside par-cluster 
SriL03.8  40  NP_631315.1 S. coelicolor A3(2) conserved hypothetical protein 
________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.4 Proteins encoded in the genomic regions covering the aacC7 of S. rimosus subsp. paromomycinus NRRL 2455 (accession codes: AJ628955) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in PM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SriA13.1  246  A32245 S. rimosus subsp. paromomycinus integral membrane protein 
SriA13.2 aacC7 287 AacC7 P30180 S. rimosus subsp. paromomycinus 3-N-acetyltransferase; PM resistance 
SriA13.3 aacA 190 AacA AAA25688.1 Pseudomonas aeruginosa 6'-N-acetyltransferase; ACAGA resistance(?) 
SriA13.4c  333  NP_821315.1 S. avermitilis MA-4680 epoxide hydrolase 
SriA13.5  180  NP_821317.1 S. avermitilis MA-4680 transcriptional regulator (TetR-family) 
SriA13.6  76  NP_624841.1 S. coelicolor A3(2) cold-shock protein 
SriA13.7  94  NP_901291.1 Chromobacterium violaceum sensor/response regulatory hybrid protein 
________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.5 Proteins encoded in the genomic region covering the liv-cluster of S. lividus ATCC 31603 (accession code: AJ748832) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in LM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SliD01.1  687  EAA46978.1 Magnaporthe grisea 70-15 predicted protein 
SliD01.2c  131  NP_626993.1 S. coelicolor A3(2) put. secreted protein 
SliD01.3  329  NP_631450.1 S. coelicolor A3(2) ABC transporter, ATP binding; iron (III) dicitrate 
      transport system 
SliD01.4  325  NP_631449.1 S. coelicolor A3(2) transport lipoprotein; iron (III) dicitrate transport system 
SliD01.5  692  NP_631448.1 S. coelicolor A3(2) put. membrane transport protein 
SliD01.6 livE 339 LivE CAE22477.1 S. tenebrarius aminocyclitol 1-dehydrogenase 
SliD01.7 livS 424 LivS CAE22472.1 S. tenebrarius L-glutamine:ketocyclitol aminotransferase (AT-I and -II) 
SliD01.8 livC 384 LivC CAE22471.1 S. tenebrarius 2-deoxy-scyllo-inosose synthase (cyclase) 
SliD01.9 livM 414 LivM BAD20768.1 S. kanamyceticus UDP-(NAc)glucosamine:2DOS 4-glycosyltransferase; 
      GT-I or paromamine synthase 
SliD01.10 livT 601 LivT NP_823966.1 S. avermitilis MA-4680 ABC transporter, ATP binding; LM(-P) export 
SliD01.11 livU 621 LivU NP_823967.1 S. avermitilis MA-4680 ABC transporter, ATP binding; LM(-P) export 
SliD01.12 livQ 546 LivQ AAR98543.1 M. echinospora aminoglycoside 6' (and 6''-)dehydrogenase (?) 
SliD01.13 livN 299 LivN ZP_00054205.1 Magnetospir. magnetotacticum Fe-S oxidoreductase; (5''-epimerase or 6''-DH ?) 
SliD01.14 livP 229 LivP BAC41220.1 B. circulans cHP; sugarphosphate phosphatase (?) 
SliD01.15 livF 357 LivF NP_630571.1 Nostoc sp. PCC 7120 glycosyltransferase III (hexosaminyl GT-II) 
SliD01.16 livD 252 LivD BAD20763.1 S. kanamyceticus TTP-D-glucosmamine synthase 
SliD01.17c livL 617 LivL BAC41207.1 B. circulans unknown; poss. involved in ribosyltransfer (?) 
SliD01.18 livB 416 LivB AAR98542.1 M. echinospora LM 6''-aminotransferase 
SliD01.19c livZ 456 LivZ AAP92510.1 S. vinaceus extracellular LM-phosphate phosphatase (?) 
SliD01.20 livI 166 LivI CAD60534.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SliD01.21 livH 170 LivH NP_828190.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SliD01.22 livG 407 LivG ZP_00110163.1 S. cinnamoneus component of sensor/response regulator syst. (?) 
SliD01.23c livA 1355 LivA AAL18480.1 Photorhabdus luminescens unknown; poss. involved in ribosyltransfer (?) 
SliD01.24c livX 80 LivX AAL18481.1 Photorhabdus luminescens cHP, (5''-epimerase) 
SliD01.25c (livO) 62 (LivO) ZP_00087677.1 Pseudomonas fluorescens fragmentary ORF, topoisomerase IA 
SliD01.26 livV 430 LivV NP_960853.1 Mycob. avium  cHP 
SliD01.27 livW 458 LivW NP_614275.1 Methanopyrus kandleri  Fe-S oxidorededucatse; 3'-dehydroxylation (?) 
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Tab. A.5 Proteins encoded in the genomic region covering the liv-cluster of S. lividus ATCC 31603 (accession code: AJ748832), continued 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in LM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SliD01.28 livY 238 LivY AAR98544.1 M. echinospora oxidoreductase; 3'-dehydroxylation (?) 
SliD01.29c (liwA) 407 (LiwA) NP_738548.1 Corynebacterium efficiens  coenzyme PQQ synthesis protein; outside liv-cluster ? 
SliD01.30  152  NP_624549.1 S. coelicolor A3(2) nitrate reductase alpha chain 
________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.6 Proteins encoded in the genomic region covering part of the btr-cluster of B. circulans ATCC 21558 (accession code: AJ781030) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in BU pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
BciH11.1 btrM (389) BtrM BAC41206.1 B. circulans hexosaminyltransferase (GT-I); paromamine synthase 
BciH11.2 btrL 604 BtrL BAC41207.1 B. circulans unknown; poss. involved in ribosylation(?) 
BciH11.3 btrA 1225 BtrA BAC41208.1 B. circulans unknown; poss. involved in ribosylation(?) 
BciH11.4 btrB 432 BtrB BAC41209.1 B. circulans hexosaminyl 6'-AT 
BciH11.5 btrC 368 BtrC BAC41210.1 B. circulans 2-deoxy-scyllo-inosose synthase (cyclase) 
BciH11.6 btrD 275 BtrD BAC41211.1 B. circulans TTP-D-glucosmamine synthase 
BciH11.7 btrE 349 BtrE BAC41212.1 B. circulans oxidoreductase; aminocyclitol 1-DH 
BciH11.8 btrF 232 BtrF BAC41213.1 B. circulans oxidoreductase; hexose-DH? 
BciH11.9 btrG 156 BtrG BAC41214.1 B. circulans HP, unknown 
BciH11.10 btrH 302 BtrH BAC41215.1 B. circulans HP, unknown 
BciH11.11 btrI 87 BtrI BAC41216.1 B. circulans acyl carrier protein; AHBA synthesis/transfer 
BciH11.12 btrJ 419 BtrJ BAC41217.1 B. circulans carboxylase; AHBA synthesis? 
BciH11.13 btrK 428 BtrK BAC41218.1 B. circulans Glu-decarboxylase; AHBA synthesis 
BciH11.14 btrO 341 BtrO BAC41219.1 B. circulans FMN monoxygenase, AHBA synthesis 
BciH11.15 btrP 213 BtrP BAC41220.1 B. circulans shorter than BAC41220.1; phosphatase or mutase 
BciH11.16 btrQ 504 BtrQ AAK89143.1 Agrobacterium tumefaciens  oxidoreductase; hexosaminyl 6'-DH 
_______________________________________________________________________________________________________________________________
__ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.7 Proteins encoded in the genomic region covering the kan-cluster of S. kanamyceticus DSM 40500 (accession code: AJ628422) 
_____________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base  Put. function in KM pathway or else a 
design. symbol aa desig. acc. code organism  
_____________________________________________________________________________________________________________________ 
SkaJ19.1  516  NP_826945.1 S. avermitilis ABC transporter 
SkaJ19.2  413  NP_626652.1 S. colicolor A3(2) ABC transporter permease 
SkaJ19.3c  406  BAA32132.1 S. griseus  methyltransferase 
SkaJ19.4  278  NP_624822.1 S. colicolor A3(2) NAD(+) synthase 
SkaJ19.5c  146  NP_522161.1 Ralstonia solanacearum unknown, cHP 
SkaJ19.6c  248  NP_823077.1 S. avermitilis unknown, cHP 
SkaJ19.7c (kaoA) 832 KaoA NP_823078.1 S. avermitilis cHP, poss. regulator, (out of cl.?) 
SkaJ19.8c (kanZ) 811 KanZ NP_630566.1 S. colicolor A3(2) efflux protein, (out of cl.?) 
SkaJ19.9c (kanY) 147 KanY NP_630565.1 S. colicolor A3(2) unknown, HP, (out of cl.?) 
SkaJ19.10c (kanX) 420 KanX NP_828653.1 S. avermitilis efflux protein, (out of cl.?) 
SkaJ19.11c (kanW) 64 KanW AAO65787.1 S. cinnamonensis unknown, HP, (out of cl.?) 
SkaJ19.12 kanA 184 KanA NP_105746.1 Mesorhizobium loti  resistance, N-6'-acetyltransferase, AAC(6') 
SkaJ19.13c kanG 382 KanG CAD60536.1 S. cinnamonensis unknown, poss. regulator system 
SkaJ19.14c kanH 195 KanH CAD60535.1 S. cinnamonensis unknown, poss. regulator system 
SkaJ19.15c kanI 160 KanI CAD60534.1  S. cinnamonensis unknown, poss. regulator system 
SkaJ19.16 kanR 369 KanR CAA55579.1 S. glaucescens KM-specific pathway regulator 
SkaJ19.17 kanE 343 KanE NP_626648.1 S. colicolor A3(2) cyclitol 1-dehydrogenase 
SkaJ19.18 kanT 418 KanT NP_625738.1 S. colicolor A3(2) export protein. 
SkaJ19.19 kanB 392 KanB BAC41209.1 B. circulans hexosamine-6'-AT 
SkaJ19.20 kanQ 508 KanQ NP_356358.1 Agrobactacterium tumefaciens hexosamine-6'-DH 
SkaJ19.21 kanS1 427 KanS1 CAA70012.1 S. griseus cyclitol AT, AT I 
SkaJ19.22 kanC 390 KanC BAA83344.1 B. circulans BtrC cyclitol cyclase, 
SkaJ19.23 kanD2 369 KanD2 NP_698342.1 Brucella suis (cyclitol-1-) or hexose-3'-DH 
SkaJ19.24 kanM2 388 KanM2 BAC41206.1  B. circulans 6-glucosyl-GT (GT II)? 
SkaJ19.25 kanD1 249 KanD NP_634124.1 S. colicolor A3(2) TTP-D-glucosmamine synthase 
SkaJ19.26 kanS2 419 KanS2 CAA70012.1 S. griseus  cyclitol or hexose-3"-aminotransferase; AT II 
SkaJ19.27 kanJ 322 KanJ AAD32731 S. lavendulae poss. to be involved the 2’ deamination process 
SkaJ19.28 kanK 329 KanK NP_809643.1 Bacteroides thetaiotaomicron poss. to be involved 2’ deamination process 
SkaJ19.29 kmr 277 Kmr CAA75800.1 S. kanamyceticus 16S rRNA methylase; KM resistance 
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Tab. A.7 Proteins encoded in the genomic region covering the kan-cluster of S. kanamyceticus DSM 40500 (accession code: AJ628422), continued 
_____________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base  Put. function in KM pathway or else a 
design. symbol aa desig. acc. code organism  
________________________________________________________________________________________________________________________________ 
SkaJ19.30 kanM1 414 KanM1 BAC41206.1 B. circulans 4-hexosaminyl-GT (GT I)? 
SkaJ19.31 (kanL) 335 KanL NP_217745.1 Mycob. tuberculosis unknown (GTPase?), (out of cl.?) 
SkaJ19.32 (kanO) 132 KanO NP_630561.1 S. colicolor A3(2) unknown, cHP, (out of cl.?) 
SkaJ19.33c (kanP) 223 KanP NP_823084.1 S. avermitilis unknown, HP, (out of cl.?) 
SkaJ15.16 (kanD3) 593 KanD3 NP_823085.1 S. avermitilis FadC1, dehydrogenase, (out of cl.?) 
SkaJ15.17 (kanU) 316 KanU AAK19882.1 S. cinnamonensis transcript. repressor (TetR fam.), (out of cl.?) 
________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX         
 
 
143 
Tab. A.8 Proteins encoded in the genomic region covering the tob-cluster of S. tenebrarius DSM 40477 (accession code: AJ810851) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in TM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SteM07.32  185  ZP_00292780.1 Thermobifida fusca acyl-CoA synthetase (NDP forming) 
SteK17.1c  336  NP_625346.1 S. coelicolor A3(2) put. integral membrane protein 
SteK17.2  302  NP_960675.1 Mycob. avium  hypothetical protein MAP1741c 
SteK17.3c  90  NP_926603.1 Gloeobacter violaceus  transcriptional regulatory pr. (MerR family; fragmentary) 
SteK17.4  986  ZP_00294447.1 Thermobifida fusca predicted helicase 
SteK17.5  574  ZP_00294448.1 Thermobifida fusca HP, unknown 
SteK17.6  200  ZP_00294449.1 Thermobifida fusca HP, unknown 
SteK17.7  384  ZP_00294450.1 Thermobifida fusca HP, unknown 
SteK17.8  281  NP_828715.1 S. avermitilis MA-4680 HP, unknown 
SteK17.9  269  ZP_00294452.1 Thermobifida fusca transcriptional regulator 
SteK17.10  366  NP_952445.1 Geobacter sulfurreducens  CRISPR-associated protein Cas1 
SteK17.11  88  ZP_00268340.1 Rhodospirillum rubrum HP, unknown 
SteK17.12c  56  XP_500831.1 Yarrowia lipolytica HP, unknown (fragmentary) 
SteK17.13  147  XP_504139.1 Yarrowia lipolytica HP, unknown 
    ZP_00294864.1 Methanosarcina barkeri transposase and inactivated derivatives 
SteK17.14  119  NP_627825.1 S. coelicolor A3(2) HP, unknown 
SteK17.15  361  ZP_00226505.1 Kineococcus radiotolerans cHP, unknown 
    NP_285525.1 Deinococcus radiodurans R1 superoxide dismutase (Cu-Zn family) 
SteK17.16 (tobY) 165 (TobY) ZP_00296600.1 Methanosarcina barkeri GTPases (G3E family) 
SteK17.17 (tobX) 217 (TobX) NP_436925.1 Sinorhizobium meliloti 1021 HP, unknown 
SteK17.18 tobE 339 TobE CAE22477.1 S. tenebrarius dehydrogenase 
SteK17.19 tobT 436 TobT CAE22476.1 S. tenebrarius transport protein 
SteK17.20 tobB 395 TobB CAE22475.1 S. tenebrarius aminoglycoside 6'-aminotransferase 
SteK17.21 tobQ 508 TobQ CAE22474.1 S. tenebrarius aminoglycoside 6'-dehydrogenase  
SteK17.22 tobZ 579 TobZ CAE22473.1 S. tenebrarius 6'-carbamoyltransferase 
SteK17.23 tobS1 424 TobS1 CAE22472.1 S. tenebrarius 2-deoxy-scyllo-inosose aminotransferase and  
      ketoaminocyclitol aminotransferase II 
SteK17.24 tobC 386 TobC CAE22471.1 S. tenebrarius 2-deoxy-scyllo-inosose synthase 
SteK17.25 tobD2 347 TobD2 CAE22470.1 S. tenebrarius hexose-3'-dehydrogenase 
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Tab. A.8 Proteins encoded in the genomic region covering the tob-cluster of S. tenebrarius DSM 40477 (accession code: AJ810851), continued 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in TM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
SteK17.26 tobM2 420 TobM2 CAE22469.1 S. tenebrarius 6-glucosyltransferase 
SteK17.27 tobD1 261 TobD1 BAD20763.1| S. kanamyceticus TTP-D-glucosmamine synthase 
SteK17.28 tobS2 416 TobS2 BAD20764.1 S. kanamyceticus L-glutamine:hexose-3'-aminotransferase 
SteK17.29  123  XP_470790.1 Oryza sativa retrotransposon protein (fragmentary) 
SteK17.30 tobM1 416 TobM1 BAD20768.1 S. kanamyceticus aminoglycoside 4-glucosaminyltransferase 
SteK17.31c (tobL) 410 (TobL) NP_782304.1 Clostridium tetani E88 carbamoyl-phosphate synthase large chain 
SteK17.32c (tobU) 325 (TobU) ZP_00294424.1 Thermobifida fusca transporter (DMT-superfamily) 
SteK17.33c (tobA) 372 (TobA) NP_577850.1 S. coelicolor A3(2) aminotransferase 
SteK17.34c (tobD3) 358 (TobD3) ZP_00187505.2 S. coelicolor A3(2) dehydrogenase (FMN-dependent) 
SteK17.35c (tobO) 327 (TobO) NP_626927.1 S. coelicolor A3(2) oxygenase (put. secreted protein) 
SteK17.36 (tobR) 163 (TobR) NP_108143.1 Mesorhizobium loti  transcriptional regulator (AsnC family) 
________________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.9 Proteins encoded in the genomic region covering the gen-cluster of M. echinospora DSM 43036 (accession code: AJ628149) 
______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in GM pathway or else a 
design. symbol aa design. acc. code organism  
______________________________________________________________________________________________________________________________ 
MecP21.15  357  NP_828616.1 S. avermitilis DNA-polymerase beta chain 
MecP21.16c  324  NP_733531.1 S. coelicolor A3(2) integral membrane protein 
MecP21.17  157  NP_628738.1 S. coelicolor A3(2) HP 
MecP21.18  556  NP_938521.1 Corynebacterium diphtheriae cHP 
MecP21.19c  339  AAS07044.1 Chlamydomonas reinhardtii sim. to agglutinin 
MecP21.20c  192  ZP_00058638.1 Thermobifida fusca HP 
MecP21.21c  200  NP_629559.1 S. coelicolor A3(2) cholesterol esterase 
MecP21.22  568  NP_602043.1 Corynebacterium glutamicum vancomycin resistance, secreted protein 
MecP21.23c  208  NP_629602.1 S. coelicolor A3(2) cHP 
MecE04.1  228  ZP_00034543.1 Burkholderia fungorum GntT, probably not in GM pathway; COG2232:  
      predicted ATP-dependent carboligase;  
MecE04.2  359  NP_219070.1 Treponema pallidum GntU; probably not in GM pathway; Trp-tRNA ligase 
MecE04.3 genO 385 GenO NP_622810.1 Thermoanaerob. tengcong. GntV; ForO; transferase in GM biosynthesis (?) 
MecE04.4 gmrB 272 GmrB A45282 M. zionensis GmrO; FmrB,O,R; 16S rRNA MT; GM resistance 
MecE04.5c genB1 417 GenB1 BAC41209.1 B. circulans GntW; GM (6-hexosaminyl-?) AT; GM AT I 
MecE04.6c genQ 557 GenQ ZP_00032020.1 Burkholderia fungorum GntX; oxidoreductase (flavoprotein): GM 6'-DH 
MecE04.7c genD3 269 GenD3 NP_822086.1 S. avermitilis GntY; oxidoreductase, put. 3’,4’dehydratase 
MecE04.8c genM1 415 GenM1 CAC93943.1 cloning vector pIJ6021 GntZ; GT I, hexosaminyl-GT, paromamine synthase 
MecE04.9c gmrA 274 GmrA P24618 M. purpurea GmrA; GM resistance  ¸16S rRNA MT 
MecE04.10 genS1 420 GenS1 CAA70012.1 S. griseus DSM 40236 GntA; L-glutamine:ketocyclitol AT I (and II ?) 
MecE04.11 genC 397 GenC BAA83344.1 B. circulans GntB; 2-deoxy-scyllo-inosose synthase (cyclase) 
MecE04.12 genD2 341 GenD2 NP_541843.1 Brucella melitensis GntC; cyclitol 1-DH or pentose-3'-DH (?) 
MecE04.13 genM2 390 GenM2 BAC41206.1 B. circulans GntD; GT II, xylosyl-GT (GM-A synthase) 
MecE04.14 genD1 659 GenD1 NP_267324.1 Lactoccocus sp. GntE; HP; GM (Fe-S-) oxidoreductase (COG1032) 
MecE04.15 genS2 418 GenS2 CAA70012.1 S. griseus DSM 40236 GntF; L-glutamine:GM 3'-AT (?) 
MecE04.16 genW 145 GenW NP_842285.1 Nitrosomonas europaea GntG; FosC; unknown; GTP cyclohydrolase fam. 
MecE04.17c genB4 445 GenB4 ZP_00112608.1 Prochlorococcus marinus GntH; ForB; hexosamine-6'- or pentose-3'-AT; GM AT IV 
MecE04.18c genP 268 GenP P13250 S. ribosidificus GntI; ForP; APH(3'), hexosamine 3'-kinase 
MecE04.19c genB3 490 GenB3 ZP_00057034.1 Thermobifida fusca GntJ; ForB; GM-6'- or -3'-AT; GM AT III 
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Tab. A.9 Proteins encoded in the genomic region covering the gen-cluster of M. echinospora DSM 43036 (accession code: AJ628149), continued 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in GM pathway or else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
MecE04.20c genK 638 GenK BAA08420.1 M. olivasterospora GntK, ForK/Fms14; put. 6'-C-MT (and 4"-C-MT ?) 
MecE04.21 genB2 414 GenB2 BAB18041.1  B. circulans  GntL; hexosamine-6'- or pentose-3'-AT; GM AT II 
MecE04.22c genX 170 GenX NP_828190.1 S. avermitilis MA-4680 GntM; HP, unknown 
MecE04.23c genU 311 GenU ZP_00110163.1 Nostoc punctiforme GntN; WD-repeat protein, regulator 
MecG05.15c genT 468 GenT AY228175.1 S. murayam GntO; put. efflux protein 
MecG05.16c genE 336 GenE NP_252842.1 Pseudomonas aeruginosa PAO1 GntP; cyclitol 1-DH 
MecG05.17 genY 504 GenY M80527.1 S. toyocaensis GntQ; FosD; antiporter/exporter (?) 
MecG05.18 genA 245 GenA ZP_00015638.1 Rhodospirillum rubrum GntR; FosE; PP-loop ATPase, unknown 
MecG05.19 genF 212 GenF NP_881273.1 Bordetella pertussis GntS; FosF; unknown, HP 
MecG05.20 genG 117 GenG NP_251356.1 Pseudomonas aeruginosa PAO1 FosG; put. phospholyase (6-pyruvoyl-THB synthesis) 
MecG05.21 genH 1138 GenH NP_823189.1 S. avermitilis ForH+ForI; efflux protein complex (?) 
MecG05.22 genJ 645 GenJ (MecG05.21) M. echinospora ForJ; efflux protein complex (?) 
MecG05.23 genI 312 GenI Q08329 M. olivasterospora ForT; GM production pr.; unknown 
MecG05.24 genL 206 GenL CAD91216.1 Nonomuraea sp. TTP-D-glucosmamine synthase  
MecG05.25 genN 321 GenN NP_579402.1 Pyrococcus furiosus GM (N-)MT(?) 
MecG05.26c  167    HP; unknown 
MecG05.28c  438  NP_624865.1 S. coelicolor A3(2) two-components syst. histidine kinase 
MecO02.15c  231  NP_826427.1 S. avermitilis MA-4680 two- components syst. response regulator 
MecO02.16  161  NP_636672.1 Xanthomonas campstris secreted serine protease; fragmentary ORF 
MecO02.17c  386  ZP_00293467.1 Thermobifida fusca DNA polymerase III, epsilon subunit 
MecO02.18c  217  ZP_00267533.1 Rhodospirillum rubrum HP; glycosyltransferase 
MecO02.19c  345  EAA38054.1 Giardia lamblia ATCC 50803 HP; unknown 
MecO02.20c  155  NP_631062.1 S. coelicolor A3(2) HP 
MecO02.21c  218  NP_631061.1 S. coelicolor A3(2) RNA polymerase sigma factor 
MecO02.22c  430  NP_285664.1 Deinococcus radiodurans R1 serine protease/subtilase family 
MecO02.23  882  NP_631059.1 S. coelicolor A3(2) HP 
MecO02.24c  167  NP_823881.1 S. avermitilisMA-4680 HP 
MecO02.25  452  YP_121867.1 Nocardia farcinica HP 
MecO02.26  126  ZP_00298424.1 Geobacterium metallireducens glycosyltransferase/PMT family 
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Tab. A.9 Proteins encoded in the genomic region covering the gen-cluster of M. echinospora DSM 43036 (accession code: AJ628149), continued 
______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in GM pathway or else a 
design. symbol aa design. acc. code organism  
______________________________________________________________________________________________________________________________ 
MecO02.27c  97  NP_636569.1 Xanthomonas campestris HP 
MecO02.28c  347  NP_693914.1 OceanoB iheyensis HP 
MecO02.29  375  CAC93708.1 Lechevalieria aerocolonigenes put. regulatory protein,  
MecO02.30c  60  NP_241565.1 B. halodurans ribosomal N-acetyltransferase 
MecO02.31  761  NP_242912.1 B. halodurans HP 
MecO02.32  779  NP_242908.1 B. halodurans HP 
MecO02.33  323  NP_148662.1 Aeropyrum pernix K1 ATP-binding protein 
MecO02.34  202  BAA95020.1 S. kasugaensis membrane protein 
________________________________________________________________________________________________________________________________ 
a
 GntA-Z = the alternative nomenclature of identical gene products in the gnt-cluster of M. echinospora ATCC 15835 (accession code AY524043); all other 
abbreviations are presented under Tab. A.1 
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Tab. A.10 Proteins encoded in the genomic region covering the for-cluster of M. olivasterospora DSM 43868 (accession code: AJ628421) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in FTM pathway or  else a 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
MolI14.1c  470  NP_250185.1 Pseudomonas aeruginosa cHP 
MolI14.2c  306  NP_769118.1 Bradyrhizobium japonicum Transposase 
MolI14.3 forY 440 ForY AAK81829.1 S. lavendulae cation antiporter, (outside cl.?); sim. to MecG05.17 
MolI14.4 forH 668 ForH EAA49750.1 Magnaporthe grisea efflux transporter system, FTM-efflux (?) 
MolI14.5 forI 503 ForI NP_823189.1 S. avermitilis efflux transporter system, FTM-efflux (?) 
MolI14.6 forJ 620 ForJ EAA49750.1 Magnaporthe grisea efflux transporter system, FTM-efflux (?) 
MolI14.7 forQ 559 ForQ ZP_00110912.1 Nostoc punctiforme FTM-AO 6’-DH, flavoprotein 
MolI14.8c forW 287 ForW ZP_00086974.1 Pseudom. fluorescens PfO-1 cytochrome in oxidoreductase complex? 
MolI14.9c forV 516 ForV P0047E11.11 Oryza sativa Fms13(?); glycyltransferase (?) 
      PQQ biosynthesis; poss. Fe-S pr. 
MolI14.10c forM 427 ForM BAC41206.1 B. circulans Fms3(?); UDP-N-acetylglucosamine: 3-amino-3- 
      deoxy-scyllo-inositol 4-GT, FTM-FU-10 synthase 
MolI14.11c forS 423 ForS AAD28492.1 S. spectabilis Fms4(?); L-glutamine: ketocyclitol 3- and 6-AT 
MolI14.12c forE 353 ForE NP_626648.1 S. coelicolor A3(2) Fms5(?); cyclitol (3-) or 6-DH 
MolI14.13c forN 244 ForN AAD41819.1 S. fradiae Fms10(?); FTM-AP 1-O-MT 
MolI14.14c forO 379 ForO AAK76881.1 Clostridium acetobutylicum Fms12(?); unknown; cHP (AstB/NirJ/MoaA-related pr.) 
       or 3',4'-reductase(?) (Fe-S oxidoreducatse) 
      PQQ biosynthesis; heme biosynthesis 
MolI14.15c forD 302 ForD ZP_00051545.1 Magnetospir. magnetotacticum TTP-D-glucosmamine synthase 
MolI14.16c forP 274 ForP AAB21326.1 M. chalcea  Fms8; GenF; FTM-KK1 3'-phosphotransferase 
MolI14.17c forB 442 ForB NP_893936.1 Prochlorococcus marinus Fms6(?); GenB3,B4; hexosamine 6'-AT 
MolI14.18c forK 553 ForK BAA08420.1 M. olivasterospora Fms7; GenK; FTM-KL1 6'-C-MT 
MolI14.19c forZ 482 ForZ BAA00940.1 M. olivasterospora Fms14; glycyl-N-formimidoyltransferase,  
      FAD-dependent FI-FTM-A synthase 
MolI14.20 forX 155 ForX BAC52860.1 Bradyrhizobium japonicum unknown; cHP 
MolI14.21 forC 353 ForC BAC69696.1 S. avermitilis cyclitol 3- (or 6-)DH 
MolI14.22 forG 280 ForG ZP_00074622.1 Trichodesmium sp. SAM-d. MT, 6-N-MT 
MolI14.23 forA 281 ForA ZP_00045395.1 Magnetococcus sp. Fms1(?); D-myo-inositol-3-phosphate phosphatase 
MolI14.24c forL 262 ForL NP_929964.1 Photorhabdus luminescens Fms11(?); 1-OMe-epimerase; Fe-S oxidoreductase 
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Tab. A.10 Proteins encoded in the genomic region covering the for-cluster of M. olivasterospora DSM 43868 (accession code: AJ628421), continued 
_________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in FTM pathway or else a 
design. symbol aa design. acc. code organism  
_________________________________________________________________________________________________________________________________ 
MolI14.25 fmrR 99 FmrR CAF34044.1 M. echinospora GM/FTM resistance, 16S rRNA MT 
MolI14.26 fmrO 293 FmrO Q08325.1 M. olivasterospora FTM-resistance, 16S rRNA MT 
MolI14.27 forT 313 ForT Q08329.1 M. olivasterospora unknown 
MolI14.28c fosG 118 FosG ZP_00087522.1 Pseudomonas fluorescens unknown; 6-pyruvoyl THB synthase family 
MolI14.29c fosF 212 FosF NP_421953.1 Caulobacterium crescentus unknown  
MolI14.30c fosE 233 FosE ZP_00015638.1 Rhodospirillum rubrum unknown; ATP/GTP-bp. of PP-loop superfamily 
MolI14.31c fosD 137 FosD AAF78928 Crypthecodinium cohnii unknown  
MolI14.32c fosC 123 FosC NP_842285.1 Nitrosomonas europaea unknown; GTP cyclohydrolase family 
PORF1  40  CAE06507.1 M. echinospora AT-II-fragment 
MolI14.33 fmrP 158 FmrP P24619 M. echinospora GM/FTM resistance, 16S rRNA MT  
PORF2  103  CAF34042.1 M. echinospora oxidoreductase 
MolI14.34c fmrB 269 FmrB CAF34044.1 M. echinospora GM/FTM resistance, 16S rRNA MT 
MolI14.35c fosA 385 FosA NP_622810.1 Thermoanaerobacterium sp. FTM biosynthetic transferase (?) 
MolI14.36  376  NP_631515.1 S. coelicolor A3(2) HP, unknown 
MolI14.37  471  NP_147838.1 Aeropyrum pernix tryptophanase 
MolJ05.1c  195  ZP_00058483.1 Thermobifida fusca GTPase 
MolJ05.2c  121  ZP_00056729.1 Thermobifida fusca HP, unknown 
MolJ05.3c  143  NP_822753.1 S. avermitilis cHP, unknown 
MolJ05.4c  493  ZP_00058480.1 Thermobifida fusca signal transduction histidine kinase 
MolJ05.5c  343  NP_628328.1 S. coelicolor A3(2) acetyltransferase 
_________________________________________________________________________________________________________________________________ 
a
 Fms1-14 = are the alternative nomenclature of identical gene products in the for-cluster of M. olivasterospora previously reported by Dairi et al. (1992a); 
all other abbreviations are presented under Tab. A.1 
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Tab. A.11 Proteins encoded in the genomic region covering the the apr-cluster of S. tenebrarius DSM 40477 (accession code: AJ629123) 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in Apr pathway or else 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
SteO08.1 aprX 205 AprX NP_733638.1 S. coelicolor A3(2) lipoprotein 
SteO08.2c aprR2 244 AprR2 NP_923854.1 Gloeobacter violaceus transcriptional regulator (AraC family) 
SteO08.3 aprR1 370 AprR1 NP_824342.1 S. avermitilis MA-4680 transcriptional regulator (AraC family) 
SteO08.4c aprN 244 AprN NP_634124.1 Methanosarcina mazei TTP-D-glucosmamine synthase 
SteO08.5c aprW 657 AprW NP_823966.1 S. coelicolor A3(2) ABC transporter; exporter 
SteO08.6c aprV 621 AprV NP_823966.1 S. avermitilis MA-4680 ABC transporter; exporter 
SteO08.7 aprU 335 AprU NP_294117.1 Deinococcus radiodurans kinase 
SteO08.8c tatA 181 TatA NP_639821.1 S. coelicolor A3(2) transposase 
SteO08.9c tatB 93 TatB NP_639821.1 S. coelicolor A3(2) transposase (fragmentary ORF) 
SteO08.10c tatC 84 TatC NP_106540.1 Mesorhizobium loti transposase (fragmentary ORF) 
SteO08.11 aprA 373 AprA AAN05728.1 S. tenebrarius unknown biosynthetic protein 
SteO08.12 kamB 155 KamB P25920 S. tenebrarius 16S rRNA methyltranserase; Apr resistance 
SteO08.13c aprO 785 AprO NP_622451.1 Thermoanaerobacter sp. put. disaccharide hydrolase or phosphorylase 
SteO08.14c aprD1 312 AprD1 NP_738423.1 Corynebacterium efficiens NDP-hexose DH or epimerase 
SteO08.15 aprF 418 AprF AAQ99278.1 S. tenebrarius unknown biosynthetic protein 
SteO08.16c aprG 296 AprG AAQ99277.1 S. tenebrarius unknown biosynthetic protein 
SteO08.17 aprH 359 AprH ZP_00054179.1 Magnetospiri. magnetotacticum glycosyltransferase; Apr-GT I or II 
SteO08.18 aprI 262 AprI NP_293969.1 Deinococcus radiodurans oxidase or N-methyltransferase 
SteO08.19c aprJ 238 AprJ NP_737699.1 Corynebacterium efficiens phosphosugar mutase 
SteO08.20c aprK 189 AprK NP_772062.1 Bradyrhizobium japonicum NDP-heptose or -octose synthase 
SteO08.21c aprM 438 AprM AAR98545.1 M. echinospora glycosyltransferase; Apr-GT II or I 
SteO08.22c aprC 384 AprC AAR98548.1 M. echinospora 2-deoxy-scyllo-inosose synthase, cyclase 
SteO08.23c aprS 454 AprS AAR98547.1 M. echinospora ketocyclitol aminotransferase I and II 
SteO08.24c aprE 373 AprE AAR98562.1 M. echinospora aminocyclitol 1-dehydrogenase 
SteO08.26c aprP 249 AprP T48846 Pseudomonas sp. amidohydrolase 
SteO08.27c aprD2 329 AprD2 ZP_00044795.1 Magnetococcus sp. MC-1 oxidoreductase 
SteO08.28c aprD3 260 AprD3 AAR98544.1 M. echinospora UDP-N-acetylglucosamine 4,6-dehydratase 
SteO08.29c aprY 285 AprY EAA49425.1 Magnaporthe grisea 70-15 (poss. not an active reading frame) 
SteO08.31 aprQ 503 AprQ NP_769359.1 Bradyrhizobium japonicum hexosamine 6-dehydrogenase 
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Tab. A.11 Proteins encoded in the genomic region covering the the apr-cluster of S. tenebrarius DSM 40477 (accession code: AJ629123), continued 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in Apr pathway or else a 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
SteO08.32 aprD4 457 AprD4 NP_614275.1 Methanopyrus kandleri biosynthetic Fe-S oxidoreductase 
SteO08.33 aprZ 462 AprZ P09401 S. griseus extracellular aminoglycoside-phosphate phosphatase 
SteO08.34 aprL 373 AprL NP_819727.1 Coxiella burnetii RSA 493 aminotransferase class IV 
SteO08.35 aprD5 348 AprD5 NP_819706.1 Coxiella burnetii RSA 493 NAD-dependent epimerase/dehydratase 
SteO08.36c (aprT) 392 (AprT) NP_817764.1 Mycobacteriophage Rosebush PP-loop superfamily ATPase 
SteO08.37c  61   no significant similarity HP 
SteO08.38c  158   no significant similarity HP 
_______________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.12 Proteins encoded in the genomic region covering the apr-cluster of St. hindustanus DSM 44523 (accession code AJ875019) 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in Apr pathway or else a 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
ShinN01.1c aprN 170 AprN NP_634124.1 Methanosarcina mazei TTP-D-glucosmamine synthase 
ShinN01.2c aprW 626 AprW NP_823966.1 S. coelicolor A3(2) ABC transporter; exporter 
ShinN01.3c aprV 600 AprV NP_823966.1 S. avermitilis MA-4680 ABC transporter; exporter 
ShinN01.4 aprU 336 AprU NP_294117.1 Deinococcus radiodurans kinase 
ShinN01.5 aprA 373 AprA AAN05728.1 S. tenebrarius unknown biosynthetic protein 
ShinN01.6 kamB 155 KamB P25920 S. tenebrarius 16S rRNA methyltranserase; Apr resistance 
ShinN01.7c aprO 780 AprO NP_622451.1 Thermoanaerobacter sp. put. disaccharide hydrolase or phosphorylase 
ShinN01.8c aprD1 312 AprD1 NP_738423.1 Corynebacterium efficiens NDP-hexose DH or epimerase 
ShinN01.9c aprF 425 AprF AAQ99278.1 S. tenebrarius unknown biosynthetic protein 
ShinN01.10c aprG 298 AprG AAQ99277.1 S. tenebrarius unknown biosynthetic protein 
ShinN01.11 aprH 358 AprH ZP_00054179.1 Magnetospirr. magnetotacticum glycosyltransferase; Apr-GT I or II 
ShinN01.12 aprI 262 AprI NP_293969.1 Deinococcus radiodurans oxidase or N-methyltransferase 
ShinN01.13c aprJ 237 AprJ NP_737699.1 Corynebacterium efficiens phosphosugar mutase 
ShinN01.14c aprK 163 AprK NP_772062.1 Bradyrhizobium japonicum NDP-heptose or -octose synthase 
ShinN01.15c aprM 469 AprM AAR98545.1 M. echinospora glycosyltransferase; Apr-GT II or I 
ShinN01.16c aprC 386 AprC AAR98548.1 M. echinospora 2-deoxy-scyllo-inosose synthase, cyclase 
ShinN01.17c aprS 424 AprS AAR98547.1 M. echinospora ketocyclitol aminotransferase I and II 
ShinN01.18c aprE 338 AprE AAR98562.1 M. echinospora aminocyclitol 1-dehydrogenase 
ShinN01.19c aprP 272 AprP T48846 Pseudomonas sp. amidohydrolase 
ShinN01.20c aprD2 319 AprD2 ZP_00044795.1 Magnetococcus sp. MC-1 UDP-N-acetylglucosamine 4,6-dehydratase 
ShinN01.21c aprD3 248 AprD3 AAR98544.1 M. echinospora biosynthetic short chain oxidoreductase 
ShinN01.22 aprQ 503 AprQ NP_769359.1 Bradyrhizobium japonicum hexosamine 6-dehydrogenase 
ShinN01.23 aprD4 456 AprD4 NP_614275.1 Methanopyrus kandleri biosynthetic Fe-S oxidoreductase 
ShinN01.24 aprZ 466 AprZ P09401 S. griseus extracellular aminoglycoside-phosphate phosphatase 
ShinN01.25 aprL 373 AprL NP_819727.1 Coxiella burnetii RSA 493 aminotransferase (SMAT-type) 
ShinN01.26 aprD5 345 AprD5 NP_819706.1 Coxiella burnetii RSA 493 NAD-dependent epimerase/dehydratase 
ShinN01.27  449  NP_817764.1 Thermus thermophilus HB27 phenylacetyl-CoA ligase 
ShinN01.28c  267  NP_626295.1  S. coelicolor A3(2) membrane protein 
ShinN01.29c  180  YP_056267.1 Propionibacterium acnes membrane protein 
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Tab. A.12 Proteins encoded in the genomic region covering the apr-cluster of St. hindustanus DSM 44523 (accession code AJ875019), continued 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in Apr pathway or else a 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
ShinN01.30  239  NP_626287.1 S. coelicolor A3(2) membrane protein 
ShinN01.31  232  BAA02038.1 S. fradiae glutamyl endopeptidase II precursor 
_______________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.13 Proteins encoded in the genomic region covering the hyg-cluster of S. hygroscopicus subsp. hygroscopicus DSM 40578 (accession code: AJ628642) 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in HM-B pathway or else a 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
ShyG17.1  164   Q50434 Mycob. smegmatis cHP 
ShyG17.2  109  ZP_00092220.1 Azotobacter vinelandii cHP 
ShyG17.3  332  NP_625292.1 S. coelicolor A3(2) poss. iron transport lipoprotein 
ShyG17.4  254  NP_250611.1 Pseudom. aerugin. cHP 
ShyG17.5  348  PSPTO3257 Pseudom. syringae pv. tomato iron ABC transporter 
ShyG17.6  272  AGR_L_2857p Agrobacterium tumefaciens FecE protein 
ShyG17.7  344  NP_737792.1 Corynebacterium efficiens cHP, not in cluster 
ShyG17.8  474  NP_624443.1 S. coelicolor A3(2) transposase 
ShyG17.9c hygV 616 HygV NP_823967.1 S. avermitilis MA-4680 ABC transporter; HM-B exporter 
ShyG17.10c hygW 604 HygW NP_629588.1 S. coelicolor A3(2) ABC transporter; HM-B exporter 
ShyG17.11 hygA 332 HygA P09979 S. hygroscopicus subsp. hygrosc.  APH(7'), HM-B-resistance 
ShyG17.12c hygK 319 HygK NP_627354.1 S. coelicolor A3(2 NDP-heptose-(or hexose) dehydrogenase 
ShyG17.13c hygU 162 HygU ZP_00080098.1 Geobacterium metallireducens put. dehydratase or phosphatase, 
      HisB/LmbK homolog 
ShyG17.14 hygD 401 HygD  BAC55142.1, Methylobacterium sp. 12S  glycosyltransferase. put. GT II 
ShyG17.15c hygO 287 HygO NP_627355.1 S. coelicolor A3(2 NDP-heptose synthase 
ShyG17.16c hygE 339 HygE NP_627680.1 S. coelicolor A3(2 aminocyclitol 1-dehydrogenase 
ShyG17.17c hygP 198 HygP NP_214627.1 Mycobacterium tuberculosis phosphoheptose isomerase 
ShyG17.18c hygX 258 HygX NP_034856.1 S. avermitilis MA-4680 dioxygenase or hydroxylase (orthoester formation?) 
ShyG17.19c hygL 377 HygL NP_440612.1 Synechocystis sp. class IV aminotransferase; (NDP-)heptose AT 
ShyG17.20c hygJ 308 HygJ NP_614008.1 Methanopyrus kandleri (NDP-)heptose (or -hexose) DH or epimerase 
ShyG17.21c hygY 343 HygY  S. netropsis FeS-cluster oxidoreductase 
      condensation; SpcY-related 
ShyG17.22c hygF 270 HygF AAD45551.1 S. netropsis HM-B GT I; SpcF-related; UDP-Gal: 2DOS  
      galactosyltransferase 
ShyG17.23c hygN 351 HygN ZP_00019295.1 Chloroflexus aurantiacus heptose-(7-P) 1-kinase 
ShyG17.24c hygC 410 HygC BAA83344.1 B. circulans 2-deoxy-scyllo-inosose synthase, cyclase 
ShyG17.25c hygM 272 HygM AAD28488.1 S. spectabilis ATCC27741 N-methyltransferase; SpcM-related 
ShyG17.26c hygS 434 HygS AAD45549.1 S. netropsis ketocyclitol aminotransferase I and II 
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Tab. A.13 Proteins encoded in the genomic region covering the hyg-cluster of S. hygroscopicus subsp. hygroscopicus DSM 40578 (accession code: 
AJ628642), continued 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in HM-B pathway or else a 
design. symbol aa design. acc. code organism  
_______________________________________________________________________________________________________________________________ 
ShyG17.27 hygT 182 HygT  no significant similarity HP, unknown function 
ShyG17.28 hygI 163 HygI CAD60534.1 S. cinnamoneus sensor-dependant regulator?; conserved in other  
      antibiotic biosynthesis clusters (Cinorf12) 
ShyG17.29 hygH 168 HygH CAD60535.1 S. cinnamoneus sensor-dependant regulator?; conserved in other  
      antibiotic biosynthesis clusters (Cinorf13) 
ShyG17.30 hygG 392 HygG CAD60536.1 S. cinnamoneus sensor-dependant regulator?; conserved in other  
      antibiotic biosynthesis clusters (Cinorf14) 
ShyG17.31c (hygZ) 662 (HygZ) AAD45557.1 S. netropsis transposase; end of hyg cluster 
ShyG17.32c  286  NP_631871.1 S. coelicolor A3(2) cHP, end of chromosome (?) 
ShyG17.33c  447  NP_624364.1 S. coelicolor A3(2) put. DNA-binding protein, end of chromosome (?) 
_______________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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Tab. A.14 Proteins encoded in the genomic region covering the ist-cluster of S. tenjimariensis ATCC 31603 (accession code: AJ845083) 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in IM pathway or else 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
StenF24.1  321  NP_821300.1 S. avermitilis MA-4680 transport permease 
StenF24.2  314  NP_825884.1 S. avermitilis MA-4680 adenine glycosylase 
StenF24.3  321  NP_825883.1 S. avermitilis MA-4680 RNA polymerase ECF-subfamily sigma factor 
StenF24.4  206  NP_825882.1 S. avermitilis MA-4680 cHP; unknown 
StenF24.5  234  NP_627566.1 S. coelicolor A3(2) two-component system response regulator  
StenF24.6  444  NP_627567.1 S. coelicolor A3(2) two-component system sensor kinase  
StenF24.7c  238  NP_627576.1 S. coelicolor A3(2) peptidase (put. secreted protein)  
StenF24.8c  841  NP_627581.1 S. coelicolor A3(2) Clp-family ATP-binding protease  
StenF24.9  237  NP_627582.1 S. coelicolor A3(2) proline-rich protein 
StenF24.10c  47  NP_627584.1 S. coelicolor A3(2) fragmentary put. acetyltransferase 
StenF24.11c  616  2124370K Amycolatopsis methanolica plasmid transfer protein 
     plasmid pMEA300 
StenF24.12c  86  NP_824907.1 S. avermitilis MA-4680 cHP; unknown 
StenF24.13c  100    HP; unknown 
StenF24.14c  111  NP_628786.1 S. coelicolor A3(2) cHP; unknown 
StenF24.15c  353  NP_106920.1 Mesorhizobium loti conjugal transfer protein 
StenF24.16c  93  NP_824897.1 S. avermitilis MA-4680 cHP; unknown 
StenF24.17c  88  NP_628789.1 S. coelicolor A3(2) cHP; unknown 
StenF24.18c  71  NP_880746.1 Bordetella pertussis Tohama I isocitrate lyase (fragmentary) 
StenF24.19 (issC) 251 (IssC) NP_824898.1 S. avermitilis MA-4680 GntR-family transcriptional regulator; 
      not in cluster? 
StenF24.20 (issB) 229 (IssB) NP_862161.1 S. violaceoruber ATP/GTP-binding protein; not in cluster? 
StenF24.21c (issA) 388 (IssA) ZP_00282077.1 Burkholderia fungorum hydrolase or acyltransferase; not in cluster? 
StenF24.22 imrA 220 ImrA D13170 S. tenjimariensis kanamycin-apramycin-resistance methyltransferase 
    P25919 Saccharopolyspora hirsuta (16S rRNA methyltransferase) 
StenF24.23c istA 397 IstA AAN05728.1 S. tenebrarius cHP; unknown; ArpA-related 
StenF24.24c istD 238 IstD BAD20763.1 S. kanamyceticus TTP-D-glucosmamine synthase 
StenF24.25c istP 276 IstP AAR98555.1 M. echinospora APH(3'); biosynthetic phosphotransferase 
StenF24.26c istB 448 IstB AAR98554.1 M. echinospora AGA 6'-aminotransferase 
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Tab. A.14 Proteins encoded in the genomic region covering the ist-cluster of S. tenjimariensis ATCC 31603 (accession code: AJ845083), continued 
________________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in IM pathway or else 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
StenF24.27c istJ 621 IstJ EAA49750.1 Magnaporthe grisea 70-15 component in transmembrane efflux complex 
StenF24.28c istF 135 IstF EAA48169.1 Magnaporthe grisea 70-15 HP; unknown 
StenF24.29c istU 277 IstU NP_641155.1 Xanthomonas axonopodis  N-methyltransferase (LmbJ related) 
StenF24.30c istZ 484 IstZ S30159 M. olivasterospora N-formimidoyl fortimicin A synthase  
StenF24.31 istH 617 IstH EAA49750.1 Magnaporthe grisea 70-15 component in transmembrane efflux complex 
StenF24.32 istW 320 IstW NP_899815.1 Chromobacterium violaceum  glucose-6-P 1-dehydrogenase  
StenF24.33c istQ 545 IstQ AAR98543.1 M. echinospora AGA 6’-dehydrogenase 
StenF24.34c istC 396 IstC BAA83344.1 S. kanamyceticus 2-deoxy-scyllo-inosose synthase/cyclase 
StenF24.35c istL2 348 IstL2 NP_558504.1 Pyrobaculum aerophilum  metallo cofactor biosynthesis protein 
StenF24.36c istL 327 IstL Q08324 M. olivasterospora Fortimicin KH epimerase (FTM KH epimerase) 
StenO22.6 istI 483 IstI NP_883648.1 M. echinospora transmembrane efflux protein in 
    NP_883648.1 Bordetella bronchiseptica RB50 complex 
StenO22.7c istS 424 IstS CAE22472.1 S. tenebrarius 2-deoxy-scyllo-inosose aminotransferase 
StenO22.8c istG 257 IstG ZP_00202638.1 Ralstonia eutropha JMP134 put. 6’-N-methyltransferase 
      
StenO22.9c istX 150 IstX  M. olivasterospora unknown 
    ZP_00275047.1 Ralstonia metallidurans CH34 
StenO22.10 istM 427 IstM BAD20768.1 S. kanamyceticus glycosyltransferase 
StenO22.11 istO 385 IstO  M. olivasterospora put. Fe-S oxidoreductase or 3’,4’ reductase  
    NP_375972.1 Sulfolobus tokodaii   
StenO22.12 istN 247 IstN  M. olivasterospora put. 1-O-methyltransferase  
    AAD41819.1 S. fradiae 
StenO22.13 istE 331 IstE  M. olivasterospora cyclitol (3-/or 6-) dehydrogenase  
    CAF60530.1 S. Kanamyceticus 
StenO22.14 (ist?) 164 Ist? NP_968608.1 Bdellovibrio bacteriovorus put. tRNA/rRNA MT; not in cl.? 
StenO22.15c (ist?) 471 Ist? NP_772500.1 Bradyrhizobium japonicum transcriptional regulatory protein; not in cl.? 
StenO22.16  222  YP_116837.1 Nocardia farcinica translocator (amino acid efflux) 
StenO22.17c  217  BAC74556.1 S. avermitilis MA-4680 integral membrane protein 
StenO22.18c  167  NP_631504.1 S. coelicolor A3(2) HP, unknown 
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Tab. A.14 Proteins encoded in the genomic region covering the ist-cluster of S. tenjimariensis ATCC 31603 (accession code AJ845083), continued 
_______________________________________________________________________________________________________________________________ 
ORF Gene Gene product Similarity to other proteins in the data base Put. function in IM pathway or else 
design. symbol aa design. acc. code organism  
________________________________________________________________________________________________________________________________ 
StenO22.19  216  NP_826538.1 S. avermitilis MA-4680 tyrosinase co-factor protein 
StenO22.20  288  NP_826539.1 S. avermitilis MA-4680 tyrosinase 
StenO22.21c  135  NP_626933.1 S. coelicolor A3(2) small membrane protein 
StenO22.22c  91  NP_626937.1 S. coelicolor A3(2) membrane protein 
StenO22.23c  182  ZP_00222667.1 Burkholderia cepacia HP, unknown 
StenO22.24  128  NP_627098.1 S. coelicolor A3(2) HP, unknown 
StenO22.25  331  NP_627099.1 S. coelicolor A3(2) HP, unknown 
StenO22.26  399  NP_627100.1 S. coelicolor A3(2) HP, unknown 
StenO22.27c  389  NP_898643.1 Rhodococcus erythropolis HP, unknown 
StenO22.28  230  YP_077641.1 B. licheniformis HP, unknown 
StenO22.29c  1065  AAL25727.1 Rhodococcus ruber transposase 
StenO22.30  210  NP_821633.1 S. avermitilis MA-4680 hsp18 transcriptional regulator 
StenO22.31  119  XP_479904.1 Oryza sativa HP (fragmentary), unknown 
StenO22.32  92    HP (fragmentary), unknown 
StenO22.33  194  YP_138136.1 Haloarcula marismortui HP, unknown 
StenO22.34c  169  NP_907570.1 Wolinella succinogenes MT, unknown 
StenO22.35c  149  NP_795557.1 Streptococcus pyogenes recombination protein 
     phage 315.4 
StenO22.36c  170  AAK02044.1 Salmonella enterica  resolvase 
_______________________________________________________________________________________________________________________________ 
a
 Abbreviations: see under Tab. A.1 
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6.2 Figures for alignments and phylograms of various proteins encoded by genes conserved 
among the ACAGA clusters analysed 
 
 
NeoC       -----------------------MQTTRIAMEDASFPYRLGTDCAEDVVARLAALEASSY 37 
RibC       -----------------------MQVTPIAMEDASFAYRLGTECTEDVVARLATLGASSY 37 
LivC       -----------------------MHVTAITMEDANFPYRLGTDCAEELVARLGVRAASRY 37 
ParC       -----------------------MHVTAITMEDTSFPYRLGTECAEEIVARLGERAASRY 37 
AprC       -----------------------MKVTTIAMGDVRFPYRLGTSCVDEIVDRLADLDASRY 37 
KanC       -----------------------MQVTTITMDDVQYPYRLGTDCLDGIVTRLGELGASRY 37 
TobC       -----------------------MQTTTITMGDVQYPYRLGTGCVDGIVTRLGELEASHY 37 
GenC       -----------------------M-EVEIRLGSVRYPFRLGTDCLGAIVEDLVAMSASRL 36 
HygC       MDLQAREPAAAADATAAPPLPSGLRERSFDIAGKRVRVVLGEHIEAEMAAALAELDADRF 60 
BtrC       -----------------------MTTKQICFADRCFNFAFGEHVLESVESYIPRDEFDQY 37 
 
NeoC       LVVADTTVAELYGAALTAHIDKEAGPSHLLTHEVGEVHKTLATVSALAEQALGRGADRRS 97 
RibC       LVVADTTVAGLYGHDLTARIDKEAGPAHLLTHESGEVHKDLTTVSVLAEQALERGADRRS 97 
LivC       LVVCDTTVAALYGHDLVARLEKDAGPAVLLTHQVGEVHKDVTTVGALAEQALGAGADRRS 97 
ParC       LVVCDTTVAALYGRDLVARLEKDAGPAVLLTHPAGEVHKRIGTVGDLAEQALAAGADRRS 97 
AprC       LVVADTTVAGLYGHDLVRRIRGTAGPADLLLHQGGEEHKGLGTLTELVESALRLGADRRS 97 
KanC       LIVSDPRVAELYGQGLRERLAEQAGPAELITHASGEQNKGLPALHDLAEEALRRGADRQS 97 
TobC       LVLCDATVAELYGHDLAARLRRSAGPASVLTHPAGEEHKGLGTLDTLADAALHAGVDRRG 97 
GenC       LIVCDSNTGPLFGAELVERLSPRV-PANLLIHRAGEPYKDLQAVGTLADSALQLGADRAS 95 
HygC       VVVTDARVAELAAGALAERLERTT-PTLLLSHPPGEEFKNLATLSRFVDLALDFGVTRRS 119 
BtrC       IMISDSGVPDSIVHYAAEYFGKLA-PVHILRFQGGEEYKTLSTVTNLQERAIALGANRRT 96 
 
NeoC       VVVALGGGVTGNIAGLMASLLFRGIRLVHVPTTVVAMLDSVLSLKQAVNTTFGKNLAGTF 157 
RibC       VVVALGGGVTGNITGLMASLLFRGIRLVHVPTTVVAMLDSVLSLKQAVNATFGKNLVGTF 157 
LivC       VVVALGGGITGNIAGLLAALLFRGITLVHVPTTVVAMLDSVLSLKQAVNASFGKNLVGTF 157 
ParC       VVVALGGGITGNIAGLLASLLFRGITLVHVPTTVVAMLDSVLSLKQAVNASFGKNLVGTF 157 
AprC       VVVALGGGITGNIAGLMAALMFRGIRLVHVPTTIVAMLDSVLSLKQAVNSSVGKNLVGTF 157 
KanC       IVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAGVGKNLVGTF 157 
TobC       VVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTF 157 
GenC       VVVAVGGGVIGNIAGLMAALLFRGIRLVHIPTSLIAMSDSVLSLKQAVNACVGKNLMGTF 155 
HygC       VVVAVGGGIPGNIAGVLAGLLFRGLRLVHVPTTVIAACDSVLSVKQAVNTGHAKNTVGLY 179 
BtrC       AIVAVGGGLTGNVAGVAAGMMFRGIALIHVPTTFLAASDSVLSIKQAVNLTSGKNLVGFY 156 
 
NeoC       YQPVEVLADTAALRTLPPREIRSGMGEVVKNALAIRPAMLDRLAGALRPDTRYDDETMRW 217 
RibC       YQPVEVLADTAFLRTLPPREIRSGLGEVVKNALAIRPAMLDRLGDALRADARYDDETLRW 217 
LivC       YQPAEVLADTAMLRTLPEREVRSGMGEVVKNALAVRPAMADRLAGLLRPDARYDDDALRW 217 
ParC       YQPAEVLADTAMLRTLPARELRSGMGEVVKNALAIRPSMIERLAAELRPDARYEDAAMRW 217 
AprC       YQPVEVLADTEFLRTLSRREIRSGLCEVVKNALAIRPSMIDRLAGLLPLDERYDDEAMRW 217 
KanC       YQPVEVLADTAMLRTLPVREVRSGMCEVVKNSLAIRPSMIDQLSAGLRPDGRYPDDTMHW 217 
TobC       YPPVEVLADTAMLGTLPVREIRSGLCEVVKNALAIRPSMIDFLAAELRPDGRYADDVLRW 217 
GenC       YAPESVLADTAMLRSLPFRETVSGLCEVVKNSLAIRPSMVEMLRTSLRQDAVYDDETMYE 215 
HygC       HIPEAVLVDLAVVANGSPRDLRSGTCETVKNALAIEPAQIPRLRRLLRREADYSPADLGE 239 
BtrC       YPPRFVFADTRILSESPPRQVKAGMCELVKNMLILENDNKEFTEDDLNSANVYSPKQLET 216 
 
NeoC       IIAESLAAKADVTSGDKHERRSGLVLEYGHTAGHAIEHASRGA------VAHGAGVAVGM 271 
RibC       IIAESLTAKADVTRDDKHERRTGLVLEYGHTAGHAIEHASRGE------VAHGAGVAVGM 271 
LivC       IIAESVAAKADVTGADKHERGDGLVLEYGHTAGHAIEHAARGA------VAHGAGVAVGM 271 
ParC       IIEESVAAKAQVTGADKHERRDGLVLEYGHTTGHAIEHAARGE------VAHGAGVAIGM 271 
AprC       IIDESIAAKAQVTENDVHERGQGLVLEYGHTVGHALEHAARGE------VSHGAAVGLGM 271 
KanC       IIYESLAAKAQVTAYDKYERGEGLILEYGHTVGHAVEHSSQGA------VPHGAAVALGM 271 
TobC       MIDESVAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGA------VSHGAGVGVGM 271 
GenC       IISESILAKASVTVDDMHECRAGLVLEYGHTVGHAIEYTAAGG------LSHGQAIGLGM 269 
HygC       IFELSLAVKGRLLLEDPYEKHAGVLLEYGHTVGHALELAGAGRGPGGDMIKHGEAVALGM 299 
BtrC       FINFCISAKMSVLSEDIYEKKKGLIFEYGHTIGHAIELAEQGG------ITHGEAIAVGM 270 
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NeoC       TLAAEVSRRLGHADAGLVALHRELVAAAGVEPAVPDHVDTALVKNWLAYDNKRGYLDSPP 331 
RibC       TIAAEVSRRLGHAGPDFVALHRELVAAAGVEPAVPAHVDPALVKNWLAYDNKRGYLDSPP 331 
LivC       VIAAEVSHRLGHASASFVARHRELISKAGLEDTVPACVRTDDVKNWLTYDNKRGYLDCAA 331 
ParC       IVAAEVSRLLGHASGDLVGLHRELVAKAGLEGSVPALVDPADVKHWLTYDNKRGYMPCPP 331 
AprC       LAEAEIARRLGLAGDDMVQLHRELIGRVGIDLEFPSHVSADDVRFRLRYDNKRGYLSDAG 331 
KanC       IAAAQVSHRAGWASAELVDLHRELVAKTGVARRIPSDIPLSAVRHRLSFDNKRGYLPASA 331 
TobC       VAAAEVARRLGHVDADLVELHRELVGKVGVATTLPADVPTEEITYRLGFDNKRGYQPLPA 331 
GenC       VVAAEVSHRLGHLDQEAVALHRELLTRAGAMVTIPEEVDLDEVMHRLRFDNKRGYLADPA 329 
HygC       TAAADVAHRAGLLDAEGLAVHEELIDRIGICRCLTVGIAPETVLHHIAYDNKRGYRSCDG 359 
BtrC       IYAAKIANRMNLMPEHDVSAHYWLLNKIGALQDIPLKSDPDSIFHYLIHDNKRGYIKLDE 330 
 
 
NeoC       GHTPMVLLSAPGEVLHTGTMPLVPVPLALLEEVVDESAARGGAGGGAAEPAAARTGPVPD 391 
RibC       GHTPMVLLSAPGEVLHTGPMPLVPVPLALLEEAVDEAARRG----RDAAPAAAYVG---- 383 
LivC       DTTPMVLLAGPGRPLRTGGMPLVPVPLAVLNETVDALAAPG--RAGTDHRTAVPV----- 384 
ParC       AATPMVLLSAPGEVLRSGPLPLVPVPLELLGRAVDALAAPAGQSAGAERLSPAPA----- 386 
AprC       DGYVIVLLKAPGVPLQSEGLPLTVADPAVVDAVVSEFAHPA---TAAAIGRRTPVG---- 384 
KanC       DTYPMVLLESPGKVLRSEGTVLTAAPRDLVDAVVDELAEPPRPAAARTDDAATVLGGAG- 390 
TobC       DHYAMVLLADVGQPLYQDGLPLTPAPRALVDEVVRELADAP----SRIGASVGSAGGAS- 386 
GenC       ESSAMVLLGGLGEPLWHDGRPLVSVPMALVGEVVNEIARPEIPNFELVAPVETVEEGRVP 389 
HygC       SEVTMVLLRAVGAPLNAEQRYLTPVPQTLVAAAVHDLLRRG----KECTAGHGPS----- 410 
BtrC       DNLGMILLSGVGKPAMYNQTLLTPVRKTLIKEVIREGL---------------------- 368 
 
 
Fig. A.1 Alignment of BtrC homologous. Alignment was performed using Clustal W program (cf. Sect. 
2.26). The numbers indicate the position within the corresponding proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. A.2 Phylogram of BtrC homologous. Phylogram was calculated using Clustal W program (cf. Sect. 
2.26). 
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BtrS        --------MTIP-------------------FDHWPEWPQHSDRTRRKIEEVFQSNRWAI 33 
HygS        MPGPVSGVTPIPGTFPGRTAGGPHRRFLMTDAQPWPAWPVHTPDTERWLLEVVRSGRWAV 60 
ParS        --------MTRS---LAVQGGSPVR------TRPWPLWPQPAPGAVRALDGVLTSGRWSI 43 
LivS        --------MAQS---LAVQGGSAVR------TRPWPVWPRPAAGAAEAVQQVLSSGRWSI 43 
NeoS        --------MVSP---LAVKGGEALR------TRPWPAWPQPAPGVPAAVAEVLGSGRWSI 43 
RibS        --------MVSQ---LAVKGGEALR------TRPWPAWPQPAPGVPDAVADVLGSGRWSI 43 
KanS1       --------MPLQSSRLAVDNGTPVR------GKPWPVWPQPTDGTLDALSRVLRSGRWAI 46 
TobS1       --------MPVH---LAINNGTPVR------TRPWPVWPQPARGALDALERVLRSGRWAI 43 
GenS1       --------MTLL----AVNGGSPIR------SQQWPLWPAPAPGALDALNEVLHSGRWAI 42 
StsC        --------MDSS---LAISGGPRLS------NREWPRWPQPGDRALKSLEDVLTSGRWTI 43 
KanS2       --------MSKK---LALFGGTPVR------NEEFYDGPHIGPHDLDRLKSVLDSG---N 40 
TobS2       --------VTSE---LALFGGTPVR------TEPFPDGPRFRERDLERIREVLESG---S 40 
GenS2       --------MTQK---LAILGGDPVR------TRPWPEWPHVGPEDVDRLRTVIESR---N 40 
 
 
BtrS        SGYWTGEESMERKFAKAFADFNGVPYCVPTTSGSTALMLALEALGIGEGDEVIVPSLTWI 93 
HygS        SGAFTGRPSYEQEFADAFARFIGVPYAVPVCNGSAALTVALEALGVRAGDEVLVPGLTWV 120 
ParS        SGPYRGAASQERRFAQAFAAYNGVEHCVPAASGTASLMLAMEACGIGAGDEVIVPGLSWV 103 
LivS        SGPYRGAASQERRFARAFAEYNGVAHCVPAASGTASLMLALEACGVGAGDEVIVPGLSWV 103 
NeoS        SGPYRGTDSHERRFARAFADYHGVPYCVPAASGTAGLMLALEACGVGAGDEVIVPGLSWV 103 
RibS        SGPYRGTESYERRFARAFAAYNGVPHCVPAASGTASLMLALEACGIGAGDEVIVPGLSWV 103 
KanS1       SGPYRGVESAERRFARRFADYHRIAHCVPASSGTASLMLALEACGVGAGDEVILPGVTWV 106 
TobS1       SGPYRGIESAERRFARDFAAYNGVAHCVPAASGTASLMLALESCGVGVGDEVIAPGLSWV 103 
GenS1       SGPYQGKQSFERRFAAAFAEFHEIGHCVPTSSGTASLMVALEACGVGAGDEVIIPGLTWV 102 
StsC        SCAYQGRDSYERQFASAFADYCGSAMCVPISTGTASLAIALEACGVGAGDEVIVPGLSWV 103 
KanS2       FGGIPFPNTHHTAFADLFTGKLGAPYGLMVSNGTISLSIALRALGVRAGDEVITTGYTWM 100 
TobS2       LGGIPFPNRTHRAFAEQFCGRLGARHGVLVANGTVSLSVALRALGVHAGDEVITTGYTWM 100 
GenS2       LGGIPFPNTMHQQFAERFTAKLGAKYGLLATNGTVTLSMALRALGIHAGDEVITTAFTWV 100 
 
 
BtrS        ATATAVLNVNALPVFVDVEADTYCIDPQLIKSAITDKTKAIIPVHLFGSMANMDEINEIA 153 
HygS        ACASAVLRVGAVPVLVDISPKTLCLSVEAAAASVTPRTRAVMAVHLHGSAVDMDALTELA 180 
ParS        ASGSTVLGVNAVPVFCDVDPDTLCLDPAAVESALTERTKAIVVVHLYSAVAAMDALRALA 163 
LivS        ASGSTVLGVNAVPVFCDVDPRTLCLDPEAVEAAVTERTKAIVVVHLYSAVADMDALTALA 163 
NeoS        ASGSTVLGVNAVPVFCDVDPDTLCVSPEAVEALITERTRAVVVVHLYSAVADMDGLTRVA 163 
RibS        ASGSTILGVNAVPIFCDVDPDTLCLSPEAVEAAITEHTRAIVVVHLYSALADMDALSAIA 163 
KanS1       ASASTVVGVNAVPVFADIDPDTLCLDPDAVEAAITPATKAIVVVHLYAAVADLTRLKEVA 166 
TobS1       ASASTIVGVNAVPVLVDIDPRTLCLDPAAVEAAITPATKAVVVVHLYSAVADLDALRAVA 163 
GenS1       ANASTVAGVNAVPVPVDVDPQTLCLDPAAVERAITPRTAAIVVVHLYSAVADLDALTAIA 162 
StsC        ASASAVLGINAVPVLVDVDPATYCLDPAATEAAITERTRAITVVHAYSAVADLDALLDIA 163 
KanS2       GTAAAIVHINAVPVLVDIDPTTWCIDPAAVEAAITPRTKVIVPVHLGNQIADLDALRAIA 160 
TobS2       GTAASIVHINAVPVLVDIDPNTWCIDPAAVEAAITPRTRAIVPVHLANQIADLDALLEIA 160 
GenS2       GTVAGIVHVNAVPVLADISDDNWCIDPVKVEEAITDRTRAIMVVHLGNQVADMDALLDIC 160 
 
 
BtrS        QEHNLFVIEDCAQSHGSVWNNQRAGTIGDIGAFSCQQGKVLTAGEGGIIVTKNPRLFELI 213 
HygS        RRHDLAVLEDCSHVHGAAWRDRRLGSLGDAAAFSLQQTKLLTSGEGGVATTSDPAVHELL 240 
ParS        DRHGLPLLEDCAQAHGAEYRGVKVGALATAGTFSMQHSKVLTSGEGGAVITRDAEFARRV 223 
LivS        ERHSLPLIEDCAQAHGAAYRGVKVGALATAGTFSMQHSKMLTSGEGGAVITRDADFARRV 223 
NeoS        ERHGLPLVEDCAQAHGASYRGVKVGALATAGTFSMQHSKVLTSGEGGAVITRDADLARRV 223 
RibS        ERHGLPLIEDCAQAHGATYRGVKVGALATAGTFSMQHSKVLTSGEGGAVITRDEDFARRV 223 
KanS1       DRHGIVLIEDCAQAHGAEFEGHKVGTFGAVGTFSMQQSKVLTSGEGGAAITADPVLARRM 226 
TobS1       DRHGLPLIEDCAQAHGAEHRGRKVGSVGDVGTFSMQHSKVLTSGEGGAAITNSAELARRM 223 
GenS1       ERHEIPLIEDCAQAHGARYRDRRVGTFGAFGTFSMQHSKVLTSGEGGAVITGDAALSRRA 222 
StsC        RRHGLPLIEDCAHAHGAGFRGRPVGAHGAAGVFSMQGSKLLTCGEGGALVTDDADVALRA 223 
KanS2       DKHGLAILEDTAHGHFAEWRGQCVGTHGDAGSFSFESSKIMTAGEGGFLVARDEDVYQRM 220 
TobS2       RKHDLVVLEDCAHAHFAEWRGRCVGTHGDAGSFSFESSKIMTSGEGGFLVSGDETTHHRA 220 
GenS2       RRHNLLLIEDCAHAHFAEWRGRCVGTIGDAGSYSFETSKIMTSGEGGFLVTATEEAFHRA 220 
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BtrS        QQLRADSRVYCDDSSELMHGDMQLVKKGDIQGSNYCLSEFQSAILLDQLQELDDKNAIRE 273 
HygS        YRKRADGRGPRPDAP---VGELQLAEHPGVQGYNYCMSEFGAALALDGLGRLAEENARRR 297 
ParS        EHLRADGRCLAGQPVG--DGQMELVETGELMGSNRCVSEFQAALLVEQLGVLDEQNERRR 281 
LivS        EHLRADGRVLAGQRPG--PGEMELVETGELMGNNRCLSEFQAALLTEQLKDLDAQHAIRR 281 
NeoS        EHLRADGRCLSDGPPA--PGAMELVETGELMGSNRCLSEFQAAILTEQLTLLDEQNRTRR 281 
RibS        EHLRADGRCLSAVPPA--PGAMELVETGELMGNNRCLSEFQAAILAEQLTILDEQNETRR 281 
KanS1       EHLRADGRCYRDQAPP--SGHMELVETGELMGSNRCISEFQAAVLTEQLGELDRFNALRR 284 
TobS1       EHLRADGRCYPDTAPA--PGRMELVETGELMGSNRCLSEFQAAVLVEQLRELDEQNALRR 281 
GenS1       EHLRADGRTYTPDEPA--VGEMELAQTAELMGSNRCLSEFQAALLLGQLELLDEQNERRR 280 
StsC        EHLRADGRVVRREPVG--VGEMELEETGRMMGSNACLSEFHAAVLLDQLELLDGQNARRT 281 
KanS2       MSLANCGRKEPGYDGF----------AGRTLGWNARASELQAAFMIGQVEQHDALHAKRA 270 
TobS2       MSLVNCGRKEEGYDSF----------EGRMLGWNNRATELQAAFLIGQVEQHDELHAQRK 270 
GenS2       MSLAHVGRKEAPYDRF----------PGRVFGWNHRATEMQAAVLLGQLDRYDALDKQRT 270 
 
BtrS        KNAMFLNDALSKIDGIKVMKRP-PQVSRQTYYGYVFRFDPVKFGGLNADQFCEILREKLN 332 
HygS        RSMRRLEELLAGFDGAAPLSRP-EAVTEDAAYQVCVRLDPDVFGPAAKHTVAAALSRELG 356 
ParS        RNAALLDKLLADE-GYRPQTTS-EGTSTRTYYTYAARLPEGELTHVDAAAVGEALTAELG 339 
LivS        RNAALLDGLLRES-GYVPQETS-EGTSTRTHYTYAVRLPEGRLTHVGLATVARALSAELG 339 
NeoS        ANAARLDGLLGEL-GLRPQATS-EGTTSRTYYTYAARLPEGALEDVPLTDVTGALTAELG 339 
RibS        ANAAHLDGLLGEL-GLRPQTTS-DGTTSRTYYTYAVRLPDGVLEDVPVTDVSCALTAELG 339 
KanS1       HNAELLDALLTDV-GYRPQRST-PGTTARTYYTYVAELPDAELPGADITKVTEALTAELG 342 
TobS1       RNAELLNTLLAEQ-GLRPQATS-PGTTSRTYYVYAAELPDDAFVGLPITTVTEALTAELG 339 
GenS1       ANAALLDEGLGAL-GIQPQVSS-PGTTERTYYEWAGRIEDDGIGQIGVERIAPAVAAELS 338 
StsC        RAADHLTDRLSEL-GMTAQATA-PGTTARAYYRYLVRLPDEVLAVAPVERFAHALTAELG 339 
KanS2       ASAAKLTAGLAEIGGFTPVGNDDPRITRRQYYEVIYRFDPAAWEGLHRDEVLSAILAEGI 330 
TobS2       SNVELLTKGLTEIGGFTPVGDDDPRVTRRQYYEVLYRFDPEQWAGVHRDRVLEALLAEGV 330 
GenS2       AMAEMLTQGLVEIGGFKPLAED-PRVTRRQRYELLFRFDTEAWDGLHRDKVLEAILAEGV 329 
 
BtrS        MGTFYLHPPYLPVHKNPLFCPWTKNRYLKSVR-KTEAYWRGLHYPVSERAS-GQSIVIHH 390 
HygS        V---HVEPIDSALNRNDLYQPLAS-VWATGDR-RRELDPARFRLPVAEAAG-ENAVVLPH 410 
ParS        ---FPVAPCYAPITRNRLYDPRSRGRFALGVQHESRIDPKRFELPVCEEAA-RRTVTVHH 395 
LivS        ---CTVAPSYAPITRNRLYDPASRRRFALGVEHQALTDPKRFELPVAEDAA-RRVLTLHH 395 
NeoS        ---FPVQPCYAPIPANRLYAPQTRRRYTLGPDHEARIDPKRFALPVCEDTA-RRTVTLHH 395 
RibS        ---FPVLPSYAPIPANRLYTPHTRRRYTLGLDHERRIDPKRFALPVCEDAA-RRTVTLHH 395 
KanS1       ---FPVAPAYSPLNANPLYDPASRSRFALGPQHEKLIDPARFVLPVSGRLT-RRLVTFHH 398 
TobS1       ---FPISPAYAPLHTNRLYAPASRRRFALGEEHEKRIDPARFHLPVCERLT-RRLITFHH 395 
GenS1       G--AAIYASYPPMNHNRLYQPATRARFKG----IAGLDLTGYSLPVAEDAG-QRVVTIHH 391 
StsC        ---FAVTQTHRPLNDNPLNRPSSRRRFATDARYLERVDPSRFDLPAAKRAH-ESVVSFSH 395 
KanS2       E--LEGDAFYPPVHKSELFAVDAVHWPMIAERYGDRIGPDSVDLPVADRAAADESVWVHH 388 
TobS2       E--FEGITFYPPLHRDSLFTVSAEDWPMIRDRYGDRMGPEDFHLPVSERAAYDESVWVHH 388 
GenS2       E--FEGNTFYPPMHRDELFHITADDWPAIRERYGEKIEPDAFHLPVAERVAFDEAVWIHH 387 
 
BtrS        AILLAEPSHLSLLVDAVAELARKFCVTH--- 418 
HygS        RMFLAEPERMG---EIVAALEKARAAS---- 434 
ParS        AALLGDESDMHDIATAFGKVVRHGALLTG-- 424 
LivS        AALLGAEDDMRDIAAAFGKVLRHGADLTA-- 424 
NeoS        AALLGDAEDMADIAAAFAKVLRHGADLAT-- 424 
RibS        AALLGDADDMGDIAAAFAKVLRHGAGLMH-- 424 
KanS1       AALLGDESDMRDIAEAFTKVLQHRAVLAA-- 427 
TobS1       AALLGDESDMHDIAAAVAKVLRHHGELRA-- 424 
GenS1       SALLGDESDMKDIVRAFEKVFANHRELRG-- 420 
StsC        EVLLAPLDAIDDIARAFRKVLDNVREVSR-- 424 
KanS2       ALLTGDDKDLGDILEAVAKVRDNLRELHDAS 419 
TobS2       SLLTGPATDVDQILEAVAKVRRNVDALR--- 416 
GenS2       SLLSVEPEDVQDMLDAVVKVRDNLGALKKSL 418 
 
 
Fig. A.3 Alignment of BtrS homologous. Alignment was performed using Clustal W program (cf. Sect. 
2.26). The numbers indicate the position within the corresponding proteins. 
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Fig. A.4 Phylogram of BtrS homologous. Phylogram was calculated using Clustal W program (cf. Sect. 
2.26). 
 
 
 
AprE-Ste    MTGPERPRPGRRGRRRADPRRRREPFAAATTRGERMKALVFDAPERALLLDKDVPEPARG 60 
AprE-Shin   -----------------------------------MKALVFDAPERALLRDKDVPEPARG 25 
KanE        -----------------------------------VKALVFHSPEKATFEQRDVPTPRPG 25 
TobE_       -----------------------------------VKALSFEAPGEAVFGTREVPVPAPG 25 
NeoE        -----------------------------------MKALVFEAPERAVLTHRDIPAPAPG 25 
RibE        -----------------------------------MKALVFEAPERALLTHRDIPDPAPG 25 
ParE        -----------------------------------MKALMFKAPLQAVLTERDVPEPAPG 25 
LivE        -----------------------------------MKALMFEAPERAVLIQRDLPEPAPG 25 
GenE        -----------------------------------MRALQFHGGHKAQIIDTPRPEAPPG 25 
HygE        -----------------------------------MRAAVLNGPRDITVTEVPGPRLPEG 25 
 
 
AprE-Ste    EVLVKIAYNSLCG-SDLSLYRGVWHGFTYPVVPGHEWSGTVVETNGVD---GDLRGARVT 116 
AprE-Shin   EALVKIAYNSLCG-SDLSLYRGVWHGFTYPVVPGHEWSGTVVEVNGAD---ESLRGAKVT 81 
KanE        EALVHIAYNSICG-SDLSLYRGVWHGFGYPVVPGHEWSGTVVEINGANGHDQSLVGKNVV 84 
TobE_       EALIHLGYNSICG-SDLSLYRGVWHGFSYPVVPGHEWSGTVVEVNGPG---AELVGRDVV 81 
NeoE        EALVRVAYNSVCG-SDLSFYKGVWHGFTYPVVPGHEWSGSVVDVNGPRG--ADLVGRNVV 82 
RibE        EALVRIAYNSVCG-SDLSFYKGVWHGSTYPVVPGHEWSGTVVDVNGPLG--AELIGTNVV 82 
ParE        EALVKLAYNSICG-SDLSFYKGVWHGFTYPVVPGHEWSGTVVEAGG-GA--ADLVGQNVV 81 
LivE        EALVRLAYNSVCG-SDLSFYKGVWHGSTYPVVPGHEWSGTVVDVNG-AD--SGLVGVDVV 81 
GenE        WAVVKVHYCCLCG-SDLWLYRGKWHGNRYPIVPGHEWAG-VVDSAPEGY--ESWVGRPVT 81 
HygE        WALVRVAYNSICG-SDVSLYNNAWHGTAFPAVPGHEWSG-VVEQAPPG---QVAPGDRVV 80 
 
 
AprE-Ste    GDLTVSCSRCAPCERGTPVLCENLQELGFNRDGACAEYMTIPAHNVYRLPDGLSLKAACQ 176 
AprE-Shin   GDLTVSCSRCAPCERGTPVLCDNLQELGFNRDGACAEYMTIPVHNVYRLPDALDLKAACQ 141 
KanE        GDLTCACGNCAACGRGTPVLCENLQELGFTKDGACAEYMTIPVDNLRPLPDALSLRSACQ 144 
TobE_       GDLTCACGSCAACGRGTPVLCENLQELGFTRDGACAEYMTIPTGNLHVLPEGLSLRAACQ 141 
NeoE        GDLTCSCGTCAHCAAGTPTLCEDLGELGFTRDGACAEYMTVPVANLRPLPDTLPLRTACQ 142 
RibE        GDLTVSCGTCAHCTARTPTLCEDLGELGFTRDGACAEYMTIPVGNLRRLPDTLPLRAACQ 142 
ParE        GDLTVACGSCRHCTVGKPTLCADLQELGFTRDGACAEYMTVPTGNLHRLPEGLSLREATQ 141 
LivE        GDLTCSCGTCRHCAEGKPTLCGDLQELGFTRDGACAEYMTIPAANLHRLPPGTSLRAACQ 141 
GenE        GDLIVGCQGCGPCRDGLPVMCENLIEIGFTVDGGCAGYVAVPITNLYLLPEGMDLAAASQ 141 
HygE        ADLTLSCGQCRWCRRSQPVMCPGLREFGFTDPGGCADYVAVPAANLVRLPPDTDLLAATQ 140 
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AprE-Ste    VEPLAVALHAVATAGVEEGDRVAVLGAGGIGLLLMQAAALRGATVTTVSEPVAERRARAR 236 
AprE-Shin   VEPLAVALHAVANAGIGEGDKVAVLGAGGIGLLLMQAAALRGATVTTVSEPVTERRERAR 201 
KanE        VEPLAVALNAVSIAGVAPGDRVAVMGAGGIGLMLMQVARHLGGEVTVVSEPVAERRAVAG 204 
TobE_       VEPVAVALHAVSTVGVEPGERVAVLGAGGIGLMLMQVARQRGGVITTVGEPVAERRAVAA 201 
NeoE        VEPLAVALNAVDRLGVTPGEKVAVMGAGGIGLLLVQAVRLRGGTVTAVAEPVPERRAAAL 202 
RibE        VEPLAVALNAVDRLGVTAGEKVAVMGAGGIGLLLAQAVRLRGGSVTAVAEPVPERRAAAL 202 
ParE        VEPLAVALNAVDRLAVTAGEKVAITGAGGIGLLLAQAVRLRGAEVTVLAEPVTERRQAAH 201 
LivE        VEPLAVALNAVDRLAVVPGEKVAITGAGGIGLLLALAVRQRGGEVTAFAEPVAERREAAA 201 
GenE        TEPLAVALHAVDRINLRPAERVAVLGAGGIGQLILQSARATGATVTLATDLVAERRKIAE 201 
HygE        AEPLAVSLHALSRVRLAPGETVAVLGCGGIGLTLLQAAQVAGAQVVLAVDPLPGRARTAG 200 
 
 
AprE-Ste    DLGALTVTSAAPGELAALVE-RRPELTPDVVLEASGYPAAVQEAIEVVRPGGRIGLVGYR 295 
AprE-Shin   ELGARTVTSAAPGELAALVE-SRPELVPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYR 260 
KanE        QLGATELCSAEPGQLAELVA-RRPELTPDVVLEASGYPAALQEAIEVVRPGGRIGLIGYR 263 
TobE_       QLGARTVTTGRPGELAELVA-KHPDLTPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYR 260 
NeoE        ALGVPAAVGGDPGALVELTR-SDPAAVPDVVLEASGYPTAVQEAVEAVRPGGRVGLVGYR 261 
RibE        ALGVPAAVSGEPGALVELTR-THPDAVPDVVLEASGYPTAVQESLEAVRPGGRVGLVGYR 261 
ParE        ALGVPHTVGGDPGELVGFVE-KHPELTPDVVLEASGYPLAVQEAVEAVRSGGRIGLIGYR 260 
LivE        ALGVSATVGGAPGDLVALVE-KHPELRPDVVLEASGYPSAVQEAIEAVRSGGRVGLIGYR 260 
GenE        ESGAAAAVH--PSELPELTSYADK---VDVVFEASGDPESVVRALDLVRPGGRVCLVGYQ 256 
HygE        LLGAGAALNT-PEEVAGWIADAGPDGLPDVVLEASGEPEAIRAATELVVPGGRVALVGYR 259 
 
 
AprE-Ste    VEESGVMAP------HHATVKALTIRGSLGPGGRFAEAIEVLASG-----AINTDALLSH 344 
AprE-Shin   VEETGVMAP------HHATVKALSIRGSLGPGGRFAEAIEVLASG-----AINTDALLSH 309 
KanE        VEETGPMSP------QHIAVKALTLRGSLGPGGRFDDAVELLAKGD----DIAVEPLLSH 313 
TobE_       VEEVGPMAT------HHVAVKALTIRGSLGPGGRFPEAIDLLARG-----EIEVEPLLSH 309 
NeoE        IEEAAVMAP------HHIVLKVLTVRASMGPGTRFEEAVDVLASG-----AVDVDALLSH 310 
RibE        IGETAVMAP------HHIVLKVLTIRASMGPGTRFEEAIEVLASG-----AVTVDALLSH 310 
ParE        IEEAATMAP------HHIVVKVLSLQASMGPGDRFGEAIELLAAG-----AVDVDALLSH 309 
LivE        VEEVGPMAP------QHIVIKMLTLQASMGPGTRFGEAIGLLSSG-----AVDVDALLSH 309 
GenE        VGAEHALET------ARLPLSYASLVGVMGPGGKYREAVDLLANG-----AIDTQPILTD 305 
HygE        VGRQVELES------ARWPLKLMETVGTMGPGRFMGAAAALVARG-----ALRTDLVVTD 308 
 
 
AprE-Ste     EFGLDDHAAALDLALRRTDGNTRSYFHFA-- 373 
AprE-Shin    EFGLDDYADALDLALRRTNGNTRSYFNLG-- 338 
KanE         EFGLADYATALDLALSRTNGNVRSFFNLRD- 343 
TobE_        EFALDDHARALDLALRRAEGNVRSFFNLRA- 339 
NeoE         EFALDDYAKALDVALRRADGNTRSYFNLRA- 340 
RibE         EFALDDYAKALDVALRRADSNTRSYFNLQA- 340 
ParE         EFGLADHDRALDVALRRADGNTRSYFNLRA- 339 
LivE         EFALEDHARALDVALRRADGNTRSFFNLRT- 339 
GenE         IVTLDDYAPAIDRAINRTDGTVRVVFDLRNE 336 
HygE         VLDLTAADEAFRLAGAPGTDTIRVAVRADGA 339 
 
 
Fig. A.5 Alignment of BtrE homologous. Alignment was performed using Clustal W program (cf. Sect. 
2.26). The numbers indicate the position within the corresponding proteins. The underlined C (cysteine) 
and H (histidine) residues given in bold are conserved amino acids that could play a role in the attachment 
to Zn++ ions. 
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Fig. A.6 Phylogram of BtrE homologous. Phylogram was calculated using Clustal W program (cf. Sect. 
2.26). 
 
 
 
 
 
 
Fig. A.7 Phylogram of BtrB homologous. Phylogram was calculated using Clustal W program (cf. Sect. 
2.26). 
 
 
 
 
 
 
RibB         ---------------------------------------------MTENS---SLLAEFP 12 
NeoB         ---------------------------------------------MTKNS---SLLAEFP 12 
ParB         ---------------------------------------------MTQNF---ATLAEIP 12 
LivB         ---------------------------------------------MTRNS---STLAEKP 12 
GenB1        ---------------------------------------------MTIDIGAGKLLAQEP 15 
GenB2        -----------------------------------------------------MIIANAD 7 
BtrB         ----------------------------------------MKQETVKSSEQLLSVLGTYI 20 
KanB         ------------------------------------MSTHPVLDWSRSAEHLRRSHGVTT 24 
TobB         -------------------------------MTRTNETIATITDWSRSAEHLRRSHEVTT 29 
IstB         ---------------------------------------MTTTGGQSNLETIERARRVTA 21 
ForB         ---------------------------------------------MKNLETIDRARRVTA 15 
GenB3        MAVADHRSSEPSWRAGRTARRRSRWHSWARVKSAREGSQDMDSANLTNRGLVERARRVTA 60 
GenB4        ---------------------------------------------MNYRELIERARRTTA 15 
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RibB         TCPRDVQDRPRVFTS-ASGAYVTDKSGFCWIDFDNARGSIVLGHGDPRVVEAVGRAATGA 71 
NeoB         TCPRDEKDRPRVFTA-ASGAWLTDESGFRWIDFDNARGSILLGHGDPVVAEAVARAATGA 71 
ParB         TCPRNAEGNPRVFVS-ASGAYVTDDAGKRWIDFDNTRGSVLLGHGDPEVAEAVGRAATGA 71 
LivB         TCPKDADGNPRIFTA-ARGARLTDRAGKEWIDFDNARGSVVLGHADPEIAEAVARAASGA 71 
GenB1        TCPRDADGRPRVFVE-GSGAYLTDPDGRRWIDFDNARGSVVLGHGDEEVAEAIARAARGR 74 
GenB2        GCTPYEVARGVTIVR-GEGAYVYDAEGRGLIDLSNSFGSVMLGHQDPVVTEAVLKTVRSG 66 
BtrB         DSPVDPFRKERVMFSRGSGAYLFDYDGGNYIDLMNGKGSIILGHNDPSVNAALRNFLEQD 80 
KanB         DPRPDEDGHYPCVLTRGSGTRVYDLDGNAYLDLTGSFGSVLIGHAEPAVVRAVTDVLSE- 83 
TobB         NPRPDEDGQYPCVLTRGSGARVHDMDGNAYLDLTCSFGTVLIGHAEREVTDAIRACLDE- 88 
IstB         AEDYDIGTRFPSVFVSAEGSWMRDVEGNRVLDVTAASGSLLLGNRHPAVVEAVTKCVAEH 81 
ForB         AEQYDIGTRFPSVFVKAQGSWMEDVEGRRVLDVTAASGALLLGNRHPAVVEAITRYIAEH 75 
GenB3        AENYDIGTRFSAMIQSGEGAWLTDVEGNRYVDLTASSGTIILGHRNQAVTEAITRQIRDF 120 
GenB4        AEEYDISGRYPSVIAHAEGAWMTDLSGNRYVDLTGADAAVILGYRHPAVNEAITRQIRDY 75 
 
 
RibB         DGTATGWSPRVDAVLERLH--ALCGGEVVGLFRSGTAAVRAAGLAVREATGRPLLVSAGY 129 
NeoB         DGTATGWSRRVDAVLERLH--ALCGGEVVGLFRSGTAAVRAAVLAVREATGRPLLLSAGY 129 
ParB         LGTATGWSPLLDTVTSRLL--ELCGGEVVGLFRTGTSAVRAAVLAVREAVGAPLVLSSGY 129 
LivB         AGTATGWSPLVDTVADRLL--ALCGGEVVGLFRTGTSAVRAAVLAVRESVGRPLVLSSGY 129 
GenB1        SGVGTAWSPVLDSLLGQLQ--EVCGGDVVGLYRTGTAALRSVTCAVRDARDRSIVLSSGY 132 
GenB2        VPAAASLDLQNHLAEQIAG--DLPGDQRVAFFKTGTAATRAAASAARQVTGKRLIASCGY 124 
BtrB         REVVTGPSKPIIDLAERIKKDSALPDAKVSFYTTGTAACRAAVYAARDYSGKKIVLSSGY 140 
KanB         GNLFYTGASPRRLALAERLLDWFPWSEQAIFYRTGSCAVSAAARLAQHATGRNRVLSSGY 143 
TobB         GNLFYTGPSPRRLALAERLLDWFPWADQALFYRTGSCAVSSVARLSQHVTGRTAVLTSGY 148 
IstB         GTVFASTISLPRLELAERLCERYPAGEKAVFCKTGSEATLAAIRLARAYTGRDLILTSGY 141 
ForB         GTVFASTLSLPRIELAERLCERYPAGEKAVFSKSGSEATTAAIRMARAASGRDIIVTSGY 135 
GenB3        GTAFASTLSVPRVELAERLCERYECAEKVVFHKTGSEGTAMAARLARAATGRELILSCGY 180 
GenB4        GTTFASTLSVPRVELAERMCERYECAEKVVFHKTGTEGTAMAVRLARAATGRELVLSSGY 135 
 
 
RibB         HGYDPMWYPSDAPLV--PNADGVVDFFFDLGLLAELLAA-PERVAAVVVSPDHMHLSAAW 186 
NeoB         HGYDPMWYPSEAPLE--PNADGVVDFFFDLGLLRELLRA-PERVAAVVVSPDHMHLSPGW 186 
ParB         HGYDPMWYPAKAPFE--PNADGIVDFFFDLDVLAGLLRDGRERVAAVVVSPDHMHLSPRW 187 
LivB         HGYDPMWYPPHEPLE--PNADGIVDFFYDLDLLAGLLRD-RDRIAAVVISPDHMHLTPGW 186 
GenB1        HGYDPMWH-CDEPFT--PNQHGIVEFLFDLDVLAEWLSR-PEQVAAVVISPDHMHLGERW 188 
GenB2        HGYDLMWE-FTPPGQ--PNSEDVLHCYHLPELIDQVLDKHAHELAAVIIAPDYIHVSPEY 181 
BtrB         HGWDPMWRQQGPLLE--PNEDGVIEFYFIPELLERALTAHKDQVALVIFSPDYTYLSAST 198 
KanB         HGWHDWHLEAVPEAKPKTFESYATEFHNDLALYRSWLDRHGEEIAAVVVTPEPHRFDHAY 203 
TobB         HGWHDWHLEAVPEAK--LFPSYATEFHDDLDVYRAYLDRHADEIAAVVVTPEPTRHPLEH 206 
IstB         HGWHDWQLTYLNMGF--DPASRVVNFGYNETALARLLEQFGSEIGGVIVTPEPAWLGADY 199 
ForB         HGWHDWHLSYLNIGY--NPGTRIACYGYNETALRRMLHEFAGEIAAVIVTPEPAWFDEAY 193 
GenB3        HGWHEWQLAGETFGY--QQTTGVVGFGYNEKALAKMLEAFGNEVAGVLISPELLYFDVEF 238 
GenB4        HGWHEWQMAGEEFGY--QQSTGVVGFGYNEKALAKMLEAFGEQVAGVIVSPEVLYFDLDH 193 
 
 
RibB         YRELRQLCSAAGVVLIADEVKVGLRYSPG--LSTAELLNPDVWVVAKGMANGHAVSAVGG 244 
NeoB         YRELRRLCSAAGVVLVADEVKVGLRYAPG--LSTAELLAPDVWVVAKGMANGHAVSAVGG 244 
ParB         YERARALLAEAAVPLIVDEVKVGLRYGPG--LSTAGLLDADVWVTAKGVANGFPTAAVGG 245 
LivB         YARARALLADAGVPLIVDEVKVGLRYGPG--LSTADLLDADVWVVAKGMANGYPTAAVGG 244 
GenB1        YTEFTRLTKEADVPVIADEVKVGLRYRAG--LSTP-LLDPAVWIVAKCLANGSPVAAVGG 245 
GenB2        IADLFERCERVGVVTIADEVKHGYRLRQGA-SVTEASVVADMYTYAKGISNGWPLSCVAG 240 
BtrB         MERILGICRAHGVLVCCDDVKQGYRHRQGSSLELVTTEKADMYVFSKGLSNGHRISCVVS 258 
KanB         YQELREVAKEHGCLFVVDEVKTGFRAGAGG-FSALAGIEPDAVTVSKGMANGHSISAVVG 262 
TobB         YRTLRDLAAEAGCLFVLDEVKTGMRAGKGG-LSARAGLEPDAVTVSKGLANGHSISAVVG 265 
IstB         YRRLSELCARHDVPFILDEVITGVRWGARG-LNGTGGVRADLITVSKGLSNGHALSAVLG 258 
ForB         YRRVSQLCAEHGVYFIIDEVITAFRYGHRG-LNGTGEVPADAITMSKGLGNGHSISAVVG 252 
GenB3        YQRMYALCARYDVPFMMDEVYTGFRAGPKG-VHGLG-VPADVVVVSKGLANGHSLAAVMG 296 
GenB4        YRRMSALCARYDVPFMLDEVYTGFRAGPKG-VHGLG-VPADVVVLGKGLANGHSLAAVMG 251 
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RibB         PRALLRPLKEVSFTSFF--EPTILAAADAVLSRVATGEPQRALREAGDRFLCHARKALQD 302 
NeoB         SRRLLKPLKEVSFTSFF--EPTILAAADAALARVATGEPQRAVREAGDRFLRHARKALDD 302 
ParB         SRTLLKPLREVSYTSFF--EPTVLAAAERTLARVATGEPQRTVRETGDLFVEHARSALAA 303 
LivB         SRTLLKPLREVSFTSFF--EPTVLAAAERTLARVATGAPQRTVREAGERFLTHARKSLAG 302 
GenB1        DAHLLAALEDVSFTSYF--EPTAMAAATTTLRRMATGEPQQAIRAAGDRFIAHTRAAFAN 303 
GenB2        DERFLKPLAEFVSTLTF--EAPSFAAASATLDRLAELDVQAQLAIDGARFVSEAAKMIST 298 
BtrB         SDEIMAETKEHTYTAYY--QMLPILSSLETLKKMESGKGYDLIRSYGQTLTGNLKELFVQ 316 
KanB         QRQLTQELSEAHVWSTYQNEQVGFAAALASLDFLERHDVAAVTRRTGEAVRQGVLQLFAE 322 
TobB         SRRITEGLAEAHVWSTYQNEQVGYAAALSTVDFLLREDVAGVVERTGRTVERAFRSAFAE 325 
IstB         KREIVDAYDKAGIAGTYTREVPPMAAALAVLDAIEDGSVHEHCEKMGRKLKDGMREILKK 318 
ForB         RREILDAYDKAGVAGTYTREVPPMAAALAVLDVTEDGSVHEHTQRMGATLRDGMRDILAA 312 
GenB3        RRDIIDAYDVSGIQGTYTREVPPMAAAMAVLDVLDTPGVYEHAEAMGRRLADGMREILTG 356 
GenB4        RRDIIDAYDVSGIQGTYTREVPPMAAALAVFEVLDTPGVYEHAEAMGRRLADGMREILTG 311 
 
RibB         AALP--VEIAGDGTFFQFVPASEELEYAFYAAANTEGLLFYAGDNQGVSAAFDDAVLTDA 360 
NeoB         ASLP--VEIAGDGTFFQFVPATEELEEALYGAANAEGLLFYAGDNQGVSAAFDEAVLGEA 360 
ParB         ASLP--LEVAGNGTFFQFVPATREVKKAFYKATEEEGLLFYRNDNQAVSAAFGPDVLDDA 361 
LivB         AGLP--VELAGDGSFFQFVAATRELEKALWWATEDEGLLFYRGDNQAVSAAFGPDVLDDA 360 
GenB1        AGVP--IDLAGNGNLFQFVCADDEVADAFHAAAAAEGLLFFEGDNQTPSAAFTDEVVEDA 361 
GenB2        RDLP--IEMAGTGAAFQFVCA-EEVEEVLLPHALAEGLILEPSDQQYPSACFRGEVVDDA 355 
BtrB         SSLP--IEVNGS-SIFQLVFGDEELEEAFYREAFIQGLILFEGDNQSLSLCMDKDVQVDL 373 
KanB         HGLPVGAPGWGPMFELDFDAADEGLAERLEAALLRHGIFC-DTGDDFNMMFHTAEHTDEL 381 
TobB         RGLPVEVHGWGPMFDLDFSAAEEDLPERLQLALLRHGVFC-DVGDDFNLMYRMADHLDEL 384 
IstB         VGIPAYIT--GPDMMFDVVVESESLSWDIYRAAFDYGAYFEDSGTHMVTAAYGDEEVEHA 376 
ForB         VGIPAFVN--GPPMMFDVVVPSEQLSWDIYRAAYDHGAYFEDSGTHMVTAAFGQAEVDHA 370 
GenB3        EGIPNWVG--GPALMFDTVLPNDDLGWEIYKTAHDFGVYFEDSGTQLVTTAFDEAAVDHA 414 
GenB4        EGIPNWVG--GPALMFDVVLPNDDLGWEIYKTAHDFGVYFEDSGTQLVTAAFDEAAVDHA 369 
 
RibB         EQRFTRVCDRLSAY---AGGEPVDEAARYRVAWNVMDGLREAERDRAATDGMLARLLDD- 416 
NeoB         ERRFARVCERLAPY---AGGEPVGDAARYRVAWNVMDGLRQAPRDREETTGLLARLLDD- 416 
ParB         RARFSRVCDRLAPF---AAAGPVGEEARYQAAWSVMDGLREAERDARETREWVDRFLDD- 417 
LivB         EARFTRVCDRLAPY---ASDAPVSEEARYLAAWNVIDGLRDAARDDRTTREWISRLLDD- 416 
GenB1        CGRIDRVSAALTGR---FTDRELTEESWYASAWGAMDGLADRPRTREETTAIVERLWED- 417 
GenB2        LERLDRALTTMAAARPDLVGREVTQLDRVNAAFCQMDGLPGRP-DGWSLDQCVEYVTAQL 414 
BtrB         IRRFANVTDVLSEQFKHLRGKEVTTEQTFRTAWNMIDGASDLLPYEKQLKLLDNLIGGG- 432 
KanB         LERFAAALGDL------------------------------------------------- 392 
TobB         LERVTAAIASV------------------------------------------------- 395 
IstB         LHAFEMGAQRVVA----TREPDFGELPEDRRMAFPLEAFGGNIRDDETVLKRIEDIVRQV 432 
ForB         LEAFEKGAREIAR----ITSFDFDALPESRLHQFASEAFGGALHDDEAVLRRIDDTVHAI 426 
GenB3        LTAFRKATRQVIADRPDIAPTSGGELTEERKLDFAEEAFGGLLRDDERTNALIDETIEKV 474 
GenB4        LTAFRKATRQVVADRPDIAPTSGGELTEERKLDFAEEAFGGLLRDDERTNALDRRDHREG 429 
 
RibB         ---------------- 
NeoB         ---------------- 
ParB         ---------------- 
LivB         ---------------- 
GenB1        ---------------- 
GenB2        ---------------- 
BtrB         ---------------- 
KanB         ---------------- 
TobB         ---------------- 
IstB         EQRDRTLGGTLDPACG 448 
ForB         ANRDPALARLLDPSCG 442 
GenB3        VNRDRSIKPVLIPAQN 490 
GenB4        GQPGPQHQAVLFPAQN 445 
 
 
Fig. A.8 Alignment of BtrB homologous. Alignment was performed using Clustal W program (cf. Sect. 
2.26). The numbers indicate the position within the corresponding proteins. 
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LivY      MGAQATESVMSGEKRYVLITGANRGLGLHSARLLAGRGWSVILACRKPEAAAPALEKLR- 59 
AprD3     -----------MEQRYVLVTGASRGLGRRSAEELAGRGWTVVLACRDVADVASLLATVRG 49 
GenD3     MDTAPANTHVRPRRGHVLVTGGNRGLGLATATLLVDDGWSVLLGCRDERRGAAAAEALRR 60 
                          ** **  ****   *  *   ** * * **     *      *  
 
LivY      -AYDVTSVRLDVTDPESVSAAVRTVRG-TAPKLHALVNNAGIFEH-AEEHLSDAPDSVSR 116 
AprD3     RGARAHAVPMDVTDPDSVAAAVDAVRE-VGGRLHALVNNAGVFRH-AEERFPGLTPGDAL 107 
GenD3     RGGRAAHVPLEVTSPASIAAAVDLVADRTGGRLAGLVNNAGVFLDERDADLESVTAEAVH 120 
                 **  ** * * ****  *       *  ****** *                  
 
LivY      DLLLTNAWGPLMVTRHFLPLLRAAGGASVVNVTSQDADPENLDGTFTGYCMSKAALNVMT 176 
AprD3     DILLTNTYGPLVVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGEFTCYRASKAALNAMT 167 
GenD3     ELLAVNAVGPLLVTRAMVPLLRAAAGAAVVNVTADDADPATADGEATGYRMSKAALNIMT 180 
            *  *  *** ***   ****** ** *****  ***    **  * *  ****** ** 
 
LivY      ANLAIALRADRVVVNGVDPGWIPTDMGGPEAPDAVADAAETVAAAVALAGTARSGDILRA 236 
AprD3     RNLAVALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVTAVVDAVELAGSDRTGVLLRA 227 
GenD3     VNLAVALREQDVVVNAVDPGWIPTDMGGPEAPDDTAAAARLVAWAVTAAREHGTTGQVLS 240 
           *** ***    *** *****************    *   *  **  *            
 
LivY      VR------------------------------- 238 
AprD3     GRDPAPPVAAPSEPNQRHQPDLPPPPVPRWSAS 260 
GenD3     VRQPPDGLRADPVTVGAPPTVVPPHGQPQ---- 269 
           *                                
 
Fig. A.9 Alignment of LivY homologous (putative 3’,4’-dehydratase). Alignment was performed using 
Clustal W program (cf. Sect. 2.26). * = identical aa residues. The numbers indicate the position within the 
corresponding proteins. 
 
 
 
 
 
 
LivW         MRHMRLGKVMLVSPKTSFGRDLQRTYAGGLGTVCKDEDFLLPPLDLMRLAGVLREAADDI 60 
AprD4        MRRMRLGTVLLVSPKTSFGRDLQRTYAGGLGTVCKDEDFLLPPLDLMRLAGVLREDADDI 60 
             ** **** * ********************************************* **** 
 
LivW         SVVDEEVTGTV-SASPGSIVICQVSLPSLHEDAERIAAFRAQGARCYAYAGMRSPAQWRV 119 
AprD4        AIADEEVTGVVPSVEPGTTVICHVSLPSLLEDAERLATFRAQGARCYAYTSIRSPAQWRT 120 
                ****** * *  **  *** ****** ***** * ***********   *******  
 
LivW         LFEQGGCEGILLPESISFARAALEGDTTVPGCVTPENLLEPRHHQPQFGDLAAEPLPARD 179 
AprD4        LFERGGCEGVLLPESISFARAALAGDHTVPGLVTPDSLLDPRHHQPAFGDLAAEPLPARD 180 
             *** ***** ************* ** **** ***  ** ****** ************* 
 
 
LivW         LVDHTPYMFPPIALTGITSINGSFGCPYPCRFYCPYPLSEGRKIRTYPVERIVAEFRQCA 239 
AprD4        LVDHTPYMFPPIARTGITSINGSFGCPYPCRFYCPYPLSEGRKIRTYPVERIVAEFRQCA 240 
             ************* ********************************************** 
 
LivW         ELGITAAVFRDPVFSFHRGRTLELCRAIEAAGTHVPWWCETRIDRLDEEVVAALVAAGCV 299 
AprD4        ELGITAAVFRDPVFSFHRDRTLELCQALKAADTGVPWWCETRIDRLDEEVVAALVDAGCV 300 
             ****************** ****** *  ** * ********************* **** 
 
 
LivW         GVEVGVESGDPEMQAKAVRKRLDLDAVRRFHALAREMNLELVFLFLVGLPDETRMSIRRT 359 
AprD4        GVEVGVESGDPDMQATAVRKRLNLDTVRKFHAVARKAGLKLVFLFLIGLPRETRMSIRRT 360 
             *********** *** ****** ** ** *** **   * ****** *** ********* 
 
 
LivW         FDFILELGLADTEFNLSIITPYPGTELHRIARDNGWIDGEQNAFTSHNAVMHTDRLSVAD 419 
AprD4        FDFILELGLADTEFNLSVITPYPGTELHQIAVDKGWIDGSQNAFTSHNAVMHTDELSIGD 420 
             ***************** ********** ** * ***** ************** **  * 
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LivW         LEQATSFVDELHAVCRKTATPQDRAEFQRRLHAWSEQDA 458 
AprD4        LERASRFVDELHAVCK--AGPAERAEFQARVHAWSTGDA 457 
             ** *  *********   * *  ***** * ****  ** 
 
Fig. A.10 Alignment of LivW and AprD4 proteins (putative 3’,4’-dehydrogenase). Alignment was 
performed using Clustal W program (cf. Sect. 2.26). * = identical aa residues conserved in all proteins. 
The numbers indicate the position within the corresponding proteins. 
 
 
NeoI         MA-GSGSAPEPSERPLLRRFDQRLNELIAALYPDE-RRRPGYARLAKEIRETTGGAISGT 58 
RibI         MA-GSGSAPEPSRRPLLRKFDQRLNELIAALYPDE-RKRPGYARLAKEIRETTGGAISGT 58 
ParI         MS-DRTSATDQEGRPLLRAFGQRLNELIAALHPDE-RKRPGYARLAKEIRETTGGAISGT 58 
LivI         MG-DNASASDQAGRPLVRKFDQRLNELIAALHPDE-RKRPGYARLAKEISESTGGTISGT 58 
Cinorf12     MS-DSRPAPDRNDRPLLRQFDQRLSELIATTAGAEGNKRPGYARLAKEIRDTTGRTISGT 59 
KanI         MR-DGAAERSESGRLLLDKLDQRIKDLICAIYPDK-GTRPGYARLAQDIRETTGGTISGT 58 
HygI         MSSEHDTAKPTPDRPVPGGFDERLARLITIYYAGE-RKRPGYARLAREISEKTGRAISGT 59 
             *            *       **   **          ********      *** **** 
 
 
NeoI         YLWELATGKKRNVTLEQLDVLAEFFGVPPEYFLNEETAARVNSQLKLATALRDSRVRNLA 118 
RibI         YLWELATGKKRNVTLEQLDVLAEFFGVPPEYFLNEETADRVNAQLKLATALRDARVRNLA 118 
ParI         YLWELATGKKRNVTLEQLDVLAEYFGVPPEYFLSDDVAERVNSQLRLAVALRDTRVRNLA 118 
LivI         YLWELATGKKRNVTLEQLDVLAEYFGVPPEYFLSEEVAERVSSQLKLATALRDARVRNLA 118 
Cinorf12     YLWELATGKKRNVTLEQLDVLAEFFGVPPEYFLDDETGRRIDDRRRLAIALRDAKVRNLA 119 
KanI         YLWELATGKKRNVTLEQLGVLADYFGVPPEYFLNDEVSERVNAQLALATALRDNRIRNLA 118 
HygI         YLWELATGRKHNVTLHQVGVLADFFGVPTDYFVDDEVAARVDAQLQLAAALRDTRVRNLA 119 
             *****************  ***  ****  **       *      ** ****   **** 
 
 
NeoI         LRAEGLSPESLDALLIMVQEARRVQNLASVDDQDHTDRTDHTAAPDGGPAGTSGSTA 175 
RibI         LRAEGLSAESLDALLIMVNEARKVQNLSSVGDQ---------AAPDGGTTGTSGRTT 166 
ParI         LRAEGLSPAALDALLTIVDEARKVQNLAPPE-----------AGGDGTQEPPAAAP- 163 
LivI         LRADGLSPATLDALLVMVNEARKVQNLASVDDL---------ADGSGTANGSVAGSG 166 
Cinorf12     LRADGLSPDCLDALIAMVNEARKTQNLSSIDD-----------DDDTATTLTSSG-- 163 
KanI         LRAEGLSPSTLDALLVMVNEARKIQNLSPPAD------------EDGRGPQHTE--- 160 
HygI         LRADGLSPATLDALLTMVNEARKVQNLPVDDS-----------AGPPPNEGGPGA—  163 
             *v* ***   *****    **** ***                    
 
Fig. A.11 Alignment of NeoI homologous. Underlined aa represent the conserved HTH DNA binding 
motif. The numbers indicate the position within the corresponding proteins. Alignment was performed 
using Clustal W program (cf. Sect. 2.26). * = identical aa residues conserved in all proteins 
 
 
NeoH         ---------------------MSYR-IARLRRRCRPLLDQLVLPRPFSLEPLCAQLSARR 38 
RibH         ---------------------MSYR-IARLRRRCRPLLGQLALPHPFSIESLCAHVSANR 38 
ParH         --------MRCPSQKKWQFSHMLYG-YSTLRRRCRAKLTDITLPTPFSVEEFCRSISEQR 51 
KanH         MHVRRTAYYRCPAQG-LRKEHMSYI-YVKLRQRCQAIVDGLSLPHPFTVESFCTRLAAQR 58 
LivH         ---------------------MPYR-YVQLRRRCQQKLDQFDLPRPFSMDALCESVSRQR 38 
Cinorf13     MPRRTYVAYRRCLRKGQREPEMPYTSDAALRRRCRALLARVSLPEPFSVEVLCRHLGEQR 60 
HygH         ---------------------MSLCDTRLRRRRCEAAMAGLRLPQPFSVPELCRQVAERR 39 
 
 
 
NeoH         GRPLHLHPLPIQAAAAGTCGLWLATDTDDHIFYEQRTARPHQEHIVLHEIGHMLFDHHTV 98 
RibH         RRPLHLHPLPLQAAVAGACGLWVATETDDHIFYEQRTARPHQEHIVLHEIGHMLFNHHAV 98 
ParH         QRPLHLHALPTHVAKMAACGLWLATDTDDHIFFEARTAPLHQEHIVLHEIGHLLFDHQML 111 
KanH         QRPLHLHALPRQAAQAGACGLWLATDIDDHIFFEQRTARVHQDHIILHEIGHMLFGHQSL 118 
LivH         GRPLYLHPLPDQAATAGACGLWLATATDDHIFFEQHTVRLHQEHIVLHEIGHMLFDHHAV 98 
Cinorf13     GRPIHLHPLPEQAALAGACGLWLATATDDHIFHERHTVRPHQEHIVLHEIGHMLFDHHSL 120 
HygH         GRPLHLHPLPAAAAAAGTCGLWLGTEAADHIFYEQRTGRLHQEHIVLHELAHILLDHHRI 99 
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NeoH         D----AGPAGLPGRLFGDLSPRLVRRVLGRTDYSTRQEQEAEMLATLIRTGDTAHRCLPP 154 
RibH         TDIATTPTAGTPGGLLGDLSPRLVRRILTRTDYSSHQEQEAEMLATLIRTGETG-----P 153 
ParH         A---DGN-SGGISSVLADLSPRLIQRMLARTNYSTRQEQEAEMLASLIRTHATGP----- 162 
KanH         E---LGEGWGDAPQLFGDLSPQLIQRLLARTDYTTRREQEAEMLASLIRTRGEQP----- 170 
LivH         D---ARTGSAILPDLFLDLDPRLVRRLLARTNYSTRQEQEAEMLASLIRAGDHGP----- 150 
Cinorf13     A---PAG--GPAGALLADLDPRLIRRLLARTNYSTRQEREAEMLASLIRTSVRAG----- 170 
HygH         V-----PGGAGTERLLPDLDRQLVRRLMPRADYSTPQEREAETLATMLRLGGAAP----- 149 
 
NeoH         DPYGKLHEALGMAGDHDLRCLPPDPYGKLHEALGMAGDHDL 195 
RibH         D-----------------RCPPADPYGKLHAALGVSTDHAL 177 
ParH         ----------------GRGPQRCATTDRADRALGITHD--- 184 
KanH         ----------------AGERHADDVLHYLGEALGVGATRGG 195 
LivH         ----------------GGE--RDGVLRNLGAALGVSGR--- 170 
Cinorf13     ----------------TGER-PPGALGRLQAALGVVGSHGR 194 
HygH         ------------------ARRPDQVLDRLRDATGVWP---- 168 
 
Fig. A.12 Alignment of NeoH homologous. Alignment was performed using Clustal W program (cf. 
Sect. 2.26). Underlined aa residues represent the hydrophilic and histidine-rich central domain; aa in bold 
represent a possible single trans-memberane domain. The numbers indicate the position within the 
corresponding proteins. 
 
NeoG         MTSDLPGNLGRVLQTAGVLLLWAAVLLRARPAARHPGQRGLWLAVACAAAALTLHLEAVS 60 
RibG         MRCDLPG-------HCSLAVLWAALLLRAGPAVRNPHQRGLWLAVASAAVAMTLHVEPVS 53 
LivG         -VTDAVAVLGPWYLVAGVSCLWSAVLLRCRSAVRSPHQRGLWLAVATAAVAMTMDLPAVD 59 
KanG         -----------VAQYVSAAAMGAVVLLRAPAAARSPAQRGLWLAVATAAVAMALQLPVVI 49 
HygG         -MAAHVPAWLVWYQPLTTGFLVAAVLSSLPGAVRRPRQRLLWGGVALAAVAMVLDLPPFR 59 
Cinorf14     ------------------------MVLRCPYAVRHPAQRGLWLAVATAALAMTLTTSIGS 36 
ParG         MTDRGPHGLFVQLEWLGLALMWVVTLLRAPVAVRTPQQRPLWLAVGLASVAMTLQLPQVS 60 
 
 
NeoG         AYAAALTGSPRAVGLVKNQAGIVSAGAILHFAVHTTGSRRRTGAVLATTAAVMAALLALA 120 
RibG         AYAAGLTGSPRAVALAKNQAGVVSVAAVLHFAVYATRGRR-TGTVLAAMAAVMAALLALA 112 
LivG         SFLQARTGLGHLHHLARDLFGLLSAGAVLRF-VAASGNCRYGRGVYVAVAALTAALITLD 118 
KanG         RAALDLTGSVHEVGLARNLFGVLSAGCVLYFVTAAAQHRWWRWGLVTSVALVVLALVLLD 109 
HygG         -HASRTSGAPWALPLARNAAGVLSAGAVLLFVAQAADKPRLRTAVRAG-APIALTLLSAL 117 
Cinorf14     VVPEAALG------LAGNLTGMVSAGAVLGFVITIMGGRRLHTWACGTVAATALALTVLG 90 
ParG         SVATAVLDP-HTVFLAKEIVGLLAATAVFEFISAIVGLRRTQLAILAAAVLTLAALVTLC 119 
 
 
NeoG         GLGSPHAPGHGPYPTLA-CPRCAAYWLLLVTVHVAACALCARVCWRYGRSGPHRSVNLGL 179 
RibG         ALGAAPTSGQGPPFTLA-RPPCVAYWILLITAHVVACAACVRVCWTYARRGTNRSVNLSL 171 
LivG         LLAAPHG-EHTAHGARS-TTETTAYWLILIAMHLFAGAMCFRLCWRYAGRADSRSLRLGL 176 
KanG         QVREQHDNPGGP-------SSLSAYWAILMGSHIVANTVCVHVCLWQGCRASAPSLRLSL 162 
HygG         VLAERTRAPTPVDGVLR-VTHSALYWLVLGGIHLAANAACATLCLRHGRRTADRGLGLSL 176 
Cinorf14     VTSRAHLSYGTIAEIP---PTATAYRLLLIGTHLAVNAACIAVCWRYGRGPSRSPLALGL 147 
ParG         VLSPPHTRHVVPSGPGQEASPDTYYWVVLLGYHLVANTACVAACWACGRQVKNTPTRAGL 179 
 
 
NeoG         TLLGWGSASAGLYWLAHYYLMAVEG-RPGG--VLRLVLSAHAVLCAAVLMVPTALQLRRA 236 
RibG         ALFGWGTALAGLFWLAHYVLLATGS-RPGT--VLCLLISLHAVLVGAALLVPSVLQLRQA 228 
LivG         WLFGWGTASAGLFWAGHFLLFCAEAQEPVP--WLRLLMVVQGVLWAAAILLPVAVASAGA 234 
KanG         WIFGAGTALVGIYWCVALGRLIIGE-PPLR--NLSLLMSLHGFLRAAALLVPLWGSMRSQ 219 
HygG         RLFGAGAVCAGIYWVGRLAMALTPASLPGEGVALRLVIGLHAVLRGAALLVPLLGAARRA 236 
Cinorf14     RLFGIGTVLAELYWLRLFAGLFTTS----------------------------------- 172 
ParG         LLFGTGIALSAVLMALSLVHVLSRDATIPH--LFPAISGAEAAFMAAGAALPLLRRPWRT 237 
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NeoG         AGHARTVWRIWPLWRDLVEAVPHVALAGTRCRPLTLLRPQLPWRQLAYRKVIEVRDALLV 296 
RibG         AGHARTIWRIWPLWRDLVDAVPHVALSATRSRLLVLLHPHLSWRLIAYRKVIEIRDAILA 288 
LivG         VGHIGTVWRLWPLWRHLVDAAPHVALMKPRNRLLELLRPRHSWRLLGYRKVIETRDAILG 294 
KanG         PSQIRTLWVLWPLWRTLVQAVPHVALHRRRSRIVEVVWPRAPRRLAVYRRMIEIRDAILS 279 
HygG         AADARALWRLWPLWHDLVRASPQVVLDGYRSRCAELLTPPSHWRFLAYRKVIETRDALLV 296 
Cinorf14     -------------------------------------------------------DALLR 177 
ParG         ARDMAVMYRLHPLWRTLVRVTPDVTLTDPRSRAVDLLSAVRHSDLRLYRRAIEIRDGLLA 297  
 
 
 
NeoG         LSHYTDPAVSRAARAHVARWGIPAERADAHVTACVLRGARAARLAGADPDPAAEVLAADR 356 
RibG         LSHYTDPAVSRSARAHVARWGVPADRVEAHVTACALSRAHAAKFAGAEPDPAAEVLTTGQ 348 
LivG         LRGYADPTVPGLARRYTATAGLADGEADLVALACELSEARRAKLAGLPRRTAPDGWFGG- 353 
KanG         LHGYVHPALPGAVKSRVEQLGLHGRSADAMTLACLLHVALRARRTGAAKDFDAS-LSHGW 338 
HygG         LRDRAGPAALDCTQRRPADP---LGSEEAVEPACLFGGG-CAQQPRSAPPAAPGAGPMGD 352 
Cinorf14     Y----------------------------------------------------------- 178 
ParG         LEDYSPEGTLARAREHVRAARVADASVEAAVTGCWASAAVANKRSGAATSGRPSGLPQS- 356 
 
 
 
NeoG         EACGLAAETAVLLRLTEAYLSPCARAFDP--AGTSGTGPAGDAGRTGSAGAPPPRTRMSE 414 
RibG         EAGDLAAETAFLLRLTEAYLSPCVRDFDT--AAAPAHATAGGDR---------------- 390 
LivG         DSRDLDDETAFLLRLSRAYHSPHVREFHLYMAVQDAAGHAAQDG----TGRPPTRSAS-- 407 
KanG         DSVNISGEESFLLELARAFRTPVARSLAGQLGGRTGGLTEVGDG---------------- 382 
HygG         GGTAVTAEVAFLHHAS--HHCPALRLFRSDAGPGEDGSRRTA------------------ 392 
Cinorf14      ------------------------------------------------------------ 
ParG         GGGDMAEELDFLLQLARFFRSPLAASFLSAEEQRHRAAPTGQAS---------------- 400 
 
 
NeoG         TPTGPDERRGTASPPLP 431 
RibG         ----------------- 
LivG         ----------------- 
KanG         ----------------- 
HygG         ----------------- 
Cinorf14     ----------------- 
ParG         ----------------- 
 
 
 
Fig. A.13 Alignment of NeoG homologous. Alignment was performed using Clustal W program (cf. 
Sect. 2.26). The Cinorf14 protein was incomplete. The numbers indicate the position within the 
corresponding proteins 
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Fig. A.14 Structural comparison of gentamicin C1, kanamycin B and fortimicin A with regard to 
their biosynthetic origin and evolution of a hybrid pathway.  
 indicates similar biosynthetic origin between gentamicin C1 and fortimicin A  
 indicates similar biosynthetic origin between gentamicin C1 and kanamycin B 
 indicates that gentamicin C1 biosynthesis could be originally derived from a merger of 
 fortimicin and kanamycin biosynthetic gene clusters. 
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